Measuring sociogenic, behavioral, and environmental impacts on circadian and rest-activity rhythms in healthy and pathological populations using actigraphy by Brooks, Chris
Boston University
OpenBU http://open.bu.edu
Theses & Dissertations Boston University Theses & Dissertations
2021
Measuring sociogenic, behavioral,
and environmental impacts on
circadian and rest-activity rhythms


















MEASURING SOCIOGENIC, BEHAVIORAL, AND ENVIRONMENTAL 
IMPACTS ON CIRCADIAN AND REST-ACTIVITY RHYTHMS IN HEALTHY 
















Submitted in partial fulfillment of the 
 
requirements for the degree of 
 








































© 2021 by  
 CHRIS BROOKS 









First Reader   
 Kevin “Kip” Thomas, Ph.D., M.B.A. 





Second Reader   
 Tara L. Moore, Ph.D. 





Third Reader   
 Farzad Mortazavi, Ph.D. 









“With only a slight touch of levity one may say that rhythms are one of the few constants 
in the biological regime.” 
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ABSTRACT 
Few biological systems are as ubiquitous as the circadian rhythm, a distributed yet inter-
connected “system of systems” that coordinates the timing of physiological processes via 
a self-regulating, flexible network present at every level of biological organization, from 
cells to cities. Its functional role as the interface between time-dependent internal processes 
and external environmental cues exposes the circadian rhythm to disruption if these drift 
out of synchrony. This is especially common in industrialized human societies, where the 
abundance of resources – in combination with the fact that anthropogenic calendars have 
largely supplanted the sun as the primary determinant of our daily cycles of rest, activity, 
and sleep  – disrupts the circadian rhythm’s ability to synchronize biological processes with 
each other and the geophysical solar day. Humans are now beholden to two increasingly 
disconnected clocks, and the ever-accelerating curve of human progress suggests our bio-
logical and social times will only grow more disconnected. 
Longitudinal “out-of-clinic” monitoring is an ecologically valid alternative to well-
controlled laboratory studies that can provide insight into how human circadian and behav-
ioral rhythms exist in day-to-day life, and so has great potential to provide contextual data 
	
	 ix 
for translating chronobiological science into clinical intervention. However, methodologi-
cal diversity, inconsistent terminology, insufficient reporting, and the sheer number of po-
tential factors has slowed progress. Herein is presented scientific work focused on detect-
ing and quantifying some of these factors, particularly “sociogenic” determinants such as 
the seven-day week. Through rhythmometric analysis of longitudinal in-home actigraphy, 
weekly behavioral patterns were observed in both young adult males (n = 24, mean age = 
23.46 years) and older adults with Parkinson’s disease (n = 13 [7 male], mean age = 60.62 
years, mean Hoehn & Yahr Stage = 2.31) that evince a seven-day “circaseptan” rhythm of 
circadian and sleep disruption. This is hypothesized to be dependent upon the seven-day 
calendar week, particularly the regular and abrupt shifts in timing between work and rest 
days. These perturbations vary by chronotype in young adults, and by disease severity in 
Parkinson’s disease. Collectively, these results contribute to the growing evidence that our 
daily rhythms are shaped by sociogenic factors in addition to well-documented environ-
mental and biological mechanisms. Moreover, the study of these subtle infradian patterns 
presents serious – yet surmountable – methodological challenges that must be overcome in 
order to accurately monitor, quantify, analyze, report, and apply findings from observa-





There is so much to see in this world, so much to learn and study, to interpret and com-
municate, to build and protect. No single lifetime is enough to do it all; the best one can 
do is experience as much as possible, and this is what led me to the study of rhythms. Os-
cillatory patterns are ubiquitous in nature, from the vibrations of an atomic nucleus to the 
life cycle of a star. Rhythms are a function of information and time; they are emergent 
patterns from natural systems that give insight into their organization; they are a common 
language for mapping the imperceptible connections between seemingly unrelated phe-
nomena; and yet they are also mundane and familiar, underpinning nearly every aspect of 
our lives, and so common and fundamental that rarely do we consciously acknowledge 
their existence. We move through invisible cycles, guided by natural forces we are only 
just beginning to understand, and we must be thorough in our examination because we do 
not know what we do not know. As we continue to push the limits of our technology and 
expand the scope of our perspective, we must acknowledge how far we’ve come and how 
far we have left to go. Humanity’s fate lies starside, and we as a species have only just 
begun to appreciate the magnitude and implications of this blunt reality. It is my earnest 
hope that our work on biological rhythms may contribute to our species’ ability to safely 
explore, study, and colonize extraterrestrial space. Through a better understanding the 
material nature of our biological rhythms, their organization and origins, their role in 
health and disease, and the major factors that influence them, I hope to deepen our 
knowledge of ourselves and our environment so that we may apply it to our imperative 
goals of exploring, studying, and ultimately understanding our place in the universe.  
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CHAPTER ONE: BACKGROUND 
Introduction 
Amongst the fundamental emergent properties of our universe is rhythmicity, or the ten-
dency for some thing to regularly and repeatedly alternate between multiple states. Rhyth-
micity is agnostic to field and scale, and has been observed at every level of nature, from 
the infinitesimal fluctuations in an atom’s potential energy, to the revolution of our planet 
and its orbit around the Sun, to the stellar life cycle that produced the “starstuff” currently 
reading this manuscript. Biological systems - at all scales, both spatially and temporally - 
exhibit rhythmicity, including cellular division, neuronal firing, temperature homeostasis, 
social behavior, prey-predator population dynamics, and the life cycle itself. Many of these 
are emergent from interactions between more fundamental factors such as chemical diffu-
sion and electrical conductance; they therefor contain information about the system they 
arose from, information which can inform and optimize other biological systems that in-
teract with the rhythmic process. For example, the metabolic enzyme phosphofructokinase 
(PFK) is inhibited by the Adenosine Tri-Phosphate (ATP) it produces, which creates a 
rhythmic negative feedback loop that inhibits ATP production when it is abundant within 
the cell and increases when ATP is scarce; this helps maintain cellular energy homeostasis 
and conveys information (through the concentration of ATP) about the cell’s energy avail-
ability to other cellular systems (e.g. deoxyribonucleic acid [DNA] replication)1 (Fall, 
2002). 
	





Fascinatingly, the process of natural selection has led to the evolution of centralized 
systems that sustain, amplify, adapt, and coordinate these emergent biological rhythms to 
exploit their latent information and synergistically maximize their efficiency in response 
to cues from endogenous (i.e. biological) and exogenous (i.e. environmental) cycles. Col-
lectively, these biological rhythms serve to synchronize an organism’s physiology to itself 
and its habitat to maintain homeostasis, regulate its behavior (e.g. eating and sleeping), and 
optimize its ability to exploit its environment. Disruption of these rhythmic regulators 
therefore reduces overall fitness through the accumulation of myriad minor inefficiencies, 
analogous to how accelerating a spacecraft before it reaches periapsis will use more fuel 
than if it accelerated at periapsis itself. Biologically, this means the disrupted organism will 
have to expend more energy to maintain certain rhythmic processes (e.g. thermoregulation) 
to overcome sub-optimal internal and external environments. For example, human body 
temperature and therefore muscular contraction velocity (Bell & Ferguson, 2009) are at 
their lowest point in the early morning when physical movement is least needed due to 
sleep; physical movement during this time will less efficiently convert stored energy into 
biomechanical force, reducing fitness. In humans, pathological and environmental factors 
(e.g. Parkinson’s disease [PD] and jet lag, respectively) interfere with biological rhythms, 
leading to negative outcomes such as fatigue, sleep disruption, and misalignment of bio-
logical rhythms. 
This chapter will discuss how biological rhythms emerge from and are maintained 




and pathological biological systems, how these biological rhythms are quantified and mod-
elled, and the causes and consequences of their disruption - particularly in the uniquely 
human context of technologically advanced societies that no longer depend on biological 
or astronomical rhythms to organize themselves. 
 
The Circadian Rhythm 
Amongst the biological rhythms, the most well known and most intensely studied is the 
circadian rhythm. While any rhythm with a period of 24 hours may be accurately called a 
circadian (circa- “about”, -dian  “day”) rhythm, the term “circadian rhythm” usually refers 
to the systemic, self-sustaining, and entrainable oscillation of biological processes - and 
their myriad controllers and drivers - observed in virtually all eukaryotic life on Earth (M. 
Bailey & Silver, 2014)2. For example, the daily oscillation in human core body tempera-
ture, our daily cycle of restful sleep and active wakefulness, the excretion of hormones 
such as cortisol at regular daily intervals, and the neuropsychological phenomenon of 
“sleep pressure” are all facets of our circadian rhythm. In other words, the circadian rhythm 
is a “system of systems”, a distributed yet coordinated network of independent biological 
rhythms that collectively harmonize vital functions at all levels of organization, from cel-
lular to behavioral. 
	





Functionally, this prepares an organism for certain expected events and/or behav-
ioral states, such as eating, physical activity, or sleeping. For example, the contraction ve-
locity of a muscle is partially dependent on its temperature (Bell & Ferguson, 2009); in 
humans, body temperature oscillates by approximately half a degree Fahrenheit across a 
24-hour day (Harding et al., 2019), reaching its nadir in the early morning, when humans 
are usually asleep and sedentary, and peaking in the early evening when we are most likely 
to be active and most in need of optimal muscle contraction time. Similarly, melatonin - a 
hormone involved in sleep regulation, especially sleep induction - increases in concentra-
tion several hours before an individual’s normal bed-time (Vetter, 2018). In these and other 
ways, the circadian rhythm enables an organism to anticipate and prepare for expected 




An organism’s ability to exploit their environment has been the central driver of the evo-
lution of life on Earth. In order to reproduce, life requires energy and raw material; extract-
ing more energy and resources from their surroundings therefore improves the odds that a 
given organism will survive, reproduce, and pass on its genetic information. As life grew 
increasingly complex and diverse, random mutations enabled new ways of exploiting the 
environment. For example, the evolution of photosynthesis - the transformation of solar 
radiation into storable chemical energy - allowed access to a vast source of untapped en-




an immense evolutionary advantage, and photosynthesis now represents the single largest 
source of biological energy in Earth’s biosphere. Of course, the sun is not a permanent 
fixture in the sky. Due to Earth’s rotation, photosynthetic organisms were only exposed to 
sunlight during certain times of day. Moreover, the relative stability of Earths rotation 3 
meant that daylight availability was periodic - i.e. occurred at consistent, regular intervals 
- and thus represented a natural and consistent clock. 
The consistency of the geophysical light-dark cycle made sunlight a potent zeit-
geber (German: “time giver”) - a temporal reference point for biological rhythms (Daan & 
Gwinner, 1998). Biological systems sensitive to this cue (through photosynthesis, temper-
ature change, radiation sensitivity, vision, etc.) now had access to temporal information 
about the current state of their environment and were subsequently subjected to tremendous 
evolutionary pressure. This is because organisms that can accurately monitor the current 
time have an innate advantage over their temporally agnostic peers, as it allows them to 
anticipate future conditions (e.g. cyanobacteria and sunlight) and apply this information to 
proactively optimize themselves for those conditions. In doing so they increase their ability 
to exploit their environment compared to those organisms which can only react to changes 
in the environment. The evolution of more efficient photosynthetic proteins and larger pho-
tosynthetic substrates would help to capture more energy, but “learning”  only needed to 
	
3 The Earth constantly experiences minute variations in rotational period due to terrestrial and as-
tronomical cycles. Overall, the rotational period is thought to be gradually slowing across geolog-
ical timescales due to tidal forces; e.g. a recent study estimated that the Earths rotational period was 
~5.5 hours shorter 1.4 billion years ago (Meyers & Malinverno, 2018). It is assumed that these 
gradual changes are imperceptible to biological systems day-to-day (and thus don’t interfere with 




expend energy on photosynthesis or mitigating heat shock during part of the day allowed 
organisms to conserve energy, energy which could then be spent on resource gathering, 
reproduction, etc. This evolutionary pressure is likely the source of the circadian rhythm 
(Bhadra et al., 2017). 
To continue using the example of photosynthesizers (e.g. cyanobacteria), this tem-
poral information would manifest as a periodic fluctuation in energy production directly 
tied to Earth’s rotation - a circadian rhythm. Downstream biochemical processes dependent 
on energy production would likewise exhibit this circadian rhythm. For example, nitrogen 
fixation is essential to cyanobacteria, but the oxygen byproduct of photosynthesis directly 
inhibits nitrogen fixation. Since cyanobacteria are unicellular prokaryoates, they cannot 
spatially sequester these reactions as eukaryotes do via membrane-bound organelles such 
as mitochondria (or as heterocystous filamentary cyanobacteria do via specialized nitro-
gen-fixing cells). Instead, ancient cyanobacteria developed the means to sequester these 
incompatible biochemical reactions temporally: photosynthesis occurs during the day 
when sunlight is available, and nitrogen fixation occurs at night once photosynthetic by-
products are cleared (Bhadra et al., 2017). 
 
A System of Systems 
The biological substrates of circadian rhythms found in cyanobacteria and those found in 
complex life (e.g. mammals) are vastly different in their scale and complexity, yet exhibit 




period across a range of temperatures, sensitivity to and ability to be entrained by endoge-
nous temporal cues (i.e. zeitgebers, especially sunlight), and the ability to independently 
maintain circadian rhythmicity in the absence of said zeitgebers (Brown et al., 2019). 
The circadian rhythm in cyanobacteria is maintained by a Post-Translational Oscil-
lator (PTO) (S. E. Cohen & Golden, 2015), a stereotyped sequence of protein phosphory-
lation and dephosphorylation events that gate access to physiological signaling pathways 
by selectively binding signaling molecules dependent on the current phosphorylation state. 
The phosphorylation-dephosphorylation cycle takes ~24 hours to complete across a wide 
range of temperatures, and can be “reset” (i.e. entrained) by the presence of byproducts of 
photosynthetic redox reactions. DNA replication, chromosome configuration, and many 
other critical cellular processes are downstream from – and so regulated by – the PTO. In 
summary, the prokaryotic PTO exhibits all three circadian properties: it continuously and 
autonomously undergoes an about daily phosphorylation cycle resistant to temperature-
dependent changes in reaction velocity, which can be modified by temporal cues from the 
environment, and which persists in their absence. 
Note that the PTO is not just a central clock that can synchronize to its environment; 
while the PTO itself can be defined by a relatively small number of proteins and their 
phosphorylation events, it is more accurately described in the context of the cellular milieu. 
To wit, the PTO lies at the physiological nexus of a distributed network of cellular systems 
and pathways, where the flow of temporal information, its biochemical computation, and 
its translation into physiological application is a continuous dynamic process orchestrated 




systems, the PTO enables the organism to flexibly integrate environmental and physiolog-
ical information to temporally coordinate and optimize biological processes downstream 
of the PTO. Much like how the development of standardized clocks allowed the nascent 
transcontinental railroad network to efficiently coordinate its widely distributed arrivals 
and departures, or how a conductor synchronizes the individual musicians in an orchestra 
to create cohesive music, the PTO enables the cell’s distributed systems to communicate 
temporal information and coordinate systemic physiological processes like photosynthesis 
and nitrogen fixation to create a “system of systems” greater than the sum of its part 
(Bhadra et al., 2017; S. E. Cohen & Golden, 2015). 
Unlike cyanobacteria, eukaryotic circadian oscillators involve transcriptional and 
translational processes - respectively, the production of Ribonucleic Acid (RNA) from 
DNA and the production of proteins from RNA. Although there are many notable differ-
ences between the cyanobacterial PTO and the eukaryotic Translational-Transcriptional 
Feedback Loop (TTFL), the basic premise of both systems is strikingly similar - a stereo-
typed series of proteomic events whose current state gates access to downstream cellular 
signaling pathways that control critical biological processes (Buhr & Takahashi, 2013; 
Dibner et al., 2010; M. H. Hastings et al., 2014). Like the PTO, the TTFL is a proteomic 
pacemaker that coordinates a distributed system of systems facilitating the maintenance 
and dissemination of temporal information to physiological systems. In mammals, cellular 
TTFLs are found in every nucleated cell4 and represent the finest, smallest “tier” of the 
	
4 Erythrocytes exhibit molecular, rather than genetic, feedback loops that resemble cyanobacterial 




circadian rhythm’s distributed network. While TTFLs coordinate biological processes at 
the cellular level, the cells themselves are synchronized at the tissue level and share tissue-
specific modifications to their TTFL and its downstream pathways tailored to the specific 
physiological systems they support (Michael H. Hastings et al., 2003). This is accom-
plished through the TTFL-dependent expression of Clock Controlled Genes (CCGs) and 
their downstream pathways; expression of CCGs varies by tissue and is selectively up- or 
down-regulated during specific points in the TTFL (i.e. time of day).   
Collectively, these “peripheral oscillators” - and their constituent cellular TTFL’s - 
are synchronized to each other and the environment through endocrine, neurological, 
and/or metabolic cues that ultimately stem from the Suprachiasmatic Nucleus (SCN), the 
“central oscillator” or “central pacemaker” of the mammalian circadian rhythm that re-
ceives mono-synaptic photic input via the Retinohypothalamic Tract (RHT). Although pe-
ripheral oscillators are incapable of detecting photic cues from their environment5, and thus 
are reliant on the SCN for this information, many are capable of reacting and synchronizing 
to physiological cues, such as food intake or body temperature (Michael H. Hastings et al., 
2003; Heyde & Oster, 2019). In addition, peripheral oscillators reinforce their mutual syn-
chrony via interactions between their physiological processes; e.g. the diurnal cycle in 
blood pressure emerges from the interaction between vasodilation/vasoconstriction and 
heart rate, which are independently regulated (in part) by TTFL-controlled CCG’s in vas-
cular and cardiac tissue TTFL’s, respectively (Michael H. Hastings et al., 2003). These 
	
5 Peripheral oscillators in “lower” species such as Drosophila melanogaster are light-sensitive, but 




emergent systemic rhythms provide yet another tier in the circadian hierarchy that can be 
fine-tuned by top-down regulators like the SCN, or bottom-up via local physiological sig-
nals. This is analogous to how an individual (i.e. cells) may set their clock to the time 
shown on their local news station (i.e. tissues and organs), who in turn set that time based 
on the United States’ National Institute of Standards and Technology’s atomic clock (i.e. 
SCN), which measures time by observing the natural resonance of cesium atoms (i.e. sun-
light).  
This model of circadian organization can be likened to an orchestra: each individual 
musician plays off the same sheet music, yet they struggle to play in harmony when they 
only have themselves (and perhaps their neighbors) to synchronize with. The individual 
can keep their own rhythm and play their assigned notes, but without a central timekeeper 
the orchestra as a whole will rapidly drift out of sync as the growing discordance interferes 
with the ability to hear and align with the other musicians. Eventually the intended music 
will be indiscernible from random noise. This is why the conductor is so essential to the 
orchestra: they provide a rhythmic reference point each musician can see and synchronize 
to, and from their harmony emerges music6. Where each musician is an individual compo-
nent in the larger system of the orchestra, each peripheral oscillator is likewise an individ-
ual constituent of an organism’s circadian rhythm; and while a single musician can main-
tain a rhythm and make music (i.e. PTO in cyanobacteria), an orchestra composed of many 
	
6 It’s not a coincidence that both the circadian rhythm and music benefit from synchrony. Destruc-
tive and constructive interference are natural properties of all rhythmic processes: misalignment 




different individuals (i.e. cellular TTFL’s) with unique functions and instruments (i.e. tis-
sue-specific CCG’s) require a central conductor (i.e. SCN) to achieve harmony and create 
music (i.e. maintain optimal homeostasis).  
In summary, the circadian rhythm is a distributed system of systems, a network of 
interconnected rhythms (ranging in scale from cellular to systemic, and from central to 
peripheral) that individually regulate biological processes within their respective domains, 
reinforce each other through harmonious physiological processes, and which are collec-
tively coordinated at the organismal level by a central pacemaker synchronized with the 
environmental day-night cycle (top-down regulation) while retaining some degree of self-
sustaining autonomy and sensitivity to local physiological signals (bottom-up regulation). 
The circadian rhythm is an emergent property of the self-optimization of our biological 
processes, the product of an integrated, dynamic, adaptable, centrally coordinated, and pe-
ripherally distributed system of systems. 
 
Circadian Anatomy in Mammals 
The SCN is the central oscillator – often colloquially referred to as the “central pacemaker” 
or “master clock” - of the mammalian circadian rhythm. The SCN receives direct photic 
inputs from photosensitive retinal ganglion cells via the RHT and physiological infor-
mation from the Median Raphe Nucleus (MRN) and Intergeniculate Leaflet (IGL) of the 
thalamus, integrates these signals to maintain an autonomous and intrinsic physiological 
oscillation at a constant phase relative to the day-night cycle, and distributes this infor-




and indirect projections (Dibner et al., 2010; Lawrence P Morin, 1999; Lawrence P. Morin, 
2013; D. K. Welsh et al., 2010).  
As its name implies, the SCN is located immediately superior to the optic chiasm - 
the merging and decussation (crossing the midline) of optic fibers as they course caudally 
from the retina - and consists of two symmetrical nuclei that flank the third ventricle in the 
inferior hypothalamus. The SCN is relatively small, with each nucleus containing ~8,000 
- 10,000 neurons in mice, ~20,000 in rats, and ~50,000 in humans (M. Bailey & Silver, 
2014). It is conspicuously cell-dense compared to the adjacent diffuse grey matter of the 
anterior hypothalamus, and is readily visualized with a Nissl stain; due to its paucity of 
internal and crossing axonal fibers, it is also easily visualized with Golgi impregnation or 
a myelin stain (Van den Pol, 1980). Its gross shape is roughly oblong or “tear shaped”, with 
a swollen ventral portion and a tapering dorsal tail (Lawrence P. Morin, 2013). As with 
many aspects of the SCN, this varies by species; for example, rats have a more oblate SCN. 
The SCN has been organized according to neurochemical, functional, and anatom-
ical criteria. Two main sub-divisions are generally recognized: a compact ventrolateral 
core that is encapsulated within a somewhat diffuse dorsomedial shell (M. Bailey & Silver, 
2014; M. H. Hastings et al., 2014; Lawrence P. Morin, 2013). Additional and/or different 
sub-divisions have been identified in species with uniquely specialized circadian systems, 
such as desert-dwelling mammals. For example, the camel SCN is unusually large and 
differentiated7, and has been divided into three partitions along the rostral-caudal axis 
based on immunohistochemical analysis (El Allali et al., 2017). In addition to differences 
	




in cell density, these regions are distinguishable by their distinct neurochemical makeups: 
the core contains neurons that express Vasoactive Intestinal Peptide (VIP) and/or Gastrin 
Releasing Peptide (GRP), where-as shell neurons express Arginine Vasopressin (AVP) 
(Dibner et al., 2010). The SCN is rich in inhibitory Gamma Aminobutyric Acid (GABA), 
and the core and shell are commonly visualized through the colocalization of GABA and 
VIP/GRP or GABA and AVP, respectively; calbindin is also a popular alternative, as it is 
found only in part of the core (Lawrence P. Morin, 2013). This neurochemically defined 
model has been supported by observed differences in the physiology – shell neurons pos-
sess robust diurnal rhythms in their spontaneous firing rate and PER gene expression, 
where-as core neurons have weak rhythms easily reset by light (Jobst & Allen, 2002) – and 
through study of afferent/efferent projections of the core and shell, most notably the obser-
vation that RHT neurons synapse almost exclusively on core neurons (El Allali et al., 2017; 
Lawrence P. Morin, 2013). Functionally, the retinorecipient cells (i.e. those which receive 
direct projections from retinal ganglion cells) in the core are capable of resetting the phase 
of neuronal oscillations in the shell through VIP-mediated paracrine signaling, which con-
veys temporal information to other regions through direct and indirect projections 
(Kriegsfeld et al., 2004); in other words, the shell is the “clock” that encodes time, and the 
Core is the “synchronizer” that keeps it in phase with the environment. 
The SCN receives diverse inputs from numerous brain regions: ~35 brain regions 
directly (monosynaptically) innervate the SCN, and this number increases to 85 if indirect 




widely innervated, the bulk of its afferents are found in three major pathways: photic stim-
ulus from the retina via the RHT, thalamic input from the IGL, and serotonergic innervation 
from the MRN. These inputs convey circadian information from both the environment 
(photic RHT) and the body (non-photic IGL and MRN) capable of influencing SCN’s la-
tent circadian oscillation, effectively creating a central “master clock” sensitive to both 
endogenous and exogenous zeitgebers (Dibner et al., 2010). Mapping the terminal fields 
of these pathways has been a major objective of neuroanatomical research on the SCN 
(Lawrence P. Morin, 2013).  
Photic input from the retina via the RHT forms the largest and most influential 
afferent to the SCN, as evinced by its large terminal field in the SCN core and the sensitiv-
ity of the SCN’s latent oscillation to environmental light (Lawrence P. Morin, 2013). RHT 
afferents consist of melanopsin-positive intrinsically photosensitive Retinal Ganglion Cells 
(ipRGC) that directly synapse on VIP+ retinorecipient cells in the SCN core (Dibner et al., 
2010). Although the RHT is the dominant photic input in virtually all mammals, the extent 
and concentration of retinorecipient cells varies between species (Karatsoreos, 2004). For 
example, interspecies differences in RHT terminal fields have been identified in the ven-
trolateral SCN in both hamsters (Johnson et al., 1988) and mice (Abrahamson & Moore, 
2001), with the latter being significantly more dense and containing additional sparse dor-
somedial RHT inputs, where-as retinorecipient cells are found only in the ventral SCN in 
the rat (R. Y. Moore, 1996). ipRGC’s project to at least 30 other brain regions in addition 
to the SCN (Lawrence P. Morin, 2013), including adjacent hypothalamic structures that are 




(Dibner et al., 2010; Kriegsfeld et al., 2004; Major et al., 2003). Interestingly, individual 
ipRGC axons have been observed to bifurcate and project to both SCNs, or to one SCN 
and either the IGL, Olivary Pretectal nucleus (OPT), the superior colliculus, or the contra-
lateral SCN (L.P. Morin et al., 2006). 
Fibers characterized by the presence of Neuropeptide Y (NPY) and GABA project 
from the IGL to the SCN via the Geniculohypothalamic Tract (GHT) (Dibner et al., 2010). 
These NPY+ cells synapse on retinorecipient neurons in the SCN core, and are particularly 
dense in rodents (Abrahamson & Moore, 2001) and dromedaries (El Allali et al., 2017). 
The IGL is bilaterally connected with over a hundred brain regions in addition to the retina 
and SCN (Lawrence P. Morin, 2013), and is believed to be an important source of inte-
grated multimodal circadian information for the SCN in non-primate mammals (L.P. Morin 
& Allen, 2006). The Pregeniculate Nucleus (PGN) is believed to be the functional analog 
of the IGL in primates as it contains NPY+ positive cells that receive overlapping photic 
and serotonergic projections from the retina and Dorsal Raphe Nucleus (DRN), respec-
tively. Moreover, their concentration and volume vary between nocturnal and diurnal pri-
mates, which would be expected of a multimodal circadian integration system (Pinato et 
al., 2009). However, there is no primate homologue of the GHT, and NPY+ fibers are 
scarce and diffuse in the human, indicating an altered functional role of the PGN in circa-
dian processing in primates (Lima et al., 2012). 
The SCN receives strong serotonergic input from the MRN and, to a lesser extent, 




rodents, serotonergic fibers synapse on ventromedial neurons in the SCN, partially over-
lapping with the core’s VIP+ RHT terminal fields (Lawrence P. Morin, 2013). Much like 
the IGL, serotonergic projections from the MRN and DRN are believed to convey inte-
grated photic and non-photic information. For example, desert-dwelling mammals such as 
the camel (El Allali et al., 2017) and jerboa (Lakhdar-Ghazal et al., 1995), possess a re-
markably large and dense serotonergic projection to the dorsomedial SCN. This implies 
that the MRN feeds the SCN extensive integrated information – primarily non-photic – to 
fine-tune the circadian rhythm and maintain tight synchrony between their peripheral os-
cillators and their harsh and dynamic environment. 
The SCN’s extrinsic efferents consist predominantly of short-distance monosynap-
tic hypothalamic projections, especially to Paraventricular Nucleus (PVN), Preoptic Area 
(POA), IGL, and sPVZ (Kriegsfeld et al., 2004), which in turn project to numerous auto-
nomic and endocrine neural controllers (Lawrence P. Morin, 2013). This hierarchal net-
work processes and distributes the temporal information encoded in the SCN throughout 
the nervous and endocrine systems, enabling the SCN to synchronize hundreds of physio-
logical processes with distinct phases (e.g. melatonin secretion and body temperature) 
through a relatively small number of projections (Dibner et al., 2010). Anatomical studies 
have provided the evidence showing that these hypothalamic projections are essential for 
circadian function, as their destruction – either through direct transection or the ablation of 
intermediate nuclei (e.g. the PVN) – suppresses diurnal rhythms such as melatonin con-
centration and abolishes the regular period of sleep-wake cycle (Abrahamson & Moore, 




ergic fibers to the melatonin-producing pineal gland; it is through this pathway that envi-
ronmental light inhibits the production of melatonin, a critical component of normal circa-
dian behavior (Dibner et al., 2010; Kriegsfeld et al., 2004). In total, the SCN monosynap-
tically projects to ~15 distinct brain regions (Lawrence P. Morin, 2013).  
Lastly, the SCN contains extensive intrinsic efferents, both to the contralateral nu-
cleus and ipsilaterally between the core and shell of a single nucleus (Lawrence P. Morin, 
2013). The majority of intrinsic efferents project from the core to the ipsilateral and, to a 
lesser extent, the contralateral shell, with sparse shell-to-core reciprocal connections. Alt-
hough the function of the contralateral projections are poorly understood, core efferents to 
the ipsilateral shell are believed to supplement the photic information conveyed through 
VIP-mediated paracrine signaling (Hamnett et al., 2019; Kriegsfeld et al., 2004). 
 
Circadian Physiology in Mammals 
The SCN regulates our circadian rhythm through three distinct components: (1) intrinsic 
oscillators in the SCN shell that autonomously maintain a 24-hour rhythm, (2) photic stim-
uli via the RHT capable of synchronizing the phase of shell oscillations to the environment 
via the core, and (3) numerous direct and indirect projections that convey temporal infor-
mation to central neurological controllers (M. Bailey & Silver, 2014; Dibner et al., 2010). 
Synchrony between SCN neurons and sub-divisions is maintained through VIP-
mediated paracrine signaling (Buhr & Takahashi, 2013; Hamnett et al., 2019). This pro-




TTFLs to environmental light and consequently ensures the SCN as a whole is synchro-
nized to a common phase (Hamnett et al., 2019; D. K. Welsh et al., 2010). VIP is released 
by SCN retinorecipient cells (primarily in SCN’s core) in response to photic stimuli via the 
RHT. The released VIP then binds to adjacent, non-retinorecipient cells in the SCN’s shell 
containing VIP Receptor 2 (VPAC2). This triggers a molecular cascade that induces mem-
brane depolarization and increased intracellular calcium retention, priming the cell for ac-
tivity; note that the highest spontaneous SCN activity is generally observed during the day, 
when photic input is strongest (M. H. Hastings et al., 2014). This paracrine cascade also 
directly upregulates the expression of period (PER) and cryptochrome (CRY), two genes 
at the center of the TTFL, effectively resetting the neurons “clock” and synchronizing the 
VPAC2 neuron’s TTFL to environmental light (D. K. Welsh et al., 2010). Note that shell 
neurons are not perfectly in sync; paracrine signaling and is restricted by diffusion and 
distance, so VPAC2 neurons exhibit staggered TTFLs that are spatiotemporally encoded 
based on their distance from the retinorecipient core, a wave of phasic synchronization that 
spreads across the SCN (Hamnett et al., 2019). 
The TTFL is ubiquitous in mammalian nucleated cells, and is the fundamental 
driver of both the central pacemaker (i.e. the SCN) and the peripheral oscillators (Dibner 
et al., 2010; M. H. Hastings et al., 2014). Although there are tissue- and species-specific 
exceptions, the generic mammalian TTFL consists of two protein heterodimers: the 
CLOCK/BMAL1 heterodimer consisting of Circadian Locomotor Output Cycles Kaput 
(CLOCK) and Brain and Muscle Aryl hydrocarbon Receptor Nuclear Translocator-Like 




1/2/3 (PER1/PER2/PER3) and Cryptochrome 1/2 (CRY1/CRY2) proteins (Buhr & 
Takahashi, 2013; Dibner et al., 2010; M. H. Hastings et al., 2014). Both heterodimers are 
transcriptional regulators that together form a continuous feedback loop: CLOCK/BMAL1 
increases expression of PER, CRY, and numerous CCGs, and PER/CRY inhibit 
CLOCK/BMAL1 transcriptional activity. Numerous cellular and metabolic functions are 
closely tied to the TTFL via CCGs that are up-regulated by CLOCK/BMAL1. As their 
expression is dependent on the central TTFL oscillator, CCGs enable the propagation of 
temporal information to downstream processes and, ultimately, the synchronization of 
physiological functions (e.g. cell division, protein expression) to optimize efficiency (Ko-
renčič et al., 2015).  
The same basic molecular machinery used by SCN is also found throughout the 
various peripheral oscillators, although the exact protein composition of the cellular TTFLs 
and the specific CCGs they activate varies widely between tissues according to their func-
tional role and physiology; on average,  ~10% of the transcriptome in a given tissue is 
under circadian regulation via TTFL/CCG (Michael H. Hastings et al., 2003). While pe-
ripheral TTFLs are usually out of phase with the SCN by ~4-8 hours, their timings relative 
to each other are maintained and stabilized by temporal information via intermediate neu-
rological (e.g. PVN), endocrine (e.g. pineal gland and melatonin), and homeostatic (e.g. 
hypothalamic control of body temperature) relays that receive mono- and multi-synaptic 
SCN efferents. Once thought to be functionally dependent on the SCN, peripheral oscilla-
tors have since been shown to be self-sustaining (Yoo et al., 2004), resilient to large dif-




et al., 2004). Note that while peripheral TTFLs can sustain themselves in SCN-lesioned 
animals for several weeks, their individual phases will gradually desynchronize from each 
other (Guo et al., 2006). This suggests that the SCN is required to maintain phase coherence 
within a tissue (Dibner et al., 2010), analogous to a conductor maintaining harmony in an 
orchestra. 
In addition to direct (e.g. hormone secretion) and intermediate (e.g. RAR and body 
temperature) pathways, the SCN entrains the billions of autonomous cellular TTFLs indi-
rect pathways as well. Consider food intake, which prompts numerous physiological and 
homeostatic changes through the production of metabolites (e.g. glucose), secretion of hor-
mones (e.g. leptin), and alteration of cellular metabolism (e.g. redox ratio) to prepare the 
body for digestion (Dibner et al., 2010). The SCN indirectly entrains food-seeking behavior 
by restricting the times when animals are mobile and able to feed, which is determined by 
their circadian rest-activity rhythms (RAR) - the daily cycle of waking activity and som-
nolescent torpor, itself reinforced by the circadian fluctuation in body temperature and cel-
lular metabolism. However, this can lead to peripheral TTFLs receiving conflicting tem-
poral information. As shown by artificial disruptions of the phase of RAR, temperature, 
sleep, and other “indirect pathways”, these are capable of decoupling peripheral oscillators 
from the SCN; e.g. limiting feeding opportunities to the day in nocturnal animals - effec-
tively inverting their RAR by forcing them to seek food when they would normally be 
asleep - desynchronizes peripheral oscillators in cardiac, pancreatic, hepatic, and renal tis-
sues from the SCN (Damiola, 2000; Stokkan, 2001). Although the liver primarily synchro-




biological rhythms like body temperature - this coupling can be overwritten by acute phys-
iological changes that occur outside their anticipated time; writ large, this property allows 
an organism to flexibly adapt to dynamic environments at the cost of short-term decohesion 
of its circadian rhythm and the subsequent stresses and inefficiencies. 
In light of these examples, the circadian rhythm may once again be appreciated as 
a distributed yet coordinated network of semi-autonomous systems who regulate and sta-
bilize each other via top-down and bottom-up integration of exogenous and endogenous 
zeitgebers in order to optimally adapt to their environmental and physiological conditions. 
 
Circadian Biomarkers and Assessment 
As a distributed system of systems, the circadian rhythm is detectable in some form or 
another in almost all biological measures. This includes the aforementioned diurnal fluc-
tuations in body temperature, cortisol, and melatonin, as well as hormonal regulators of 
appetite such as ghrelin and leptin (Challet, 2015; P. C. Smith & Mong, 2019), metabolic 
processes such as glucose uptake and insulin concentration (Panda, 2016), neurotransmit-
ters like dopamine (Poceta et al., 2009) and serotonin (Matheson et al., 2015), biological 
responses such as inflammation and the immune response (Bellet et al., 2013), homeostatic 
regulators such as heart rate (Morris et al., 2012) and cutaneous blood flow (Vaughn et al., 
2018), biochemical reactions such as mitochondrial respiration and gene expression (de 
Goede et al., 2018), and even anatomically as demonstrated by diurnal fluctuations in the 




fluctuation may be used as a measure of the circadian rhythm, melatonin and body temper-
ature have been the most popular due to their relative ease of measurement, robust ampli-
tude of oscillation, and their “centrality” to the circadian rhythm vis-à-vis the large role the 
SCN plays in their regulation (Benloucif et al., 2005). In addition to specific biomarkers 
and biological processes, an individual’s circadian rhythm may be assessed through their 
behavior; specifically, both the sleep-wake cycle and RARs exhibit a strong circadian pat-
tern (Ancoli-Israel et al., 2003; Pollak et al., 2001). In other words, humans regularly and 
periodically shift between gross behavioral states in synchrony with the solar day, a circa-
dian rhythm which can be measured through self-report (e.g. sleep diaries) and/or objective 
monitoring (e.g. wearable accelerometers). 
The circadian rhythm has been assessed in numerous models using a multitude of 
measures since antiquity (McClung, 2019). The first written record of a circadian process 
was made by Androsthenes, a 4th century Greek explorer who accompanied Alexander the 
Great, when he noted that certain tree leaves moved in a predictable pattern throughout the 
day (Androsthenes, n.d.; Bretzl, 1903, p. 412). Over 2,000 years after Androsthenes penned 
“The Navigation of the Indian sea”, French biologist Jean-Jacques d'Ortous de Mairan pro-
duced the first experimental evidence of an intrinsic circadian rhythm when he observed 
that the diurnal movement of plants continued even in complete darkness (de Mairan, 
1729). A century later, Swiss botanist Augustin Pyramus de Candolle showed that shifting 
the light-dark cycle subsequently shifted the daily rhythm of movement, the first evidence 




Throughout the mid-1900’s, German physician Jurgen Aschoff contributed to sev-
eral fundamental findings about human chronobiology, including the first description of 
circadian fluctuations in body temperature; he is also credited with coining zeitgeber to 
describe environmental cues capable of entraining the circadian rhythm (Daan & Gwinner, 
1998; Foster & Roenneberg, 2008). Together with Rütger Wever, Aschoff pioneered novel 
methods such as an isolation “bunker” for human subjects where zeitgebers could be rig-
orously controlled, an experimental paradigm that has since become fundamental to the 
field of chronobiology. 
Much of our understanding of circadian biology has been derived from in-labora-
tory experiments built upon the foundation of Wever’s and Aschoff’s methodology. This 
approach allows for careful experimental design and precise measurement with which sub-
tle effects may be detected and distinguished (Vetter, 2018). However, controlled labora-
tory settings cannot replicate the circadian rhythm’s in situ function for several reasons. 
Consider sleep studies, normally conducted in-clinic with polysomnography (PSG); clearly 
the unfamiliar technicians, myriad instruments attached to the subject, and the dramatically 
different clinical setting each have poorly understood effects on sleep biology (Roenneberg 
et al., 2015). Moreover, while controlled sleep studies have advanced our knowledge of 
sleep’s structure and neurological substrates, they have given relatively little insight into 
the functional interactions between an individual’s sleep and circadian rhythm, and their 
behavior and normal environment. Said another way, in-laboratory studies lack ecological 




limits their generalizability and therefore our ability to translate their findings into clinical 
and functional applications (Andrade, 2018; Roenneberg et al., 2015; Vetter, 2018). 
In contrast, field and observational studies – which monitor an individual’s “natu-
ral” behavior outside of the laboratory – offer ecologically valid data at the cost of reduced 
precision and control (Andrade, 2018; Bei et al., 2016; Vetter, 2018). By measuring the 
cumulative effect of the interactions between an individual’s biology, environment, and 
behavior through a systemic circadian marker (e.g. sleep timing), one can measure that 
individual’s authentic8 circadian rhythm as it exists in their day-to-day life. More practi-
cally, the reduced cost of out-of-laboratory methods allows for larger cohorts to be assessed 
over longer periods of time, but this also increases the variance of the sample. This is both 
a benefit and a drawback: while the data may be ecologically valid and clinically relevant, 
one cannot easily distinguish between the numerous effects that may have influenced the 
measured rhythm from each other, or from normal inter- and intra-individual variance. For 
example, Jane may have disrupted sleep, but is it attributable to a sleep disorder, a restless 
bed partner, binge drinking, a stressful work-week, or just an artifact of normal intra-indi-
vidual variance in the measurement? 
 
	
8 Observation bias and the white-coat effect undeniably exist even in observational and field stud-
ies, though the use of subject diaries, wearable sensors, and lengthy out-of-clinic recording periods 





Much like personality, there is considerable variability in the precise phase of an individ-
ual’s circadian rhythm relative to the light-dark cycle. One’s “circadian phenotype” is re-
ferred to as their chronotype, defined as “the individual phase of entrainment, i.e. the phase 
at which an individual synchronizes to the 24 hr day” (Roenneberg et al., 2012; Vetter, 
2018). More generally, chronotype refers to one’s preference for “morningness” or 
“eveningness”, embodied by the colloquial idioms “morning lark” and “night owl”9. 
Although chronotypes vary widely in humans, there are predictable population-
level trends related to age and sex; in general, women and older people are more likely to 
have a morningness chronotype. A cross-sectional analysis of self-reported chronotype 
showed that children tend toward morningness, then progress toward eveningness with in-
creasing age throughout adolescence and peaking at ~20 years old (19.5 for females, 21 for 
males), and thenceforth gradually shifting back toward morningness with increasing age 
(Foster & Roenneberg, 2008; Roenneberg, 2004). The sex difference in peak eveningness 
- specifically the 1-2 year delay in males - may explain why men are typically observed to 
have later chronotypes then women, especially in age-controlled studies. However this sex 
difference diminishes as age increases beyond the early 20’s and disappears (i.e. men and 
women’s average chronotype is the same) at ~52 years of age, which is also the typical age 
for menopause (Foster & Roenneberg, 2008). Beyond 52, interpretation becomes difficult 
	
9 “Robin” has been proposed as a moniker for intermediate chronotypes with neither a strong morn-




due to high variance in the data and the possibility of statistical confounders (i.e. survivor 
bias, limited sample size, unrelated age-dependent factors, etc.). 
 
Infradian Rhythms 
Although the circadian rhythm is by far the most well-known and documented, rhythms 
with longer and shorter periods have also been observed in biological systems. For exam-
ple, ~4-hour rhythms in dopamine concentration in the brain and in locomotor activity have 
been observed in mice (Blum et al., 2014), and the human menstrual cycle has a regular 
period of ~28 days. Rhythms with periods shorter than 20 hours or longer than 28 hours 
are referred to as ultradian and infradian rhythms, respectively (F. Halberg, 1960; Reinberg 
et al., 2017)10. This mirrors the nomenclature used for classifying wavelengths of electro-
magnetic radiation; i.e. ultraviolet light has a longer wavelength than visible light, and 
infrared light likewise has a shorter wavelength than visible light. 
Just as the circadian rhythm ultimately derives from the light-dark cycle caused by 
earth’s rotation, most infradian rhythms are likewise tied to periodic macroscopic changes 
in the environment attributable to the earth’s astronomical properties; i.e. seasons and 
years. A well-known example is hibernation, a behavioral state characterized by reduced 
metabolic demand, lowered body temperature, and decreased locomotor activity that typi-
cally occurs in the winter. Hibernation is induced through several endogenous circannual 
	
10 Rhythms with periods between 20 and 28 hours are considered circadian, as these represent the 




(circa- “about”, -annual “year”) rhythms, such as changes in sleep duration (with the max-
ima occurring in winter), thermogenesis, and vasoconstriction that persist even when envi-
ronmental conditions are kept constant (Frare et al., 2019; Walker et al., 1980). Hibernation 
is considered a systemic behavioral outcome that emerges from physiological circannual 
rhythms, analogous to how sleep is a systemic behavioral outcome produced by a conflu-
ence of physiological circadian rhythms. Interestingly, hibernation and sleep are both in-
duced through similar rhythmic physiological changes - decreased body temperature, vas-
oconstriction, and increased sensitivity of adenosine A1 receptors (Frare et al., 2019) – 
albeit on dramatically different temporal scales. 
Seasonal variations in behavior, physiology, and pathology have also been ob-
served in humans. Stothard and colleagues (2017) demonstrated that the length of the bio-
logical night - i.e. when melatonin secretion is elevated, usually co-occurring with sleep 
and night-time - adapts to seasonal differences in the light-dark cycle, growing longer in 
the winter as nights also grow longer. As light is the primary zeitgeber in humans, the 
presence of artificial lighting confounds and largely abolishes the circannual rhythm in 
melatonin secretion, instead inducing a relatively constant duration of biological night that 
resembles those observed in the natural summer photoperiod. Cortisol exhibits a strong 
circannual rhythm (Morgan et al., 2017), as does body temperature, although it’s been ar-
gued that the increases/decreases in temperature observed in the summer/winter (respec-
tively) are attributable to ambient temperature and fall within a constant homeostatic range 
(Harding et al., 2019). Behaviorally, human reproduction exhibited a profound circannual 




amplitude has since fallen to ~0-5% in modern industrialized populations (Foster & 
Roenneberg, 2008)11. Similar trends and their diminishment have been observed in other 
population-level statistics: seasonality is observed in the frequencies of births, deaths, and 
diseases, but the amplitude of these fluctuations is lower in more industrialized countries. 
While lunar cycles are essential for certain ecosystems (e.g. tidal zones), and although they 
have been fundamental in shaping human cultures and calendars, there is little evidence 
that lunar cycles directly influenced our biological evolution (Foster & Roenneberg, 2008). 
 
Circaseptan Rhythms 
Of special interest to this dissertation are circaseptan rhythms (circa- “about”, -septan 
“seven”), a class of infradian rhythms with a period of ~7 days (Franz Halberg et al., 1965; 
Levi & Halberg, 1982). The extent to which circaseptan rhythms arise from innate biolog-
ical processes, as opposed to emerging from non-biological circaseptan cycles such as the 
seven-day week, is a topic of much study and controversy. 
Unlike days (earth’s rotation), months (lunar cycle), and years (earth’s revolution), 
the week has no clear astronomical or geophysical correlate (Franz Halberg, 1984; Levi & 
Halberg, 1982; Reinberg et al., 2017). In other words, there is no apparent natural zeitgeber 
capable of entraining circaseptan rhythms à la the 24-hour light-dark cycle that entrains 
	
11 Unlike most animals who reproduce and rear offspring during specific periods of the year, hu-
mans reproduce year-round and care for their young for several years after birth; this precludes 
strong, centrally controlled circannual rhythms tied to reproduction, and thus human birth-rates are 
much more sensitive to exogenous changes in resource availability, temperature, and other envi-
ronmental circannual rhythms, as well as sociocultural factors like the summer migration of Inuit 
families resulting in more opportunities for intimacy (Condon’ & Scaglion, 1982), and historical 




circadian rhythms or the seasonal changes that entrain circannual rhythms. This naturally 
leads to the hypothesis that all circaseptan rhythms are artificial or emergent from interac-
tions between artificial constructs and biological processes. For example, the habit of sleep-
ing in on the weekend creates a circaseptan rhythm in the timing of sleep and activity that 
oscillates between later on the weekends and earlier during the work week (Beauvalet et 
al., 2017; Hulsegge et al., 2019; Vetter, 2018). 
Numerous endogenous circaseptan rhythms have nevertheless been documented in 
spite the lack of a natural circaseptan zeitgeber (Reinberg et al., 2017), including water 
uptake in pole bean (Phaseolus vulgaris) seeds (Spruyt et al., 1987), melatonin production 
in the pike fish (Esox lucius) SCN (Cornélissen et al., 1995), physical activity in the beach 
beetle (Chaerodes trachyscelides) (Meyer-Rochow & Brown, 1998), Immunoglobulin Y 
(IgY) antibody concentration in chicken (Gallus gallus domesticus) egg yolk (He et al., 
2014), and myriad physiological biomarkers in rodents: melatonin content of the pineal 
gland (Sánchez de la Peña et al., 1986), urinary sodium content while on high-sodium diets 
(Uezono et al., 1987), and systemic responses to therapeutic interventions like vaccines 
(DeLisi et al., 1983) and toxic conditions such as irradiation (Reinberg et al., 2017). 
 
Sleep 
Essential for health yet poorly understood, sleep is “an active, repetitive and reversible 
brain process of reduced perception and responsiveness to environmental stimuli” (Dahl & 
Lewin, 2002; Krueger et al., 2016). Being diurnal, humans are normally active during the 




thus entrained by the geophysical light-dark cycle. Specifically, photic input to our retinas 
(which is greatest during daylight hours) is received by specialized retinal ganglion cells 
and relayed to the SCN via the RHT, effectively “resetting” the SCN’s intrinsic oscillators 
and ultimately causing a shift in the timing of the SCN’s, and thenceforth the body’s, cir-
cadian rhythm (M. H. Hastings et al., 2014). Physiologically, peak “sleepiness” usually 
occurs between 03:00 and 04:00 when the rate of melatonin excretion is greatest and body 
temperature is lowest, two systems closely regulated by the circadian rhythm (Lack & 
Wright, 2007). Although sleep and wakefulness are promoted by the circadian rhythm at 
certain times of day, humans can (and often do) consciously delay sleep for myriad reason, 
and sleep itself is homeostatically regulated through “sleep pressure” independently of the 
circadian rhythm. Sleep may therefore be seen as a systemic behavioral output partially 
regulated by the circadian rhythm: sleep timing is entrainable via diurnal rhythms in body 
temperature and melatonin, yet sensitive to other factors such as conscious control and 
homeostatic sleep pressure (Vetter, 2018). 
 
Architecture and Classification 
Sleep is heterogeneous in terms of its physiological and neurological markers, which have 
been used to divide sleep into distinct stages. At the grossest level, sleep is part of a spec-
trum of behavioral states that reflect different levels of arousal. Colloquially defined as an 
evoked response especially in the context of waking up from sleep, arousal in scientific 




relation to the sleep-wake cycle (Oken et al., 2006). Arousal’s functional meaning is de-
pendent on the field: for example in the context of behavior arousal refers to the sensitivity 
of an organism to stimuli (Beri & Reddy K, 2019), and in neurophysiology it refers to the 
overall activity and capacity of a neurological system (Schiff, 2008). In this manuscript, 
these definitions are combined, with arousal referring to generalized behavioral states char-
acterized by differences in responsiveness to stimuli and cortical activity (Goldfine & 
Schiff, 2011). 
While arousal is typically conceptualized as a spectrum of behavioral states, this 
continuity is often divided into two broad categories - sleep and wake - with sleep being 
further divided into two distinct states. In descending order of sensitivity to stimuli and 
neurological activity, these three broad arousal states are: wakefulness, Rapid Eye Move-
ment (REM) sleep, and non-REM (NREM) sleep (Goldfine & Schiff, 2011). As these are 
systemic states that affect the entire organism, they can be differentiated using a broad 
variety of biomarkers (e.g. heart rate, muscle activity, response to stimuli, metabolic rate, 
etc.). In sleep and circadian research, polsysomnography (PSG) is considered the most ac-
curate and reliable method (the “gold standard”) for identifying the level of arousal, as 
sleep entails major changes to neurological function readily visualized via electroenceph-
alography (EEG) (Ancoli-Israel et al., 2015; Colten & Altevogt, 2006). PSG also fre-
quently incorporates physiological and biomechanical measures in addition to EEG, such 
as heart rate, blood oxygenation (aids in screening obstructive sleep apnea), electromyog-
raphy of lower limbs (aids in screening restless leg syndrome), electrooculography (to de-




Sleep has historically been divided into five stages - NREM1, NREM2, NREM3, 
NREM4,12 and REM - based on Rechtschaffen and Kales’ (1968) criteria for scoring sleep 
off of cortical EEG data13. These criteria have been reviewed several times since, with the 
most recent standards being set by the American Academy of Sleep Medicine’s (AASM) 
official guidelines (Moser et al., 2009). In addition to changes in scoring and reporting, 
these new standards define only four sleep stages (N1, N2, N3, and REM) with N4 and N3 
being merged together; N3 is often referred to as slow-wave sleep (SWS). 
Humans normally progress through the sleep stages in a regular, stereotyped cycle 
with an approximate duration of 90 minutes: starting from wakefulness, an individual will 
enter N1 upon falling asleep and progress to the “deeper”14 stages of N2, N3, and finally 
to REM, before returning to N1 and repeating the cycle (Atkin et al., 2018). The time spent 
in each stage varies predictably throughout the night, with REM growing longer and N3 
shorter with each successive cycle. The cycle is also significantly affected by age, with 
older individuals experiencing longer N1 and N2 stages, a shorter N3 stage, and fewer full 
sleep cycles on a given night (Mander et al., 2017). Older age is also associated with ad-
vanced (i.e. earlier) sleep timing, greater sleep onset latency, higher sensitivity to arousing 
	
12 Often abbreviated as N1, N2, N3, and N4, respectively 
13 Two additional stages were included in these criteria: Wake for periods of wakefulness, and 
Movement Time for periods where movement artifacts prevented accurate scoring. Movement Time 
has since been removed from the official AASM standards, and such periods are now scored based 
on data from proximal epochs. 
14 Colloquially, it is more difficult to rouse someone from a “deeper” sleep than from a “lighter” 
sleep. Sleep stages also follow this paradigm: an individual would be less responsive to stimuli in 




stimuli, and a corresponding increase in sleep fragmentation and Wake After Sleep Onset 
(WASO). 
Each stage has distinct resting and transient waveforms created by differences in 
neural activity, which are used to identify sleep stages in cortical EEG recordings. Briefly, 
N1 is the transition from wakefulness to sleep and is marked by a pronounced theta oscil-
lation (~4 - 7 Hz) and the absence of the waking alpha rhythm (~8 - 15 Hz). N2 is charac-
terized by a greater amplitude in the theta rhythm and the appearance of low-frequency K-
complexes and high-frequency sleep spindles, the latter of which is produced by 
thalamocortical interactions (Atkin et al., 2018). N3 is the deepest stage of NREM and is 
frequently referred to as SWS due to the presence of relatively low frequency delta waves 
(~0.1 - 3 Hz). Collectively, NREM stages (especially N3) are characterized by reductions 
in body temperature, breathing rate, blood pressure, muscle tone, and diminished activity 
in cognitive, memory, and emotional systems. Note that, although muscle tone decreases 
in NREM, it is still present and the individual can unconsciously respond to potentially 
dangerous stimuli, suggesting that motor and somatosensory systems are less dampened 
(Atkin et al., 2018; Koella, 1982; Schulz, 2008). 
Aside from its titular rapid eye movements, REM sleep is distinguished from 
NREM by arousal of the CNS, the appearance of low-amplitude high-frequency theta 
waves in EEG, the abolition of muscle tone throughout the body, and a relaxation of ho-
meostatic regulation resulting in fluctuating body temperature, heart rate, blood pressure, 
and so on (Atkin et al., 2018; Parmeggiani, 2011). REM is also referred to as “paradoxical 




awake brain - despite the fact they’re asleep. Dreaming occurs primarily in REM sleep - 
likely facilitated by the sudden arousal of cognitive and memory systems - whereas para-
somnias such as sleepwalking usually occur in N3 (Atkin et al., 2018). Since NREM is 
characterized by the depression of higher order brain functions and maintenance of motor 
systems, NREM parasomnias usually involve motor acts (e.g. sleepwalking) without con-
scious awareness; in contrast, dreams in REM sleep can be recalled and narratively de-
scribed due to arousal of cognitive systems, but the physical actions occurring in those 
dreams are suppressed by the loss of muscle tonicity (Koella, 1982; Schulz, 2008). 
 
Homeostatic and Circadian Regulation of Sleep 
Sleep timing is believed to be regulated through the interplay of two circadian rhythms 
(Landolt & Dijk, 2019): a centrally controlled oscillation in melatonin secretion, and a 
physiological “sleep pressure” that increases while awake due to the accumulation of cer-
tain neuromodulators (referred to as somnogens) in the central nervous system (CNS). 
These systems and their interactions are collectively known as the “two process model” of 
sleep regulation. 
Melatonin is secreted from the pineal gland in response to indirect innervation from 
the SCN via the hypothalamic Paraventricular Nucleus (PVN). Melatonin is a chronobiotic 
- i.e. a modulator of the timing of biological rhythms - that is primarily secreted during 
periods of darkness and which is associated with decreased physical activity and increased 
sleep proposensity (Arendt & Skene, 2005; Silva et al., 2019). The duration of melatonin 




entrain photoperiodic processes dependent on the length of the night (e.g. sleep timing, 
body temperature), and feeds back on the SCN via G-protein coupled receptors to adjust 
the phase of its TTFLs (Pévet, 2016). The sudden increase in melatonin secretion before 
sleep is referred to “dim light melatonin onset” (DLMO), occurring around dusk and fol-
lowed by a marked increase in sleepiness and decrease in body temperature. The proximity 
of the pineal gland to the SCN in terms of synaptic intermediaries and latency, as well as 
the relative ease by which melatonin can be measured and the high amplitude of its crepus-
cular secretion, has made DLMO a popular and robust indicator of circadian phase (Pévet, 
2016). 
In contrast to the centrally regulated DLMO, the accumulation of somnogens is 
thought to be a byproduct of normal neurometabolic processes during wakefulness – e.g. 
extracellular adenosine, a classic somnogen, is produced from ATP catabolism (Lazarus et 
al., 2019). Numerous somnogenic molecules have been identified, including the aforemen-
tioned adenosine, prostoglandin-2, and several cytokines. Although the production, neuro-
logical targets, and anatomical localization of several somnogens have been well charac-
terized, the complexity and broad distribution of the neurological sleep propensity system 
has slowed the consolidation of a unified theory of sleep-wake regulation (Landolt & Dijk, 
2019). Where-as DLMO prepares the body for sleep based on environmental conditions 
(time of day), sleep pressure does so based on neurobiological conditions (time spent 
awake). Their interaction through sleep regulation at a systemic level allows for the inte-





Sleep and Circadian Disruption 
In previous sub-chapters, the anatomical, physiological, and functional aspects of the cir-
cadian rhythm have been discussed in the context of an idealized organism that is effec-
tively synchronized with its environment. As with any other biological system, however, 
the circadian rhythm can be disrupted by intrinsic and extrinsic factors. The impacts of 
circadian disruption are myriad and generalized, manifesting as impairments to systemic 
processes like cognition, sleep, metabolic efficiency, and disease risk. Although the causes 
of circadian disruption (e.g. misalignment between biological and environmental phases) 
are well understood and in fact a core element of chronobiological experimental design, 
the precise biological mechanisms that translate misalignment into systemic impairments 
are poorly understood (Vetter, 2018). Circadian disruption is becoming increasingly com-
mon in humans for myriad reasons: artificial zeitgebers created by technological (e.g. arti-
ficial lighting) and sociological (e.g. food availability) factors can interfere with the circa-
dian rhythm’s ability to synchronize to the geophysical day/night cycle, individuals can 
and often do choose to shift their sleep timing out of phase with their circadian rhythm in 
response to personal, professional, and social pressures, and activities unique to modern 
society – such as long distance travel and daylight savings time – can abruptly decouple 
one’s circadian rhythm from the environment with deleterious consequences (Chattu et al., 
2018; Colten & Altevogt, 2006). Certain populations (e.g. shift workers) are disproportion-
ately vulnerable to circadian disruption, and the circadian rhythm can be further disrupted 





Definition and Scope 
Any discussion of circadian disruption must account for the fact that the circadian rhythm 
is innately adaptive. The circadian rhythm constantly receives and integrates internal and 
external zeitgebers to optimize the timing and coordination of biological processes. Con-
sider the fact that the TTFL - the fundamental oscillator in the mammalian circadian rhythm 
- has an innate period of ~24.2 hours (Burgess & Eastman, 2005; Czeisler et al., 1999). 
Without constant entrainment to environmental cues (i.e. light), the circadian TTFL (and 
it’s downstream processes such as CCGs) would gradually drift out of sync with the envi-
ronment even in ideal conditions. In other words, the circadian rhythm is constantly “dis-
rupted” because it is a dynamic system of systems that is constantly adapting to changes in 
exogenous and endogenous zeitgebers. Small changes in timing are easily tolerated; for 
example, the gradual day-to-day change in sunrise time is a constant challenge, but the 
shift of several dozen seconds per day is easily and quickly accommodated with minimal 
systemic effects (i.e. we are not jet lagged every morning). In other words, humans can 
tolerate some degree of variance in the relative timing and amplitude of our myriad circa-
dian rhythms and their zeitgebers/regulators. Therefore any discussion of circadian disrup-
tion must distinguish between normal adaptations, tolerable variation, and abnormal dis-
ruptions in the circadian system/endpoint of interest (Vetter, 2018). 
In this context, circadian disruption refers to a significant challenge to the circadian 
rhythm (i.e. an unexpected or out-of-phase stimulus) and the adverse negative outcomes it 
incurs. The circadian rhythm’s distributed and multifaceted nature means it cannot “turn 




- meaning larger deviations are proportionally more difficult to adapt to. For example, fly-
ing from New York to Los Angeles phase advances environmental (i.e. solar) time by three 
hours relative to biological time within a single day, a shift several orders of magnitude 
larger than the normal day-to-day change in daylight. Such a dramatic shift results in a 
multitude of negative symptoms as the circadian rhythm “lags behind” and slowly resyn-
chronizes with the environment; colloquially referred to as jet lag, these symptoms include 
daytime sleepiness, mood shifts, and difficulty sleeping.  
Building upon the seminal example of jet lag, consider the different zeitgebers and 
their interaction with the circadian rhythm in this hypothetical New York to Los Angeles 
flight. The retinorecipient SCN core quickly detects the abnormal environmental shift via 
signals from retinal ganglion cells and begins resetting its non-retinorecipient shell TTFLs 
to align with the new Los Angeles time. As this information slowly propagates throughout 
the SCN via paracrine signaling, the body’s peripheral oscillators (which are largely insen-
sitive to environmental conditions) continue unaware of the shift. As the sun begins to set 
in New York (yet is still high in the Los Angeles sky), the peripheral oscillators enter “bi-
ological night” as melatonin is secreted, heart rate slows, temperature decreases, and so on. 
Some are influenced by conflicting temporal information conveyed by non-photic behav-
ioral and physiological zeitgebers. For example, the individual is awake past their usual 
bedtime, resulting in greater buildup of somnogens and reduced cognitive performance. 
Meals are suddenly taken at a later time, forcing the liver and other digestive organs to 
work at a reduced efficiency as the body is homeostatically prepared for fasting, causing 




consequence of their body temperature and peripheral blood flow increasing with the rising 
sun in New York, and they experience daytime sleepiness due to their “sleep debt”; i.e. 
residual somnogens that were not cleared due to an incomplete night of sleep. Meanwhile, 
the SCN and its neurological relays, now well on their way to synchronizing with the Los 
Angeles day, are entraining the peripheral oscillators at varying rates depending on their 
scale, functional “distance” from the SCN, and the influence of non-photic zeitgebers like 
feeding. The symptoms of jet lag emerge from these conflicting stimuli and misaligned 
biological processes, and it takes several days before the combination of top-down (i.e. 
SCN and light) and bottom-up (i.e. digestive organs and feeding) signals fully adapt to the 
new environment and each other. Of course, the individual then returns to New York and 
once again decouples the phase of their circadian rhythm from the environmental phase. 
Despite the common perception of jet lag as a minor annoyance that causes drowsiness, 
headaches, and nausea, its symptoms demonstrate the fundamental importance and sys-
temic influence the circadian rhythm has on our biology (Evans & Davidson, 2013): a rel-
atively minor misalignment of biological and environmental times is enough to cause cir-
cadian disruption, resulting in myriad minor inefficiencies from unoptimized biological 
processes that cumulatively manifest as generalized systemic symptoms. 
As mentioned earlier, circadian disruption has been used as a general term to de-
scribe the adverse effects that manifest as the circadian rhythm resynchronizes itself to 
environmental zeitgebers and its constituent rhythms to each other (Vetter, 2018). More 




jet lag, neurodegenerative disease, unique photoperiods such as polar latitudes, genetic pre-
disposition) acting through a range of mechanisms (e.g. misalignment, sleep disruption, 
behavioral interference, etc.) at different levels of biological organization (e.g. cellular, 
tissue, systemic, behavioral) (Potter et al., 2016). Furthermore, behavioral and environ-
mental factors may only disrupt specific aspects of the circadian rhythm; e.g. by shifting 
meal times while keeping environmental zeitgebers unchanged, the diurnal fluctuation in 
blood glucose concentration can be discretely decoupled from the circadian rhythm (Vetter, 
2018; Wehrens et al., 2017). Circadian disruption is often treated as an umbrella term that 
takes on different meanings and scopes in different scientific and clinical contexts, in much 
the same way that “mental illness” may refer to a broad spectrum of pathologies, or to 
specific symptoms and etiologies. This manuscript will use the definition provided by Qian 
and Scheer (2016, p. 4): “circadian disruption is a disturbance of biological timing, which 
can occur at different organizational levels and/or between different organizational levels, 
ranging from molecular rhythms in individual cells to misalignment of behavioral cycles 
with environmental changes.” 
Sleep disruption is closely related to and is often used as a proxy for circadian dis-
ruption - e.g. jet lag can be quantified by changes in sleep timing relative to the local envi-
ronment (Vetter, 2018). There is considerable overlap in terms of their causes, mecha-
nisms, and symptomology (Potter et al., 2016): one can be caused by the other (e.g. shift 
work disorder), both can be the consequence of a common insult (e.g. jet lag), and both can 
synergistically contribute to a common symptom. For example, both sleep and circadian 




through dysregulation of the gut microbiome, and both interfere with normal endocrine 
function (Potter et al., 2016). Obese individuals are more likely to develop sleep disorders 
such as Obstructive Sleep Apnea (OSA), which in turn can further disrupt sleep (and thus 
circadian rhythms related to it) via sleep fragmentation. Conversely, sleep fragmentation 
can occur as a result of the misalignment between circadian and somnogenic rhythms 
caused by jet lag, and the abrupt change in sleep timing can decouple elements of the cir-
cadian rhythm from each other and/or the environment (Vetter, 2018). Circadian disruption 
can also directly cause sleep disruption. For example, a study evaluating different combi-
nations of on/off duty shifts on United States Naval vessels found that a 5-hour ON / 10-
hour OFF shift had the greatest reduction in performance despite spending more hours 
asleep than any other shift. The authors attributed this seemingly paradoxical finding to the 
fact that the timing of 5/10 sleep periods was highly irregular and misaligned with both 
their natural environment and their circadian rhythm; i.e. they induced chronic circadian 
disruption, which subsequently disrupted their sleep and thus their performance (Shattuck 
& Matsangas, 2016). Lastly, sleep disruption (as with circadian disruption) can be caused 
by behavioral and social factors that restrict sleep duration and timing, such as staying up 
late for a social event, waking up early to go to work, etc. Put simply, sleep disruption can 
be considered a specific type of circadian disruption. 
In summary, the circadian rhythm is a distributed yet coordinated system of systems 
that dynamically adapts to constantly changing internal and external conditions. Dysregu-
lating, misaligning, or otherwise disrupting one system inevitably impacts the adjacent sys-




circadian rhythm to disruption, it is also protective in the sense that the effects of an isolated 
insult will be attenuated and dissipated by the unaffected systems, analogous to a trampo-
line distending to absorb kinetic energy, or an out-of-time musician falling back in measure 
with their orchestra. The circadian rhythm is innately adaptive; following acute disruption 
it will, over time, resynchronize its constituent biological rhythms to each other and (via 
the SCN) the environment (Vetter, 2018). Ultimately, circadian disruption describes this 
period of dynamic adaptation, its functional and biological etiologies, and the adverse ef-
fects that emerge during it. 
 
Epidemiology and Consequences 
Sleep and circadian disruption are widespread in modern industrialized societies (Colten 
& Altevogt, 2006; D. R. Hillman & Lack, 2013), and have been found to be associated 
with numerous health issues, including but not limited to obesity and metabolic diseases 
(Potter et al., 2016), cardiovascular disease (Portaluppi et al., 2012), neuropsychiatric dis-
orders (Musiek & Holtzman, 2016), neurodegenerative diseases (Colten & Altevogt, 2006; 
Videnovic, Lazar, et al., 2014), and disruption of the endocrine system (Bedrosian et al., 
2016; Vetter, 2018). Acute symptoms of circadian disruption (e.g. fatigue and impaired 
attention) have contributed to the occurrence of fatal accidents (Gottlieb et al., 2018) - the 
rate of which has increased in the United States of America (USA) over the past decade 
(Murphy et al., 2018) - and has been implicated as a contributing factor in numerous high 
profile accidents and catastrophes such as the Three Mile Island disaster, the Chernobyl 




Union Carbide disaster in Bhopal, India (Colten & Altevogt, 2006; RAND Corporation, 
2016). Insufficient sleep, which is both a cause and consequence of circadian disruption, 
has been linked with seven of the fifteen most common causes of death in the USA15 
(RAND Corporation, 2016) and is associated with worse academic performance in school-
children and undergraduates (Okano et al., 2019). 
Epidemiological studies quantifying the full extent of circadian disruption are 
scarce due its multifaceted and indistinctly defined nature (D. R. Hillman & Lack, 2013); 
however, epidemiological studies of sleep disruption have estimated that over a third of 
Americans experienced insufficient sleep (Liu et al., 2016) and a similar proportion of 
Australians reported sleep disorders (D. R. Hillman & Lack, 2013). Another study esti-
mated that young and middle aged French adults slept ~1.5 hours less than recommended 
(Léger et al., 2011). Sleep disruption is not limited to western countries and is as or even 
more common in Asian countries, including China, Taiwan, Thailand, and Singapore (Lin 
et al., 2017). An international survey (National Sleep Foundation, 2013) estimated that over 
half of Japanese adults achieved less than seven hours a sleep a night; by comparison, the 
proportion of insufficient sleep amongst American, British, German, and Canadian adults 
ranged from 26% to 45% (RAND Corporation, 2016). Moreover, the problem appears to 
be worsening over time: retrospective analyses of Swedish and Finnish cohort studies sug-
gest that sleep duration has declined by as much as 18 minutes/night over a period of ~30 
years (Kronholm et al., 2008; Rowshan Ravan et al., 2010), and the prevalence of sleep 
	
15 Cardiovascular disease, malignant neoplasm, cerebrovascular disease, accidents, diabetes, septi-




disruption is expected to continue rising, particularly in at-risk populations (Ferrie et al., 
2011). 
A recurring16 theme in the study of the circadian and sleep regulation is the sheer 
breadth and interconnectedness of their constituent elements, including the complex sys-
temic properties that arise from their dynamic interactions. This is well demonstrated by 
the myriad risks associated with increased sleep disruption, which run the gamut from bi-
ological to artificial and include behavioral, genetic, and social factors. To wit, lower sleep 
duration has been associated with higher Body Mass Index (BMI), habitual cigarette smok-
ing, habitual consumption of sugary drinks, low physical activity, being at high risk of 
experiencing mental health problems, experiencing financial stress, having children, being 
male, being divorced, never having been married, experiencing workplace stress, incon-
sistent work schedules (i.e. shift workers), having long commute times, and having limited 
workplace autonomy (RAND Corporation, 2016). Determining the causal relationship of 
these risk factors with respect to sleep and circadian disruption – i.e. the degree to which 
disruption gives rise to and/or is caused by, e.g., obesity – is a major objective of current 
chronobiological research. Furthermore, multiple populations have been identified as hav-
ing an elevated risk and/or incidence of sleep disruption. For example, the demanding 
schedule of United States Military Academy cadets leaves them severely sleep deprived 
throughout their education (Miller et al., 2010) and into their military service (Miller et al., 
2011), and medical residents on intensive care units often work lengthy hours and conse-
quently suffer from sleep disruption during their residency, leading to increased rates of 
	




serious medical errors compared to residents working less demanding schedules (Colten & 
Altevogt, 2006; Landrigan et al., 2004; Lockley et al., 2004). Night-time shift workers, 
employees with unusual schedules (e.g. off-shore oil workers), and those with unpredicta-
ble shifts (e.g. emergency first responders) risk decoupling their circadian rhythm from 
natural zeitgebers via behavioral disruption, with the resultant circadian maladjustment 
leading to sleep disruption; in other words, their daily schedule changes independently of 
the day-night cycle, depriving biological circadian regulators access to a consistent zeit-
geber schedule (Colten & Altevogt, 2006). 
Analogous to how desynchrony between different zeitgebers gives rise to biological 
inefficiencies that manifest as systemic symptoms, circadian disruption impairs the effi-
ciency of employees with significant economic implications. Increased rates of fatigue, 
absenteeism, presenteeism, and accidents undoubtedly reduce productivity, and the en-
demic nature of circadian disruption in modern industrialized societies has made these in-
efficiencies increasingly common. While it is difficult to unambiguously separate out 
productivity lost due to sleep and circadian disruption from other causes, the use of symp-
tomatic proxies such as fatigue and behavioral outcomes like tardiness has allowed for  
estimation. In 2002, the total economic cost of lost productive time at work was estimated 
at $226 billion per year in the USA alone, of which 70% was attributable to reduced per-
formance at work caused by personal health reasons (Stewart et al., 2003). 14 years later, 
one international model (RAND Corporation, 2016) estimated that this cost had increased 
to ~$350 billion, making up over half of the $680 billion estimated yearly economic burden 




ranging from ~0.85% to 2.92% of their national Gross Domestic Products (GDP). In Aus-
tralia, the estimated economic burden roughly doubled between 2004 and 2017, reaching 
~$45 billion per year (D. Hillman et al., 2018; Koritala & Çakmaklı, 2018). 
The increasing prevalence of sleep disruption, accumulating evidence of its numer-
ous deleterious health outcomes, identification of numerous risk factors and susceptible 
populations, and a growing burden on the global economy has led to its recognition as a 
public health crisis, a modern day  (Bonnet & Arand, 1995; Chattu et al., 2018; Colten & 
Altevogt, 2006; D. R. Hillman & Lack, 2013; Wittmann et al., 2006).   
 
The Seven-Day Week and Sociogenic Circaseptan Rhythms 
The social construct of a “week” was likely borne from a confluence of utilitarian, socio-
logical, and potentially biological factors (Meyer-Rochow & Brown, 1998; Zerubavel, 
1989). The seven-day week serves an important utilitarian function as an intermediary unit 
of time between the natural circadian (daily) periodicity of Earth’s rotation and the larger 
circatrigintan (monthly) and circannual (yearly) periodicity of the Moon’s revolution about 
the Earth and Earth’s revolution about the Sun, respectively. In the same way that it is 
easier to carry $0.55 as two quarters and a nickel than as 55 pennies, it is easier to define 
the sabbath as “the last day of the week” than as “the 7th, 14th, 21st, and 28th days of the 
lunar cycle”. In other words, tiered units of proportional magnitude (i.e. day, week, month, 
year) can convey information more efficiently than the absolute number of the smallest 
unit (i.e. day) and so entail a utilitarian benefit. Sociologically, the week acts as a “temporal 




an intermediary unit of time provides a tractable means to establish, organize, and maintain 
societal customs and activities that cannot be accomplished within a single day but which 
would be inefficient or inappropriate to extend over the course of a month (e.g. work and 
rest days). Biologically, circaseptan (i.e. weekly) periodicity has been documented in hu-
mans in biological phenomena – e.g. 17-ketosteroid concentration in urine (Franz Halberg 
et al., 1965) – as well as secondary biological outcomes – e.g. sudden cardiac death (Rab-
kin, 1980). 
Whether these effects are attributable to an intrinsically circaseptan biological pro-
cess, are the consequence of our biology conforming to an exogenous socially-mandated 
7-day week, or a mixture of both remains an open question. Even if one assumes that there 
are no natural phenomena with an intrinsically circaseptan period, it is still a reasonable 
assertion that the first societies to employ a seven-day week did so by quartering the ~29 
day lunar cycle into four seven-day periods (Levi & Halberg, 1982) - or perhaps derived it 
from the circaseptan harmonic of the circadiseptan rhythm in spring and neap tides driven 
by the lunar cycle (Meyer-Rochow & Brown, 1998). In other words, if the observed cir-
caseptan periodicities in our biology did not emerge from natural circaseptan pressures in 
human evolution, then they did so as a consequence of how modern humans organized 
their society. 
Notwithstanding the biological, sociological, and/or utilitarian origins of the 7-day 
week, it has now become fundamental to the organization of our society and therefore has 
quantifiable implications on our behavior and health (Levi & Halberg, 1982). The common 




quantitatively realized by Santorio Sanctorios who, in the 17th century, accumulated nearly 
thirty years of longitudinal metabolic data. Although Sanctorios’ data was lost, a more 
recent and similarly inspired longitudinal collection of metabolic data – specifically urinary 
volume and 17-ketosteroid secretion – was found to contain a significant circaseptan com-
ponent (Franz Halberg et al., 1965). More recently, an increased incidence of sudden car-
diac events on Mondays has been documented for nearly half a century using cohorts dating 
back to the second World War (Rogot et al., 1976). Interestingly, this may be associated 
with an intrinsic circaseptan rhythm in the secretion of neurohypophyseal hormonal secre-
tions (Rabkin, 1980), and exacerbated by the psychological (e.g. anxiety), environmental 
(e.g. pollutants), and physical (e.g. activity) stressors that accompany the return to societal 
and professional obligations at the beginning of the work week. It is conceivable that these 
same stressors, regularly experienced on a seven-day cycle, would also impact other as-
pects of health such as sleep and rest-activity cycles (Rabkin, 1980). In other words, our 
social calendar, societal organization, and their influence on our behavioral, emotional, and 
psychological states may disrupt biological rhythms independently of intrinsic biological 
and extrinsic environmental challenges, a phenomenon referred to a sociogenic (socio-: 
social, -genic: origin) disruption in this manuscript. 
 
Sociogenic Disruption 
Humans are innately social creatures who self-organize into complex cooperative systems 
- i.e. societies. Amongst the myriad benefits of communal organization is the logistical 




analogous to how the circadian rhythm synchronizes biological processes to maximize the 
organism’s fitness. Much in the same way the evolution of photosynthesis opened up a new 
source of energy in the form of solar radiation, humanity’s development of technology, 
language, and science has given us access to vast new sources of energy - fire, wood fuel, 
animal husbandry, hydropower, steam, fossil fuels, electricity, nuclear fission, and even 
artificial photosynthesis vis-à-vis solar power - and led to our dominance of Earth’s bio-
sphere. Industrialized human society embodies the epitome of biological evolution, con-
cerned primarily with optimizing the efficient and widespread exploitation of our environ-
ment to improve our fitness and resiliency. Ironically, this has increasingly divested us 
from the biological systems we evolved to exploit. The unique capacity of humans to 
gather, infer, integrate, record, communicate, and apply information has enabled us to ex-
ploit our environment in ways never before seen on Earth, but it has also made us dependent 
upon the artificial systems and technologies we use to do so. Moreover, our technological 
development has rapidly outpaced our biological evolution. Consider the fact that most 
modern Homo sapiens in industrialized regions live independently of the geophysical solar 
day; i.e. a doctor in Chicago need not look outside to know if she should eat, sleep, or leave 
work, only at her watch and her calendar. She no longer sleeps in synchrony with the sun, 
but with her shift schedule. 
This is not unique to medicine, as many industries function autonomously from the 
geophysical day based on their practical needs: a cargo ship will dock when it’s cheapest 
and safest to do so, not because the sun is at a certain point in the sky. This independence 




ship may have only been able to safely dock during the day when the offshore reefs were 
visible and could be navigated around. Such restrictions imposed on human behavior and 
social time by the day-night cycle have been gradually alleviated by technology, allowing 
the artificial pressures of economics, logistics, and convenience to grow in influence. Glob-
alism, international trade, electronic media, air travel, and the internet have increased the 
interconnectedness (and interdependence) of human societies around the globe, contributed 
to the modern phenomenon of “24/7” industry, and exacerbated the growing irrelevance of 
local solar time to human society. These are reminders that modern society keeps its own 
time; one might note that our modern calendar is to our society what our circadian rhythm 
is to our body. While the calendar does not have a circadian rhythm, we do. Fundamentally, 
it is this disconnect between our social calendar and our biological circadian rhythm that 
leads to sociogenic circadian disruption (Foster & Roenneberg, 2008; Roenneberg et al., 
2015; Vetter, 2018). 
Perhaps one of the most well-studied sociogenic disruptions is Social Jet Lag (SJL), 
the habitual discrepancy in behavioral chronotype between days of the week, especially 
work days and rest days (Roenneberg et al., 2012; Vetter, 2018; Wittmann et al., 2006). 
SJL arises from the difference in internal (i.e. biological) and external (i.e. social) timing 
systems; put simply, people do not always get to choose when they wake up. Much of the 
population is forced by social and professional obligations to adapt to a social schedule too 
early or too late for their natural chronotype during work days, and then revert back to their 
natural preference once these social constraints are removed on rest days. This is analogous 




(e.g. sleep), and waking up early to go to work likewise abruptly decouples the behavioral 
rest-activity rhythm from the biological circadian clock. People who experience SJL may 
therefore be described as living in two separate time zones: a social time during the work 
week, and a biological time during the rest week (Roenneberg et al., 2015). Looking across 
multiple weeks, this periodic transition between social and biological “time zones” may be 
described as a circaseptan rhythm of chronic circadian disruption, where-as jet lag is acute, 
non-rhythmic, and relatively infrequent by comparison. 
SJL is usually assessed subjectively through self-reported sleep times and stand-
ardized instruments like the Munich Chronotype Questionnaire (MCTQ) or Morningness-
Eveningness Questionnaire (MEQ), and/or objectively with actigraphy collected by wear-
able accelerometers (Roenneberg et al., 2019). The low cost, ease of use, and good scala-
bility of these methods have led to SJL being widely assessed in numerous studies; how-
ever, the rapid proliferation of SJL as an endpoint has led to considerable methodological 
inconsistencies in its application, calculation, and interpretation (Beauvalet et al., 2017; 
Roenneberg et al., 2019). Nonetheless, there is a growing consensus that SJL (like other 
forms of sleep disruption) is widespread in modern populations and associated with similar 
negative health outcomes: greater SJL has been linked with decreased academic perfor-
mance (Díaz-Morales & Escribano, 2015; Haraszti et al., 2014), a higher chance of smok-
ing cigarettes (Wittmann et al., 2006), developing metabolic disorders (Koopman et al., 
2017; Wong et al., 2015), including obesity (Alves et al., 2017; Malone et al., 2016; Par-
sons et al., 2015; Roenneberg et al., 2012; Rutters et al., 2014), poor diet (Almoosawi et 




al., 2019; Malone et al., 2016; West & Bechtold, 2015; Wittmann et al., 2006), although 
this is debated (Knapen et al., 2018; Roenneberg et al., 2019). 
Epidemiologically, SJL is widespread in the general population (Islam et al., 2020; 
McMahon et al., 2019; Sűdy et al., 2019), with over 30% of European adults reporting two 
or more hours of SJL (Roenneberg et al., 2012). Those living in latitudes further from the 
equator may have increased SJL, potentially due to latitudinal changes in exposure to and 
intensity of sunlight (Leocadio-Miguel et al., 2018). This effect was observed to be more 
pronounced in persons with the 4-repeat PER3-(4/4) allele, itself associated with a prefer-
ence for evening chronotype (Hida et al., 2018). Secondary evidence, such as the delayed 
timing in power grid consumption on weekends versus weekdays (Stowie et al., 2015) and 
in peak social media usage (Leypunskiy et al., 2018), further supports the notion of a reg-
ular delay in sleep timing on weekends in a large portion of the general population. 
Certain cohorts, especially those already known to be susceptible to circadian dis-
ruption (e.g. shift workers, students, first responders, etc.), are more susceptible to devel-
oping SJL (Parsons et al., 2015). Moreover, the severity of SJL is closely related to chro-
notype, with evening chronotypes being disproportionately more likely to have SJL 
(Roenneberg et al., 2019; Takahashi et al., 2018; Wittmann et al., 2006; Zerbini et al., 
2020). While the distribution of chronotypes in the general population is broad, ranging 
from extreme eveningness to extreme morningness, the distribution of work schedules is 
far more compact and constrained by nonbiological factors such as economics, logistics, 




and professional obligations therefore are more likely to have SJL. Other factors such as 
commute time, can further impinge upon one’s chronotypical sleep time and induce SJL. 
Closely related to SJL is Sleep Debt, the cumulative effect of sleep deprivation over 
time (Saghir et al., 2018). Where-as SJL is the difference in sleep timing between work and 
rest days, Sleep Debt is calculated as the difference in sleep duration between work and 
rest days (Wong et al., 2015). On average, human adults require 6 – 9 hours of sleep a night 
to feel rested and to avoid Excessive Daytime Sleepiness (EDS), as recommended by the 
American Centers for Disease Control (Hirshkowitz et al., 2015). Although the body may 
be able to adapt to minor changes in sleep timing (J. Horne, 2011), chronic sleep depriva-
tion will lead to increased sleep pressure and tiredness, and the body will homeostatically 
compensate by extending sleep duration (unless otherwise interrupted, e.g., by waking up 
early for work) until the “debt is paid”. These variations in sleep duration also extend to its 
quality, and vary by age and chronotype; e.g. both adults and schoolchildren tend to sleep 
longer, later, and poorer on weekend nights, reflecting increased Sleep Debt, SJL, and sleep 
disruption, respectively (Bei et al., 2016; Crowley & Carskadon, 2010; Taylor et al., 2008). 
As with SJL, these effects are more pronounced in those with chronotypes (usually 
eveningness) whose preferred sleep time conflicts with their social obligations (i.e. work). 
When this obligation is removed on rest days, they “sleep in” to make up the sleep debt 
accumulated during the workweek (Vitale et al., 2015). In this way Sleep Debt and SJL 
can compound each other: those with high SJL are likely to have high Sleep Debt, so not 




as they recoup their Sleep Debt, which in turn delays their rest-activity rhythm, light expo-
sure, meal times, social interactions, and other important influential zeitgebers. 
In summary, humans, as social creatures, are beholden to two times: solar time 
(which entrains our circadian rhythm and maintains synchrony between our body and our 
environment) and social time (which constrains our behaviors, responsibilities, and our 
interactions with others). For most of human history, social time has been defined by solar 
time. With the advent of industrialization and the ensuing growth in population and pro-
duction - further accelerated by the exponential increase in producing and harnessing en-
ergy - social time needed to expand beyond daylight hours to maintain social order and 
cohesion. The proliferation of standard calendars and clocks and artificial lighting has fur-
ther detached social time from solar time. However, our biology - when we feel tired, when 
we eat, when we seek out shelter - is still entrained solar time. As a result, our behavior is 
increasingly disconnected from our biology. This manifests as chronic circadian disruption, 
a growing 'sleeping crisis' in modern industrialized societies (Chattu et al., 2018; Colten & 
Altevogt, 2006; D. R. Hillman & Lack, 2013). 
 
Parkinson’s Disease 
Idiopathic Parkinson’s disease (PD) is the second most common neurodegenerative dis-
ease, affecting 1% of the population over 60 (de Lau & Breteler, 2006). The onset of PD’s 
characteristic motor symptoms – bradykinesia, tremor, rigidity, and postural instability and 




initial appearance of neuropathology in the CNS. There are numerous non-motor symp-
toms associated with PD as well, including cognitive impairment, autonomic dysfunction, 
and disruption of sleep and the circadian rhythm (Jellinger, 2015). These features have 
been clinically defined and the initial diagnosis of PD is based on their observation in a 
neurological exam (Postuma et al., 2015). However, in the absence of validated biomarkers 
– i.e. measures sensitive to a biological or pathological process (Lana M. Chahine & Stern, 
2017; Espay et al., 2017; Horak & Mancini, 2013) – the gold standard diagnostic criteria 
remains post-mortem confirmation of PD neuropathology in the substantia nigra pars com-
pacta (SNpc) (Kalia & Lang, 2015). 
PD is markedly heterogeneous, with significant variability in its clinical presenta-
tion, rate of progression, response to treatment, and underlying neuropathology (Kalia & 
Lang, 2015). This is compounded by the fact that its clinical features and pathological 
mechanisms often overlap with other neurodegenerative diseases, movement disorders, 
and a growing continuum of “parkinsonisms” (Dickson, 2012; Espay et al., 2017), which 
has contributed to a diagnostic false positive rate of 10%-20% (Hughes et al., 2001, 2002). 
This is considered unacceptably high given the deleterious side effects of levodopa/car-
bidopa dopamine replacement therapy, the primary means of ameliorating PD’s motor 
symptoms (Kalia & Lang, 2015). As a result, the development of asymptomatic disease-
modifying treatments, the identification of valid biomarkers sensitive to disease progres-
sion, and the translation of these to clinical practice are considered the highest priorities in 





Neuropathological Progression and Evaluation 
Neurodegeneration and clinical progression in PD are closely associated with the appear-
ance and gradual spread of intraneuronal protein aggregates throughout the central, periph-
eral, and enteric nervous systems (Braak et al., 2003; Lana M. Chahine & Stern, 2017; 
Goedert et al., 2013). These are commonly referred to as Lewy bodies (aggregates, usually 
in cell body) and Lewy neurites (strands, usually in neurites) after Fritz Heinrich Lewy, the 
pathologist who first described them in PD in 1912 (Goedert et al., 2013). 
In 1997, the presynaptic protein alpha-synuclein (ASN) was identified as the bulk 
component of Lewy aggregates (Spillantini et al., 1997) and an ASN mutant was identified 
in familial PD (Polymeropoulos, 1997), findings that ultimately led to PD’s classification 
as a synucleinopathy (Goedert et al., 2013). While there has been substantial progress in 
uncovering the mechanisms underlying the formation of Lewy pathology, notably the 
prion-like spread of ASN between neurons (Visanji et al., 2013), the relationship between 
the pathological aggregation of ASN and neurodegeneration remains unknown (Goedert et 
al., 2013). Similar to amyloid beta in Alzheimer’s disease, a decrease in the concentration 
of ASN in cerebrospinal fluid is believed to reflect an uptake of ASN into Lewy aggregates, 
and therefore may be able to predict the onset of clinical features associated with Lewy 
pathology prior to motor symptom onset. This is supported by the lower concentration of 
cerebrospinal fluid ASN in PD patients compared to healthy controls (Lana M. Chahine & 
Stern, 2017), and is considered a promising potential biomarker of PD’s pathological pro-




Potential biomarkers like ASN are validated against changes in clinical features 
assessed using semi-quantitative clinical scales. The most widely used scale, the Unified 
Parkinson’s Disease Rating Scale (UPDRS), is considered the gold standard for assessing 
PD’s clinical features. Originally published in the 1980’s, the scale was extensively revised 
by the Movement Disorder Society (MDS) in 2008 (Goetz et al., 2008). The updated 
“MDS-UPDRS” consists of a structured interview and motor examination, during which 
50 items are scored on a rating scale from 0 ("no symptoms") to 4 ("severe"). Due to its 
comprehensive nature, compatibility with clinical practice, and clinimetric validation, the 
MDS-UPDRS has seen widespread use as a measure of disease severity and progression in 
clinical research (Espay et al., 2017). However, attempts to validate ASN against the MDS-
UPDRS have produced inconsistent results, as have other biomarkers (Espay et al., 2017; 
Kalia & Lang, 2015). Methodological concerns, such as inconsistent assay methods, have 
been cited as possible explanations (Lana M. Chahine & Stern, 2017). In addition, there is 
a growing body of evidence implicating amyloid beta (AB) and phosphorylated-tau181 
(pTau) in PD’s neuropathology. For example, amyloid beta plaques and neurofibrillary 
tangles have been found in the brains of PD patients at levels similar to those seen in Alz-
heimer’s; moreover, their presence predicts a quicker onset of dementia (Irwin et al., 2012; 
Kalia & Lang, 2015). These neuropathological markers may have a synergistic effect with 
ASN as they are associated with increased Lewy pathology, and it is hypothesized that 
subtle differences in their relative concentrations may contribute to the heterogeneity of 




Nearly two decades ago, Braak and colleagues (2003) proposed a six-stage neuro-
anatomical model for the stereotypical spread of Lewy pathology throughout the peripheral 
and central nervous systems. Although vigorous debate continues regarding the validity of 
Braak’s staging scheme, it has been found to be consistent with roughly 80% - 90% of 
neuropathological specimens (Goedert et al., 2013; Hawkes et al., 2010). Additionally, the 
spread of Lewy pathology predicted by Braak’s model correlates with the appearance and 
progression of PD’s symptoms (Peterson & Horak, 2016). Braak Stages I and II are defined 
by the initial appearance of Lewy pathology in autonomic and sensory systems – notably 
the olfactory bulb, enteric nervous system, reticular formation, and the nuclei of several 
Cranial Nerves (CN) including the glossopharyngeal (CN IX) and vagus (CN X) nerves – 
which comports with the early appearance of autonomic and sensory deficits (e.g. anosmia, 
sleep disorders, constipation, circadian disruption, etc.) in prodromal PD (Goedert et al., 
2013; Jankovic, 2008). The first clinical symptom - in the form of bradykinesia and often 
accompanied by tremor and rigidity – appear in Braak Stage III, which is defined by the 
appearance of Lewy pathology in the substantia nigra pars compacta (SNpc) and the basal 
forebrain. The appearance of bradykinetic motor symptoms is likely due to extensive do-
paminergic cell death in the SNpc and the subsequent degeneration of the nigrostriatal 
pathway (Goedert et al., 2013; Hawkes et al., 2010; Jankovic, 2008; Kalia & Lang, 2015). 
The resulting depletion of dopamine in the basal ganglia leads to systemic dysfunction in 
the form of increased inhibitory output to thalamocortical and brainstem motor networks, 




under-recruitment of muscles and decreased force generation and amplitude (Kalia & 
Lang, 2015; Obeso et al., 2008; Peterson & Horak, 2016). 
Postural instability and gait disturbances (PIGD) typically appear in more advanced 
PD, and have been linked with the appearance of Lewy pathology in the pedunculopontine 
nucleus (PPN) of the mesencephalic locomotor region in Braak Stages III and IV, and in 
premotor and then motor cortices in Stages V and VI (Hawkes et al., 2010; Kalia & Lang, 
2015). Extensive animal research has established the PPN’s role in the initiation and 
maintenance of gait through the integration of ascending sensory and proprioceptive feed-
back and top-down control over spinal central pattern generators (Takakusaki, 2013). This 
has been supported by evidence in humans using deep brain stimulation (DBS), a common 
surgical intervention that provides rhythmic stimulation to the basal ganglia, usually via 
the Subthalamic Nucleus (STN), using an implanted electrode, and which can ameliorate 
motor symptoms. In studies where the PPN in persons with PD was targeted with DBS - 
both directly (Stefani et al., 2007) and indirectly via the STN (Weiss et al., 2015) – PIGD 
decreased. The delayed progression of PIGD symptoms may be due to increased volitional 
control of locomotion as a compensatory mechanism to circumvent the impaired sub-cor-
tical motor networks (Bohnen & Jahn, 2013; Peterson & Horak, 2016). This hypothesis is 
supported by the vulnerability of gait to dual-task cost and cognitive loading (Kelly et al., 
2012), an abnormal increase in cortical activity when performing tasks that normally rely 
on sub-cortical motor programs (Wu & Hallett, 2005), the impaired ability to sequence 
motor tasks (such as turning while walking), and the general variability in gait metrics (e.g. 





Neuroanatomical Substrates underlying Clinical Heterogeneity 
The heterogeneity of PD’s presentation and progression complicates the assessment of the 
clinical features against which potential biomarkers are validated (Espay et al., 2017). Mo-
tor symptoms are evoked through the performance of motor tasks and the degree of im-
pairment is observed by the clinician, who then assigns an ordinal score as defined by the 
MDS-UPDRS’ criteria. However, these task ratings may not account for the differential 
effects individual clinical features have on task performance. Consider the Gait assessment 
(MDS-UPDRS, Item 3.10), which requires the patient to walk away from the clinician, 
turn, and walk back. The MDS-UPDRS instructs the clinician to assess multiple aspects of 
the patient’s gait – e.g. step length, arm swing amplitude, etc. – and to assign a single rating 
representing the overall severity of impairment. However, walking and turning are com-
plex behaviors that are dependent on multiple neural control systems which are not fully 
understood, and whose impairment may differentially affect performance on the Gait task 
(Curtze et al., 2015; S. Lord et al., 2013; Sue Lord et al., 2013; Peterson & Horak, 2016). 
For example, decreased step length may be caused by decreased force generation attribut-
able to bradykinesia, an increase in double stance time to compensate for general postural 
instability, cognitive effects such as fear of falling leading to shorter and quicker steps, or 
some combination of these factors.  
There is growing evidence to suggest that these differential impairments result from 
the dysfunction of distinct motor systems (Nonnekes et al., 2016; Peterson & Horak, 2016). 




resulting in over-inhibition of descending motor output, where-as disruption of the brain-
stem motor nuclei responsible for gait maintenance is the likely cause of PIGD (Peterson 
& Horak, 2016). While these systems are by no means isolated from each other – the PPN 
is extensively connected with both the basal ganglia and the SNpc, for example – their 
impairment is differentially affected by dopamine replacement therapy (Peterson & Horak, 
2016). Levodopa ameliorates bradykinetic symptoms and improves speed and amplitude, 
where-as PIGD has a variable response: gait speed and asymmetry are generally improved 
(Galna et al., 2015), while balance and fall risk are insensitive to dopaminergic replacement 
(Nonnekes et al., 2016; Smulders et al., 2016). Moreover, the integration of wearable sen-
sors and gait analysis systems into walking assessments have revealed that certain dis-
cretely measurable properties of gait (e.g. step length) are differentially sensitive to levo-
dopa therapy (Curtze et al., 2015; Nonnekes et al., 2016; Rochester et al., 2017; Smulders 
et al., 2016). For example, mean step length is significantly greater ON levodopa compared 
to OFF, where-as the variability of step length is unchanged (Peterson & Horak, 2016). In 
addition, a factor analysis (S. Lord et al., 2013) identified multiple “domains” of gait prop-
erties that closely correlate with each other and are thought to reflect similar aspects of gait 
performance (e.g. measures of variability). These domains were identified in healthy older 
adults, replicated in PD (Sue Lord et al., 2013), and were found to have differential re-
sponses to levodopa therapy over 18 months (Galna et al., 2015).  
These observations may be explained by considering the neuroanatomy of these 
networks. Levodopa increases the concentration of dopamine in the striatum, reducing in-




2016). Unlike the dopaminergic nigrostriatal pathway, the projections of the PPN are pre-
dominantly cholinergic and GABA-ergic, which may explain the limited effect levodopa 
therapy has on postural instability (e.g. variability of step length) despite the PPN’s con-
nections to dopaminergic centers (Peterson & Horak, 2016). This is further supported by 
the therapeutic effect cholinergic agents and cholinesterase inhibitors have on postural in-
stability (Smulders et al., 2016). Together, these data suggest that multiple neural systems 
underlie the clinical features of PIGD (Peterson & Horak, 2016; Smulders et al., 2016; Zuo 
et al., 2017). 
These systems are differentially affected by PD’s neuropathological progression. 
For example, bradykinetic symptoms appear after the death of approximately 50% of the 
dopaminergic cells in SNpc (Fearnley & Lees, 1991; Hawkes et al., 2010) and post-mortem 
pathological studies have identified that approximately 40% of PPN cholinergic cells have 
died in Hoehn and Yahr stages (H&Y) IV and V (Hepp et al., 2013). This suggests that the 
SNpc degenerates quicker and may be able to tolerate more cell death than the PPN before 
bradykinesia and PIGD symptoms manifest. In addition, their impairment is likely miti-
gated by different compensatory mechanisms, e.g. increased reliance on volitional control 
of gait (Hawkes et al., 2010; Peterson & Horak, 2016). Together, this evidence suggests 
that clinical evaluations of PIGD (and possibly other clinical features) may be simultane-
ously assessing the dysfunction of multiple, differentially impaired motor systems, and 
thus may be insensitive to their individual impairment and contribution to overall clinical 
presentation (Espay et al., 2017). This may contribute to the inconsistent findings of bi-




disease state and severity; small changes in ASN (indicative of Lewy pathology) or in am-
yloid beta or pTau (which have poorly understood interactions with Lewy pathology) may 
reflect a change in the severity of some symptoms more than others. In other words, studies 
attempting to validate a potential biomarker by its correlation with a clinical feature may 
instead be measuring its correlation with the sum of a wide range of impairments (Espay 
et al., 2017), each with an unknown severity and, due to their distinct neuropathological 
substrates, a different relationship to the biomarker. 
 
Objective Measures of Task Performance 
Certain properties of task performance may reflect discrete impairments that are sensitive 
to a single neural control system (Curtze et al., 2015; Horak & Mancini, 2013; Peterson & 
Horak, 2016; Smulders et al., 2016). As a result, objective measures of task performance 
are increasingly applied in conjunction with clinical evaluation to improve the precision 
and sensitivity with which we can monitor disease state in scientific research (Espay et al., 
2017; Horak & Mancini, 2013). Body-mounted accelerometers are well positioned to ob-
jectively measure these sub-components (Espay et al., 2016; Horak & Mancini, 2013). 
These “wearable sensors” are capable of continuously recording actigraphy throughout a 
patient’s daily life, often producing data with a temporal resolution < 10 milliseconds, and 
have been integrated into a wide variety of standard posture and gait tasks over the last 
decade, such as the instrumented Timed Up-and-Go (iTUG) (Podsiadlo & Richardson, 
1991; Salarian et al., 2010; Zampieri et al., 2010), instrumented Timed Walk (iTW) (Horak 




the methodological challenges of wearable accelerometers remain a significant obstacle to 
their translation into routine clinical practice (Espay et al., 2016; Horak & Mancini, 2013). 
Specifically, their high resolution and sensitivity leaves them susceptible to noisy interfer-
ence, complicated and time-consuming analytical techniques are required to derive clini-
cally meaningful endpoints from the large amounts of data they produce, and the lack of 
standardized methods for their construction, application, and interpretation has created iso-
lated “islands of expertise” that struggle to integrate their different methods (Lana M. 
Chahine & Stern, 2017; Espay et al., 2016, 2017; Horak & Mancini, 2013; Rabuffetti et 
al., 2011). These challenges are amplified in the MDS-UPDRS, as the scale’s semi-stand-
ardized motor tasks (i.e. compared to the iTUG) introduce significant noise into the signal, 
and its loosely structured format (e.g. patient interview, passive assessments, etc.) further 
complicates interpretation and crosswalk between studies. 
If sensor-derived endpoints and potential biomarkers are indeed sensitive to dis-
crete impairments beyond the resolution of the MDS-UPDRS, and if the MDS-UPDRS is 
the gold standard means of determining the clinical validity of these impairments, then how 
should these promising endpoints be validated? This problem has been approached in three 
main ways. The first approach, a macroscopic “paradigm shift” where-by biomarkers are 
used as the new gold standard for defining clinical features, was proposed by Espay and 
colleagues (2017). A second approach is to “cut out the middleman” and relate sensor-
derived endpoints directly to the potential biomarkers; e.g. Rochester and colleagues 




cerebrospinal fluid concentration of ASN, AB, and pTau over three years. The third ap-
proach argues that sensors integrated directly into the MDS-UPDRS itself may be able to 
provide objective measures of task performance in parallel with clinical ratings, but this 
approach has only seen scant exploratory work (Criss & McNames, 2011). 
 
Sleep and Circadian Disruption 
Although PD’s hallmark motor symptoms are its most conspicuous and studied feature, 
there are numerous non-motor symptoms (NMS) that manifest throughout the course of 
the disease (Fifel & Videnovic, 2019). In fact, NMS such as anosmia, autonomic dysfunc-
tion, and constipation appear up to 10 years before the onset of motor symptoms and pro-
gressively worsen over time (Jankovic, 2008). Two NMS - sleep disruption and circadian 
disruption - are closely interconnected and of particular interest to this manuscript. 
As a systemic disease that affects the entire nervous system, it is no surprise that 
the circadian rhythm is impacted in PD. Generally speaking, circadian rhythms in persons 
with PD are more fragmented, lower amplitude, and more resistant to entrainability, and 
often have altered phases relative to the light-dark cycle. This “dampening” is perhaps most 
visible in the diminished amplitude of daily rest-activity rhythms (RARs) caused by dis-
rupted sleep and restricted movement due to motor symptoms and fatigue. Similar damp-
ening has been observed in numerous circadian biomarkers (Videnovic, Lazar, et al., 2014), 
including melatonin secretion (Videnovic, Noble, et al., 2014), CLOCK gene expression 
(Breen et al., 2014; Cai et al., 2010), retinal dopamine (Wirz-Justice et al., 1984), cortisol 




Suzuki et al., 2007). Other circadian biomarkers undergo pronounced phase shifts; e.g. a 
phase reversal of the diurnal blood pressure rhythm (Kallio et al., 2000; Senard et al., 1992). 
Circadian rhythms have also been observed in PD’s symptomology: motor symptoms are 
most responsive to dopaminergic medication early in the morning (Bonuccelli et al., 2000) 
and most severe late in the day (Piccini et al., 1991). Intriguingly, chronotherapeutic inter-
ventions using light exposure at specific times of day has reduced both motor and non-





CHAPTER TWO: METHODS 
Introduction 
This chapter will review the historical background, theoretical basis, scientific context, and 
practical application of the various methods used in subsequent chapters, which include 
subjective assessments, quantitative scales, qualitative questionnaires, and objective sen-
sors, among others. While each method was developed and optimized for a specific purpose 
(and are thus individually discussed herein), they are rarely used in isolation. As navigators 
use multiple reference points to triangulate a location, multiple methods can be synergisti-
cally integrated to better understand, characterize, and “triangulate” the true nature of a 
variable of interest. 
 
Actigraphy 
Wearable accelerometers17 allow for the continuous, longitudinal, and objective monitor-
ing of physical activity; i.e. actigraphy. The applications of actigraphy are diverse (Meyer-
Rochow & Brown, 1998), but in humans it is primarily used to quantify rest-activity 
rhythms (RARs), characterize sleep, assess motor impairment, and infer metabolic activity 
via physical movement (Ancoli-Israel et al., 2015). Actigraphy has been in use for over 
half a century (Ancoli-Israel et al., 2015; J. L. Martin & Hakim, 2011; Tryon, 2013) and 
the first battery-powered wrist-worn actigraphy device was developed nearly four decades 
	
17 Also referred to as Inertial Measurement Units (IMU), actigraphs, wearable sensors, and on-body 
accelerometers. “Accelerometer”, “actigraph”, and “sensor” are often used interchangeably, as are 




ago (Aubert-Tulkens et al., 1987), though technological developments and sensor minia-
turization have greatly increased the quality of actigraphic data through higher accelerom-
eter resolution, greater memory capacity, reduced weight, and increased battery life. As 
with consumer health monitoring devices (e.g. the FitBit), this has fostered the proliferation 
of commercially available actigraphy devices and, likewise, research studies employing 
them. Most actigraphy devices are wrist-worn - most often intended for the non-dominant 
wrist - though others are designed to be worn around the ankle or strapped to the torso 
(Ancoli-Israel et al., 2015). 
Actigraphy has been applied to the clinical evaluation and monitoring of sleep and 
circadian disorders, such as shift work disorder and insomnia (Ancoli-Israel et al., 2015; 
Fekedulegn et al., 2020; Morgenthaler et al., 2007; M. T. Smith et al., 2018). It is consid-
ered a useful supplement to standard sleep assessment methods (e.g. sleep diaries and pol-
ysomnography [PSG]) and is included in the International Circadian and Sleep Disorder, 
Third Edition (ICSD-3) diagnostic criteria for several sleep disorders (Ibáñez et al., 2018; 
Sateia, 2014). In clinical trials of movement disorders such as Parkinson’s disease (PD), 
actigraphy improves the accuracy of clinical endpoints quantifying motor and non-motor 
symptoms and thus has the capacity to hasten the evaluation of critically needed symptom- 
and disease-modifying interventions (Merola et al., 2018). Despite growing support from 
medical directors in industry, actigraphy was included in less than 3% of clinical trials as 
of 2018 (Artusi et al., 2018). 
 Actigraphy is quantitative, applicable in a wide variety of populations and environ-




measuring a physical signal (i.e. movement/acceleration), but also has notable drawbacks: 
the large data-sets it produces can be logistically challenging to store and manage, the raw 
data itself requires significant processing to produce useful endpoints, actigraphy infers 
complex behaviors such as sleep through measures of movement, and there is no standard-
ized method for collecting, processing, or analyzing the data, creating “islands of expertise” 
(Espay et al., 2016) that hinder replicability and complicate meta-analysis (Ancoli-Israel 
et al., 2015; Chow et al., 2016; Goldstone et al., 2018; Ibáñez et al., 2018; M. T. Smith et 
al., 2018). These drawbacks can be mitigated through synergistic use of other methods; for 
example, sleep diaries provide subjective sleep information that can be cross-referenced 
with actigraphic estimates to detect sleep detection errors (Schwartz, 2012), and gyro-
scopes embedded in actigraphy devices allows the sensor’s orientation to be easily deter-
mined, greatly simplifying analysis (van Hees et al., 2013). Ultimately, actigraphy’s acces-
sibility, reduced cost, and ability to continuously monitor behavior in naturalistic environ-
ments (e.g. in-home) makes it easily scalable and an appealing option for studies with large 
sample sizes, long monitoring periods, and/or a desire in capturing ecologically valid data 
(Andrade, 2018; Fekedulegn et al., 2020). However, there is a strong need for methodo-
logical transparency and harmonization, and a growing acknowledgment that future scien-
tific reports should provide detailed technical, scoring, and analytical information to facil-





Data Quality and Pre-Processing 
Before they can record data, actigraphy devices must be configured according to the sci-
entific and/or clinical specifications of their application. Generally, this entails defining a 
sampling rate for recording accelerometry, a duration of recording, which sensors to record 
from (e.g. gyroscope, accelerometer, light sensor), and a recording period18. The intended 
location for the device to be worn on the body should also carefully considered, both to 
maintain consistency with previous studies and to preserve data integrity; i.e. the location 
should not irritate the subject to avoid unintentionally encouraging noncompliance, and 
should minimize the effect of confounding movement (e.g. lateralized resting tremor in 
PD) (Maglione et al., 2013). The intended use of the actigraphy device (i.e. period to be 
worn, location, etc.) and instructions on how to care for it (e.g. charging, remove when 
swimming, etc.) should be clearly conveyed to the subject to maximize compliance (An-
coli-Israel et al., 2015). Last, but certainly not least, the processing and analysis of actigra-
phy should follow a consistent and predetermined protocol that includes criteria for data 
filtering, artifact identification, statistical analysis, and other study-specific requirements 
such as sleep detection algorithms and missing data tolerance for RAR modelling and phys-
ical activity computations (J. L. Martin & Hakim, 2011). 
Actigraphy produces large data-sets that must be exported, cleaned, filtered, con-
densed, and visualized using computer software. This processing is often handled by pro-
prietary software bundled with actigraphy devices (e.g. Philips ActiWare), though this can 
	
18 By default devices will begin recording as soon as configuration is finished, though some actig-





also be done using publicly available scripts (e.g. GGIR). Processing begins when the rec-
orded data is exported off the used device; depending on the device used, the exported data 
may consist of raw accelerometry or endpoints derived using a proprietary algorithm (e.g. 
activity counts). Actigraphy devices with an onboard clock will usually provide timestamps 
for the data; otherwise, timestamps will have to be manually derived from the recording 
start time. If there are any other data-sets of interest that were collected in parallel (e.g. a 
second actigraphy device, concomitant PSG recording, etc.), these should be synchronized 
once all data is properly timestamped. Temporal drift is a ubiquitous temporal confound 
that must be accounted for during synchronization, especially in multimodal data19. Alt-
hough the rate of drift is often quite small, it can accumulate to a considerable magnitude 
in longitudinal studies with long recording periods. This drift can be accounted for in syn-
chronization using common references at the beginning and end of a recording; this can be 
as simple as noting the times when the recording(s) began and ended, or involve more 
complex strategies such as having the device(s) record a known acceleration signal (e.g. 
shaking for 10 seconds) at known times throughout the recording20. Regardless, once the 
	
19 It is possible to avoid drift by continually synchronizing the device’s clock to an absolute refer-
ence, such as Network Time Protocol (NTP) servers, though this consumes extra power and is not 
feasible in most monitoring studies 
20 As internal clocks can be affected by environmental conditions such as temperature and mechan-
ical stress, the rate of drift can also vary over time within the same device; i.e. inter-sample latency 
is not constant. Therefore adjusting all timestamps to match the true duration would correct for the 
cumulative net drift, but individual samples may still have incorrect timestamps due to acute vari-
ability in drift rate. By using multiple known signals scattered throughout the recording at known 
times, the drift rate can be more precisely resolved; however, this introduces obvious methodolog-
ical and logistical challenges, so researchers must weigh the increased temporal resolution of more 




true duration of recording is known its internal timestamps can be corrected and allow the 
accelerometry to be aligned with other data. 
 Invalid data should be identified and judiciously removed (Ancoli-Israel et al., 
2015). This includes “off-body time” when the sensor was not being worn by the subject, 
abnormal data indicative of device malfunction or that contradicts parallel measures (e.g. 
persistently high night-time activity during the sleep period recorded on a sleep diary), and 
confounds and artifacts (Ancoli-Israel et al., 2015; Evenson & Terry, 2009; Fekedulegn et 
al., 2020). Times when the device can be confirmed to be off-body - such as the begin-
ning/ending of a recording before/after the subject has donned/removed the device - are 
easily removed, but inferring potential off-body times without a ground truth reference is 
considerably more difficult. Off-body time can be visually identified by plotting the data 
and looking for the absence of movement; i.e. a “flatlined” signal means the device is per-
fectly still and thus almost certainly not on the subject. Actigraphy logs, where-in subjects 
record when and why they removed actigraphy devices (among other contextual infor-
mation), can also help identify off-body times; some devices also have a binary “marker” 
button that can be pressed to indicate specific events, such as donning or removing a device. 
Although there are algorithms for automatically detecting off-body time, these should be 
considered in addition to - not in place of - manual review (Ancoli-Israel et al., 2015). 
Differentiating “abnormal” accelerometry from normal data is much more ambiguous; 
without a ground truth confirmation of the subject’s actual behavior, such as via a video 
recording, it can be difficult to determine whether the fault lies with the actigraphy device 




high activity during a time the subject indicated they were asleep could be attributable to 
an erroneous sleep diary entry, restlessness during sleep the subject failed to notice or re-
port, or device failure. In such situations, it is useful to determine if the device is still mal-
functioning and if the error can be recreated, which might indicate the data should be ex-
punged. Artifacts and confounding signals can also be ambiguous, both in their identifica-
tion and in defining what signals should be considered artifacts. However, very consistent 
signals such as footsteps (Czech & Patel, 2019) can be identified using feature detection 
algorithms a la eyeblink artifact filtering in PSG, and detailed annotation of involuntary 
activity such as a parent recording when they were rocking their child to sleep in child 
actigraphy studies (Ancoli-Israel et al., 2015). Missing data is, nonetheless, common in 
actigraphy due to subject noncompliance and the aforementioned data quality issues (Fus-
ter-García et al., 2013). 
 
Epoching and Epoch-Level Endpoints 
Raw accelerometry is rarely directly used in analysis, but is instead condensed into epochs 
ranging from seconds to minutes in length (Ancoli-Israel et al., 2015), a process colloqui-
ally referred to as “data condensation”, “epoching”, or “binning”. This may be done auto-
matically by the device or its accompanying software, by using freeware scripts, or manu-
ally via spreadsheet software. Epoching greatly simplifies analysis by reducing the overall 
volume of data and condensing the raw high-frequency tri-axial accelerometry into epoch-
level summary statistics; e.g. a 1-minute 100 Hertz (Hz) recording would contain 60 sec-




to a single variable representing the entire minute of recording. This aids statistical analysis 
by reducing the dimensions of the time-series data and binning key features (e.g. overall 
activity) into discrete spans of time; this latter aspect also facilitates categorical analysis, 
such as determining whether an epoch should be classified as asleep or awake. Epochs 
were borne of necessity due to technological limitations in data storage and epoch lengths 
of 1-hour were used in the 1990’s (van Someren et al., 1996); as the resolution and capacity 
of wearable accelerometers continues to improve, epoching lengths have become more 
flexible and capable of shorter durations. 
Currently, epoch lengths are usually measured in seconds and are cleanly divisible 
into a minute; e.g. 60-second, 30-second, 15-second, and 1-second epochs. As is often the 
case in science , selecting epoch length requires determining the optimal trade-off of ben-
efits and drawbacks . Longer epochs reduce data volume, ease processing, and emphasize 
long-duration trends in the data (e.g. diurnal RAR), but lose most information related to 
events shorter than itself (e.g. a 3-second sneezing fit may account for most of the recorded 
activity in a 60-second epoch). However, this coarse resolution “smooths out” and reduces 
the confounding effects that random noise and irrelevant transient signals have on gross 
actigraphy data. Shorter epochs have higher temporal resolution and so can more easily 
capture briefer signals, distinguish temporally proximal events, and more accurately detect 
sleep (Ancoli-Israel et al., 2015), but this comes at the cost of increased data volume and 
thus more processing, as well as greater sensitivity to noise. If the goal is to assess large-
scale trends (e.g. diurnal RAR) or if a dataset is particularly large, then the costs of using 




and/or high-frequency behaviors (e.g. postural transitions, tremor) would benefit from the 
increased resolution of shorter epochs. 
The activity content of a given epoch can be summarized using a variety of end-
points, both proprietary and public. An example of the former are Activity Counts (AC), 
which are automatically computed by Actiware software using a private algorithm when 
exporting accelerometry data from an Actiwatch. However, one can infer the principles of 
this algorithm by considering how other devices, such as the Motionlogger Sleep Watch 
(Ambulatory Monitoring, Incorporated, NY), collect and process their raw signals 
(Fekedulegn et al., 2020). Each axial accelerometer21 continually produces a voltage via an 
analog transducer that changes in response to movement and which is sampled at the de-
vice’s sampling frequency; these measured voltage data from the transducer are then pro-
cessed in one of three ways to produce epoch-level endpoints. Zero Crossing Mode (ZCM) 
defines some reference voltage (usually near 0) and outputs the number of times the meas-
ured voltage crosses the predetermined reference threshold; ZCM is often interpreted as 
measuring the frequency of movement. Time Above Threshold (TAT) is similar in that it 
also defines a reference threshold, but instead of yielding how many times it was crossed 
by the transducer’s measured voltage, it outputs the duration of time the measured voltage 
was higher than the reference; TAT is therefore interpreted as the duration of movement. 
Proportional Integration Mode (PIM) quantifies the area-under-the-curve of the measured 
voltage; because it integrates both duration and amplitude, PIM is interpreted as the inten-
	




sity of movement (Fekedulegn et al., 2020). Of these, ZCM is likely the basis for Acti-
watch’s AC algorithm because its high accuracy of sleep detection has made it the most 
commonly used method in sleep research (Fekedulegn et al., 2020); however, it is suscep-
tible to inflation from high-frequency artifacts (e.g. rapid vibration) and is the least sensi-
tive to movement amplitude (Ancoli-Israel et al., 2003). Moreover, the AC produced by 
ZCM, TAT, and PIM algorithms significantly diverge from each other even when applied 
to the same data; in combination with the tendency for studies to omit the algorithm they 
used and report actigraphy as just AC, this creates confusion and undermines the validity 
of between-study comparisons (Ancoli-Israel et al., 2003). Fortunately, there are publicly 
available methods that compute epoch-level endpoints directly from raw accelerometry 
using simple vector equations22. Vector Magnitude (VM) is the square root of the summed 
squares of the x-, y-, and z-axis voltages in a given sample: VM = sqrt(x2 + y2 + z2). VM 
thus represents the magnitude of acceleration. The VM is usually calculated sample-by-
sample, then either summed or averaged across an epoch. 
One significant drawback of all methods described so far is their inability to account 
for the constant acceleration of earth's gravity (Bakrania et al., 2016). Since the three axial 
accelerometers are at fixed, orthogonal orientations to each other, the directions of their 
vectors are known and their magnitudes easily integrated into VM using the above men-
tioned equation. However, the direction of the gravitational vector with respect to the ac-
celerometer can change without restraint by simply reorienting the device. Accelerometers 
	
22 Some devices, such as the Actiwatch, only allow for proprietary algorithms; the raw accelerom-




with built-in gyroscopes can easily monitor the device’s orientation; this information can 
be used to calculate the gravitational vector’s direction for each sample, and allowing it’s 
magnitude to be removed from the VM. without a gyroscope, the crudest method of ac-
counting for gravity is to uniformly subtract the standard acceleration due to gravity (g; i.e. 
9.8 meters/second2) from the VM; negative values are imputed as 0 since a vector cannot 
have a negative magnitude. This converts VM into an endpoint called Euclidean Norm 
Minus One (ENMO) which can similarly be summed or averaged across an epoch. Another 
derivation of VM is Mean Amplitude Deviation (MAD), which is calculated by subtracting 
each VM in a given epoch from the average of VMs for all i samples in that epoch, sum-
ming the differences, and multiplying the sum by the inverse of the number of samples (n) 
in the epoch (Bakrania et al., 2016): MAD = ( 1 / n ) * Σ( VMi + ( Σ( VMi ) / n ) ). 
 
Sleep Scoring Algorithms in Actigraphy 
Regardless of the epoch-level endpoint used, a time-series of actigraphy epochs can be 
algorithmically segmented into different behavioral periods via analysis of activity levels. 
At the most basic level, sleep scoring algorithms - also known as (AKA) sleep scoring 
functions - dichotomously categorize epochs as either asleep or awake (Fekedulegn et al., 
2020). Although existing sleep scoring algorithms are tailored to the specific actigraph 
used, activity endpoints generated (e.g. ZCM), the selected epoch length, and – to a lesser 
extent – the age and clinical status of the subject, most work off the same general principles 
with relatively minor variations (Ancoli-Israel et al., 2015; Fekedulegn et al., 2020). Gen-




which includes the current epoch and those immediately preceding and following it, by 
multiplying each epoch’s activity level by a unique constant or “weight”. These weighted 
activity levels are then either averaged or summed, depending on the specific algorithm, 
and are sometimes further scaled by some constant. Other descriptive statistics derived 
from epoch-level activity levels (e.g. variance) may be incorporated in some sleep scoring 
algorithms. Regardless, the final output of a sleep scoring algorithm for a given epoch - i.e. 
its sleep score - is then compared against some predetermined threshold - i.e. the wake 
threshold value - representing the theoretical upper limit of activity observable during 
sleep. If the sleep score exceeds the wake threshold value, then the activity level is consid-
ered too high for sleep and the epoch is scored as awake; otherwise it is scored as asleep 
(Fekedulegn et al., 2020). Note that “invalid” epochs determined to have missing data or 
some other issue preclusive to analysis are typically removed prior to application of a sleep 
scoring algorithm. 
While there are several sleep scoring algorithms currently in use, the most relevant 
to this manuscript is the Actiware sleep scoring algorithm for 1-minute epochs (Fekedulegn 
et al., 2020; Mini Mitter Company, Inc., 2006). As described above, the Actiware algorithm 
samples a moving average, weighting the activity levels of individual epochs based on their 
temporal position relative to the current epoch being scored. The specific formula is: 
 





...where T is the sleep score being calculated, w is the weight for a given epoch, and A is 
the AC for a given epoch, with the subscripts defining the epochs based on their position 
relative to the current epoch being scored (e.g. w-2 refers to the epoch that came two epochs 
before the current epoch being scored) (Fekedulegn et al., 2020). The wake threshold value 
for determining sleep has three default settings provided in Actiware - low = 20, medium 
= 40, and high = 80 - though the specific number can be set by the user. The Actiware 
algorithm has been found to have comparable sensitivity and specificity in comparison to 
other algorithms (Benson et al., 2004; Meltzer et al., 2012; Tonetti et al., 2008), such as 
the Cole-Kripke algorithm (Cole et al., 1992), though another study comparing these two 
algorithms concluded that the Cole-Kripke had “nominally better agreement with PSG” 
(Rupp & Balkin, 2011). Note that these studies were principally concerned with comparing 
the Actiwatch to other actigraphs; since the Actiwatch’s data can only be processed through 
the proprietary Actiware algorithm, this resulted in an indirect comparison of the Actiware 
algorithm to whichever publicly available sleep scoring algorithm was used to analyze data 
from the other actigraph. 
There are several publicly available algorithms in use today; amongst the most pop-
ular are the Cole-Kripke algorithm (Cole et al., 1992), the University of California San 
Diego (UCSD) algorithm (Jean-Louis et al., 2001), and the Sadeh algorithm (Fekedulegn 
et al., 2020; Sadeh et al., 1994). Briefly, the Cole-Kripke and UCSD algorithms23 use the 
	
23 Although developed and evaluated separately, the Cole-Kripke and UCSD algorithms are nearly 




same basic “moving average” strategy as the Actiware algorithm, with three major differ-
ences. First, both algorithms are explicitly designed for ZCM epoch data - although Acti-
ware’s AC are likely calculated with ZCM, the specifics of their ZCM algorithm are pro-
prietary and thus cannot be generalized to other ZCM data as easily as the Cole-Kripke and 
UCSD algorithms can be. In addition, the UCSD algorithm is the only one of the four 
algorithms to be compatible with PIM and TAT epoch data. Second, both the Cole-Kripke 
and UCSD algorithms use a broader window than the Actiware algorithm, including the “-
3” and “-4” epochs when calculating sleep score. Third, both algorithms scale the sliding 
average/sum by the multiplicative constant P to derive the sleep score, where-as the Acti-
ware algorithm simply uses the raw sliding average/sum (Cole et al., 1992; Fekedulegn et 
al., 2020; Jean-Louis et al., 2001). The Sadeh algorithm is distinct in that it simplifies the 
sliding window calculation by using a uniform weight for all epochs, expands the sliding 
window to 11 epochs (compared to Actiware’s five epoch and UCSD and Cole-Kripke’s 
seven epoch windows), and integrates three additional measures: the standard deviation of 
the first six epochs (including the current epoch being scored), the number of epochs in the 
sliding window whose activity levels fall within a moderate activity range, and the natural 
log of the activity level of the current epoch being scored. All of these measures are sub-
tracted from a constant positive value, and a given epoch is scored as asleep if the differ-
ence is ≥ 0 (Fekedulegn et al., 2020; Sadeh et al., 1994). All three algorithms have been 
shown to have high sensitivity and moderate specificity for the correct identification of 




2020; Haghayegh et al., 2019; Quante et al., 2018)24. However, all three have reduced sen-
sitivity for correctly detecting wake epochs and thus tend to overestimate the amount of 
sleep, although this is not as severe in the Sadeh algorithm and can be reduced through 
structured post-hoc rescoring of the dichotomized asleep/awake epochs (Webster et al., 
1982). 
 
Algorithmic Derivation of Sleep Characteristics from Actigraphy 
Once a sleep period is segmented into asleep and wake epochs, a number of sleep charac-
teristics can be calculated that reflect distinct dimensions of sleep behavior (Berger et al., 
2005; Fekedulegn et al., 2020)25. This begins by defining the Sleep Period (SP); i.e. the 
difference in units of time between the Sleep Onset (SON) and Sleep Offset (SOFF) times. 
Actiware defines SON/SOFF as the first/last epoch of the first/last series of n consecutive 
epochs scored asleep, with n being a customizable number known as the immobile minutes 
value (by default, n = 10). Alternatively, Actiware can determine SON/SOFF using a mo-
bility threshold, which categorizes an epoch as mobile if its AC ≥ m or as immobile if its 
AC is < m, where m is the predetermined mobility threshold (by default, m = 4). These 
dichotomized epochs are then analyzed in the same way as the sleep scoring method: i.e. 
SON/SOFF is defined as the first/last epoch of the first/last series of n consecutive epochs 
scored immobile  (Fekedulegn et al., 2020; Mini Mitter Company, Inc., 2006). Sleep Onset 
	
24 The similarities between the Actiware algorithm principally used in this manuscript and the pub-
licly available Cole-Kripke and UCSD algorithms allow us to tentatively extrapolate these findings 
to our interpretation of the Actiware algorithm 





Latency (SONL) and Sleep Offset Latency (SOFFL) represent the time it took for the indi-
vidual to fall asleep after going to bed and the time it took them to get out of bed after 
waking up, respectively. While it is technically defined as the time elapsed between when 
the individual reported going to bed (either through a sleep diary or by pressing their acti-
graph’s marker button) and the first epoch scored as sleep, Actiware can automatically 
calculate SONL via the number of immobile, awake epochs flanking the SP. By adding 
SONL and SOFFL to SP, the Time in Bed (TiB) can be calculated; i.e. TiB = SONL + SP 
+ SOFFL, where SP = SOFF - SON (Fekedulegn et al., 2020; Mini Mitter Company, Inc., 
2006). TiB can also be expressed as the sum of Total Sleep Time (TST) and Wake After 
Sleep Onset (WASO), themselves defined as the cumulative duration of all sleep epochs 
and all wake epochs, respectively. This allows Sleep Efficiency (SE), a general measure of 
sleep quality (Berger et al., 2005), to be calculated thusly: SE = TST / TiB or, written dif-
ferently, SE = TST / (SONL + (SOFF - SON) + SOFFL). Percent Sleep Time (PST) is a 
similar – and often conflated (Fekedulegn et al., 2020) – measure calculated thusly: PST = 
TST / SP. In other words, PST is SE without the inclusion of SOFFL and SONL (Mini 
Mitter Company, Inc., 2006). 
Numerous other sleep characteristics can be derived via simple arithmetic: the num-
ber of awake bouts and sleep bouts, their average duration, their variance in duration, and 
maximum/minimum durations observed in a night, activity levels, including peak activity 
and average activity throughout the night, during wake, and during sleep, as well as abso-




mobility threshold (Fekedulegn et al., 2020; Mini Mitter Company, Inc., 2006). This ena-
bles the calculation of Fragmentation Index (FI), a measure of how likely a person is to 
transition between sleep and wake periods throughout the night (Fekedulegn et al., 2020; 
Natale et al., 2009), which can be derived thusly: FI = ([number of mobile bouts] + [num-
ber of immobile bouts ≤ 1 minute]) / [number of immobile bouts] (Mini Mitter Company, 
Inc., 2006). However, FI has been calculated differently; e.g. FI = [number of wake bouts] 
/ TST (Fekedulegn et al., 2020). This serves as a reminder that many of the sleep charac-
teristics reported in the literature – especially those reported without an accompanying 
equation – were produced using unknown or unverified equations due to insufficient meth-
odological reporting (M. T. Smith et al., 2018). 
 
Cosinor Models 
Three-Parameter “Basic” Cosinor Model 
When analyzing time-series data to identify and/or quantify a rhythmic feature, it is helpful 
to fit the data to an oscillating regression model from which the rhythm’s parameters and 
estimates of its statistical significance can be derived (Cornelissen, 2014). The three-pa-
rameter “basic” cosinor is amongst the simplest such models26. The term cosinor was 
coined by Halberg and colleagues (1965) as a derivation of the term sinor, which refers to 
the vectorial plots used to modelling rhythmicity in voltages and currents (LePage, 1949), 
	
26 This is often referred to as simply the “cosinor model” or just “cosinor”; the terms “basic cosinor” 
and “three-parameter cosinor” appear but are not extant in the literature. They are used in this man-
uscript for clarity to distinguish between the basic three-parameter cosinor and the extended five-




due to the similarities in applying rhythmic functions to model and visualize oscillations in 
time-series data. Since then, the basic cosinor has become a common tool employed by 
chronobiologists for the quantification of biological rhythms, especially the circadian 
rhythm (Cornelissen, 2014)27. Any rhythmic signal with a constant period can be modelled 
using the basic cosinor, but the most common signals are homeostatic (e.g. temperature), 
hormonal (e.g. cortisol), physiological (e.g. heart rate), and behavioral (e.g. physical activ-
ity) measures that exhibit a circadian rhythm. Cosinor models are usually fit to data with a 
duration ≥ 2 * period, providing an averaged model that “smooths out” the expected normal 
inter-daily variance; this is analogous to the application of signal averaging to produce 
evoked potentials in electroencephalography. Uniperiodic cosinors are also used. 
The basic cosinor is a parametric function that assumes a normal distribution of 
data, and is most often fit using linear least squares regression (Cornelissen, 2014; Neikrug 
et al., 2020). The core formula of the basic cosinor model is: 
 
Y(X) = MESOR + ( Amplitude * cosine( ( X * 2 * π ) + Acrophase ) ) + e(X) 
 
...where Y is the measured signal being modeled, X is the time associated with the time-
series data, cosine is the trigonometric cosine function, and e(X) is the error term. In addi-
tion, there are three fundamental parameters that are defined in a basic cosinor model: the 
Midline Estimating Statistic of Rhythm (MESOR) is the average value of Y across the time-
	
27 Interestingly, the basic cosinor was first applied to model circaseptan rhythms in 17-ketosteroid 




series, the Amplitude (Amp) is the difference between the maximum value of Y and the 
MESOR, and Acrophase (Acro, AKA Phi or Φ) is the temporal offset (i.e. phase-shift) of 
the model relative to some constant arbitrary reference (e.g. midnight). As the parameter’s 
values are selected by fitting the model to data through regression (e.g. ordinary least 
squares), an R2 value28 representing model fit can be calculated. A higher MESOR indicates 
a higher average activity across the day and night, a higher Amp indicates a higher maxi-
mum activity and “more rhythmic changes”, a later Acro indicates a later period of “peak 
activity” in the model and can reflect a shift in the model’s temporal phase, and R2 is a 
conventional statistical endpoint where higher values indicate a better (more accurate) 
model fit. In the context of rhythmometric analysis, higher R2 values are often interpreted 
to reflect a more robust circadian rhythm - i.e. one that exhibits consistent high amplitude 
sinusoidal oscillations (Neikrug et al., 2020). Cosinors are usually reported by presenting 
it’s best-fit parameters, often accompanied by a graphical representation of the model over-
laid on a plot of Y by X. 
The basic cosinors simplicity is both its greatest strength and its greatest weakness. 
Requiring only three parameters (MESOR, Amp, and Acro), it is not computationally inten-
sive to fit and the details of its pre-processing and application can be easily reported and 
replicated. This also allows the basic cosinor to be run on a wide variety of scripting lan-
guages (e.g. R, Python), analysis programs (e.g. MATLAB, PRISM), dedicated circadian 
analysis toolkits, and other software. Cosinors also do not require equidistant data and can 
	
28 Occasionally referred to as the “Circadian Rhythmicity Index” (Grierson et al., 2016; Robillard 




tolerate missing data, giving it great flexibility especially in situations where the data can 
only be measured sporadically (e.g. salivary melatonin). However, the basic cosinors sim-
plicity entails several restrictive assumptions, most notably that the oscillating signal ex-
hibits a continuous, symmetrical, and sinusoidal “rise” and “fall” in amplitude with equi-
distant peaks/nadirs that remains constant over multiple periods. However, biological 
rhythms are rarely symmetrical and are frequently characterized by non-sinusoidal patterns 
(Marler et al., 2006; J. Martin et al., 2000; Refinetti et al., 2007; Smagula, Boudreau, et al., 
2015). For example, the basic cosinor is often applied to model human Rest-Activity 
Rhythms (RARs) using actigraphic data collected via wearable sensors. While human 
RARs are strongly rhythmic and possess readily distinguishable “high” and “low” activity 
periods, they are not sinusoidal: activity is low to nonexistent during sleep, then rapidly 
increases upon waking and “plateaus” for most of the waking day with intermittent periods 
of higher- and lower-than-average activity (e.g. exercising and napping, respectively), be-
fore rapidly decreasing with sleep onset (Dowling et al., 2005). Human RAR’s are also not 
symmetrical, as demonstrated by the fact that we only spend ~33% of the day in low-ac-
tivity torpor and sleep. Put simply, human RAR’s resemble “square waves” more-so than 
the inflexible symmetrical sinusoid assumed by the basic cosinor model; this causes it to 
over- or under-estimate activity levels for most of the day, especially during sleep/wake 
transitions when the most rapid changes in activity level occur. Many signals (e.g. actigra-




infrequent and brief moments of very high activity29. Lastly, the basic cosinor has been 
criticized for its poor model fit; one exemplar study found that their basic cosinor model 
accounted for less than a quarter of the observed variance in actigraphy data (Neikrug et 
al., 2020; Satlin et al., 1995). This contributes to the difficulty in translating basic cosinor 
models into clinical applications.  
 
Five-Parameter “Extended” Cosinor Model 
The extended cosinor is an expansion of the basic cosinor model (Franz Halberg et al., 
1965) developed to more accurately model the waveform of human RARs in actigraphy 
data (Marler et al., 2006; J. Martin et al., 2000). The first use of the so-called “extended 
cosine function” was in 2000 (J. Martin et al., 2000), and the model was later expanded in 
2006 (Marler et al., 2006)30. As with the basic cosinor, the extended cosinor is used to 
model rhythmic signals in time-series data by fitting them to a cosine function; unlike the 
basic cosinor, the extended cosinor uses non-linear least squares regression and therefore 
requires initial starting values (Marler et al., 2006). Moreover, the extended cosinor in-
cludes two additional parameters (Alpha and Beta) that modulate the waveform to better 
fit the data, and which are incorporated into the model via a “sigmoidal transformation” of 
the data31. The original authors proposed three versions of the extended cosinor, each using 
	
29 This can be partially corrected for using log transformations and/or by reducing excessively high 
activity data to a uniform maximum threshold using a “high-pass filter” 
30 Except where stated otherwise, Marler et al.’s (2006) terminology is used to describe components 
of the extended cosinor in this manuscript. 
31 The original paper that introduced the extended cosinor referred to it as the “sigmoidally trans-




a different sigmoidal transformation: the Hill function, the anti-logistic function, and the 
arctangent transform (Marler et al., 2006). The authors also noted that no function can 
perfectly recreate a model generated by a different function, but clarified that these inevi-
table qualitative differences between sigmoid functions may be negligible. While most ar-
ticles employing extended cosinors do not state which sigmoidal transformation they used 
(Grierson et al., 2016; Reimúndez et al., 2018; Robillard et al., 2014, 2016; Rodriguez-Zas 
et al., 2012; Spira et al., 2015; Walsh et al., 2014), the anti-logistic function is the most 
common amongst those that do provide this information (Davoudi et al., 2018; Paudel et 
al., 2010; Smagula, Ancoli-Israel, et al., 2015; Smagula, Boudreau, et al., 2015); the Hill 
function is also rarely used (Pagani et al., 2016). Although the additional parameters and 
flexibility of the modelled waveform improves the accuracy of the model and the richness 
of its information, it is still subject to the same assumption of normality in the data which 
most biological signals do not adhere to (Neikrug et al., 2020). 
MESOR, Amp, and Acro/Phi represent the same general rhythmometric properties 
in the extended cosinor as they did in the basic cosinor (i.e. average, range, and timing, 
respectively), but MESOR and Amp are calculated differently (Marler et al., 2006): MESOR 
is the average of Y’s maximum value and minimum value (rather than the average of all Y 
values), and Amp is the difference between the model’s maximum Y value and minimum 
Y value (rather than maximum Y value and MESOR). The two new parameters affect the 
waveform’s shape: Alpha is the width of the modelled sinusoid’s trough (higher Alpha 
indicates a longer in-bed/sleep/somnolescent period), and Beta is the steepness of the tran-




magnitude nocturnal activity to high-magnitude diurnal activity, and vice versa). Since the 
extended cosinor allows “peaks” and “troughs” to have different durations, two additional 
endpoints can be derived by calculating when the modelled activity crosses the MESOR: 
the time when modelled activity exceeds MESOR is referred to as Up-MESOR, and it’s 
descending corollary is Down-MESOR. These are often interpreted to represent the approx-
imate onset and offset of waking activity, respectively (Marler et al., 2006; Neikrug et al., 
2020; Smagula et al., 2018)32; similarly, the slope of the modelled activity at the MESOR 
intercepts has been interpreted to represent the . Note that Up-MESOR and Down-MESOR 
can be derived from the basic cosinor as well; however, since the basic cosinor is symmet-
rical, Up-MESOR and Down-MESOR would be exactly 12 hours apart from each other, 
and fall exactly 6 hours before and after Acro/Phi (respectively), and thus offer no infor-
mation not already provided by Acro/Phi. An R2 value indicative of the accuracy of the 
fitted model can be calculated a la the basic cosinor. Lastly, a Pseudo-F Statistic can be 
derived from the residual sums of squares of a basic and extended cosinor modelled on the 
same data; this represents the extended cosinors improvement in model fit relative to the 
basic cosinor (Marler et al., 2006). 
 
Clinical Evaluation of Parkinson’s Disease 
In the absence of validated biomarkers of Parkinson’s disease (PD), clinimetric assessment 
remains the primary means of evaluating disease status and translating clinical presentation 
into analyzable data (Espay et al., 2016). Generally, this entails a trained and experienced 
	




clinician observing the subject’s clinical presentation and subjectively rating the severity 
of individual symptomatic domains using predetermined criteria, often accompanied by a 
patient/informant interview and discrete motor tasks. However, PD’s marked heterogene-
ity, broad array of motor and non-motor symptoms, and fluctuating symptomatic severity 
(whose variability is exacerbated by dopaminergic therapy, a common means of controlling 
PD motor symptoms) have complicated the clinimetric assessment of PD and the integra-
tion of these observations into standardized, sensitive, and clinically relevant summary 
scores (Opara et al., 2017). Both the clinical validation of potential neuropathological bi-
omarkers (e.g. alpha-synuclein) and the refinement of existing methods for quantifying 
disease severity are considered high-priority goals of the PD research community (Lana 
M. Chahine & Stern, 2017; Espay et al., 2016). Currently, PD is assessed through a com-
bination of gross staging (e.g. Hoehn and Yahr scale [HY]) (Hoehn & Yahr, 1967), disease-
specific detailed clinical scales (e.g. Unified Parkinson’s Disease Rating Scale [UPDRS]) 
(Goetz et al., 2008), patient- and informant-reported outcomes (e.g. Hauser diaries) 
(Hauser et al., 2000), and quantitative motor tasks that evoke parkinsonian symptoms (e.g. 
Timed Up-and-Go [TUG]) (S. L. Mitchell et al., 2000). 
 
Hoehn and Yahr Scale 
Although PD was first described in 1817 (Parkinson, 1817), the H&Y was the first attempt 
at using clinical symptoms to stage PD into a standardized disease severity scale. The orig-
inal H&Y was published almost exactly 150 years after Parkinson’s seminal work to ad-




& Yahr, 1967); specifically, the lack of a common nomenclature and standard clinical cri-
teria created controversy regarding the efficacy of therapeutic interventions and descrip-
tions of PD’s natural history and progression. Initially the H&Y consisted of five stages - 
denoted as I, II, III, IV, and V - representing increasing levels of “clinical disability” 
(Hoehn & Yahr, 1967); these ranged from “unilateral involvement ... with minimal or no 
functional impairment” (Stage I), to “fully developed [symptoms]” where the patient is 
“markedly incapacitated” (Stage IV), and ultimately “confine[d] to bed or wheelchair” 
(Stage V). Hoehn and Yahr acknowledged that these did not necessarily reflect distinct 
pathophysiological stages, and that functional impairment and disability were chosen as 
staging criteria to support reproducibility, simplify assessment, and emphasize clinical rel-
evance (Goetz et al., 2004; Hoehn & Yahr, 1967). A modified H&Y that updated the cri-
terion language and added two intermediate stages - 1.5 and 2.5 - gained popularity in the 
1990’s after it was employed in several clinical trials (Jankovic et al., 1990). However, the 
Movement Disorder Society (MDS) recommends the original H&Y be used until the mod-
ified H&Y can be clinimetrically validated (Goetz et al., 2004; Poewe, 2012). 
While the H&Y has been largely eclipsed by the significantly larger and more de-
tailed Unified Parkinson’s Disease Rating Scale, both the original and the modified H&Y 
continue to see widespread use, especially as screening tools in research studies and clinical 
trials (Goetz et al., 2004; S. L. Mitchell et al., 2000). This is primarily due to its simplicity 
and brevity (Goetz et al., 2004), its pivotal role in PD research before the development of 




ing the H&Y), its use as a gold standard for the development of subsequent clinical instru-
ments (Ramaker et al., 2002), and its correlation with other measures of disease progression 
such as the UPDRS (P. Martínez-Martín et al., 1994) and MDS-UPDRS (Skorvanek et al., 
2017), neuropathological markers such as fluorodopa positron emission tomography 
(Vingerhoets et al., 1994), motor impairment (Reynolds & Montgomery, 1987), and quality 
of life (M. Welsh et al., 2003). However, its basic structure limits its ability to capture all 
of PD’s diverse clinical presentations and precludes its use as a sensitive measure of ther-
apeutic efficacy. Moreover, it’s focus on posture and laterality to stage patients over-em-
phasizes PD’s motor symptoms at the cost of its historically undervalued non-motor symp-
toms. Nonetheless, the H&Y remains a valuable and accessible tool that will remain a 
mainstay in basic and clinical PD research for the foreseeable future (Goetz et al., 2004). 
 
Movement Disorders Society’s Unified Parkinson’s Disease Rating Scale 
The Unified Parkinson’s Disease Rating Scale (UPDRS), is considered the gold standard 
for assessing PD’s clinical features. Originally published in the 1980’s, the scale was ex-
tensively revised by the Movement Disorder Society (MDS) in 2008 (Goetz et al., 2008). 
The updated “MDS-UPDRS” consists of a structured interview and motor examination, 
during which 50 items are scored on a rating scale from 0 ("no symptoms") to 4 ("severe"). 
Due to its comprehensive nature, compatibility with clinical practice, and clinimetric vali-
dation, the MDS-UPDRS has seen widespread use as a measure of disease severity and 




tial biomarkers (such as alpha-synuclein) against the MDS-UPDRS have produced incon-
sistent results (Espay et al., 2017; Kalia & Lang, 2015). Methodological concerns, such as 
inconsistent assay methods, have been cited as possible explanations (Lana M. Chahine & 
Stern, 2017). 
The MDS has recommended that each of the MDS-UPDRS’ sub-sections be re-
ported separately and not condensed into a single summary score due to their unstable fac-
tor structure (Goetz et al., 2008). Nonetheless, the MDS-UPDRS is usually reported as the 
sum of all of its item’s scores, meant to represent the overall disease burden of the subject. 
Several other summary scores have been developed that quantify the severity of specific 
symptoms and classify patients into different disease phenotypes. For example, the brady-
kinesia sub-score is the sum of the scores of items assessing bradykinesia (Zampieri et al., 
2010), and the normalized ratio of scores of items assessing postural instability to items 
assessing tremor is used to classify subjects into “Tremor Dominant”, “Postural Instabil-
ity/Gait Difficulty”, or “Indeterminate” phenotypes (Stebbins et al., 2013). In addition, to-
tal scores of the MDS-UPDRS’ individual sections are often reported and interpreted as 
representing some aspect of the patient’s clinical presentation; e.g. the total score for Sec-
tion III (the motor assessment) is frequently used to represent the severity of motor impair-
ment. Cut-off scores for each of the MDS-UPDRS’s sections have been proposed to grossly 
categorize disease severity into three tiers: mild, moderate, and severe33 (Pablo Martínez-
Martín et al., 2015). 
	
33 Section I: 10/11 and 21/22, Section II: 12/13 and 29/30, Section III: 32/33 and 58/59, Section IV: 






Arising from a seated to a standing posture is one of the most common physical movements 
humans engage in. The Sit-to-Stand (SitS) postural transition requires expending a rela-
tively large amount of energy to facilitate rapid movement of the body, and recruits several 
major muscle groups to do so (Goulart & Valls-Solé, 1999; W. G. Janssen et al., 2002). 
This makes SitS mechanically demanding and thus easily impaired in those with restricted 
mobility, postural instability, and/or motor disorders (Kerr et al., 1997; Riley et al., 1991). 
Subsequently, SitS is frequently impaired in PD and is used as an indicator of motor disa-
bility (Parisi et al., 2015). Given its ubiquity in activities of daily living and integral role in 
human locomotion, impairment of the SitS likewise impairs functional independence, and 
thus is clinically relevant to many populations and a key factor in their reduced quality of 
life (van Lummel et al., 2016). As a result, SitS transitions are widely used in scientific 
research and clinical practice, either as a standalone assessment or as part of a larger battery 
(e.g. the MDS-UPDRS), and are increasingly instrumented with kinematic and actigraphic 
sensors (Parisi et al., 2015; van Lummel et al., 2016). The primary outcomes of SitS tasks 
are duration and success of the transition; some tasks require multiple consecutive SitS 
(e.g. the “5x SitS”) or provide a set window of time during which as many SitS transitions 
as possible should be executed (e.g. the “60 Second SitS”), and so have additional out-
comes related to frequency and success rate. 
Functionally, SitS is the ability to independently transition from a stable and sta-




often does) easily transition to walking. SitS is therefore an essential for functional inde-
pendence and an important activity of daily living, as it is the basic obstacle a person needs 
to overcome before they are able to begin walking, an energy-efficient and primary method 
of independent locomotion (Kerr et al., 1997; van Lummel et al., 2016). Kinematically, 
SitS is a dynamic state where the Center of Mass (CoM) is mobile and the body is unstable 
- if one were to stop halfway through a SitS, it would require significant energy to hold the 
CoM stable - and so it can be defined as the period between the first and last significant 
shift of the CoM. Unbalanced muscle contractions exert a net force on the CoM through 
their fibers and tendons, and this momentum is transformed (i.e. the direction of the CoM’s 
movement and movement speed is changed) by the agonistic and antagonistic forces of 
other stabilizing muscles. SitS can thus be described by the changes in momentum with 
respect to the CoM, allowing its kinematics to be simulated in rigid-body biomechanical 
models (Matthew et al., 2018). Neurologically, the SitS is a complex and physically de-
manding task that requires the coordinated actions of multiple muscle groups in parallel 
and in sequence, and is executed by a combination of different neuromotor systems involv-
ing both conscious and reflexive action (Goulart & Valls-Solé, 1999). Actions such as flex-
ion of the trunk, stabilization of the head, and flexion/dorsiflexion of the lower limb are 
executed in preparation of a SitS sequence to reduce the energy required and stabilize the 
body, and include both conscious actions and anticipatory postural adjustments. In order 
to provide the force needed to accelerate the body vertically, the SitS employs some of the 
largest muscle groups in the body, including hamstrings, quadriceps, and lumbar extensors, 




2002). Throughout the SitS, reflexive postural stabilizers activate as needed to maintain 
stability.  
The SitS has been divided into four main stages (W. G. Janssen et al., 2002; Kerr 
et al., 1997; Matthew et al., 2018). The “Flexion-Momentum” phase involves the genera-
tion of forward momentum via flexion of the torso, ending when the person’s weight is 
fully transferred to their feet (i.e. their CoM has shifted forward). The “Momentum Trans-
fer” phase continues the production of forward momentum, and additionally generates ver-
tical momentum through flexion of the thigh and extension of the knees; this vertical mo-
mentum is reinforced by antagonistic muscle action redirecting forward momentum verti-
cally. In the “Extension” forward momentum is no longer being generated, while the ex-
tension of the lower limbs and torso continues to generate vertical momentum. The “Sta-
bilization Phase” marks the transition from momentum generation to stabilization where 
the body, now fully upright, bleeds off any residual momentum by swaying until the CoM 
is fully within the individual’s base of support. These gross stages have also been further 
subdivided into discrete movements (Kerr et al., 1997).  
 
Self-Reported Questionnaires 
Parkinson’s Disease Questionnaire, 8-Item 
The Parkinson’s Disease (PD) Questionnaire (PDQ) is a self-administered disease-specific 
questionnaire designed to evaluate health domains impacted by PD in order to determine 
the respondent’s health status and Health-Related Quality of Life (HRQOL). The original 




contained 39 questions scored on a five point ordinal scale; this version is referred to as the 
PDQ39. A factor analysis of the PDQ39 during its validation grouped questions into eight 
distinct “dimensions” of health: mobility, activities of daily living (ADL), emotional well-
being, stigma, social support, cognition, communication, and bodily discomfort (Peto et 
al., 1995). A short-form version of the PDQ39 was developed in 1997 by selecting, for 
each health dimension, the question whose score best correlated with that dimension’s total 
score (Crispin Jenkinson et al., 1997); this short-form version is referred to as the PDQ8. 
In both the PDQ8 and PDQ39, a summary index (SI) representing the respondent’s health 
status for each dimension can be calculated by averaging all scores in that dimension (Cris-
pin Jenkinson et al., 1997). An SI can also be calculated for the respondent’s overall health 
status by averaging the dimensional SI’s34 ; these are referred to as the PDQ8SI and 
PDQ39SI. While these scores are recommended for assessing HRQOL in PD, some anal-
yses have found that SI is multidimensional and thus influenced by confounding factors 
(Franchignoni et al., 2008; Hagell & Nilsson, 2009; Kuspinar et al., 2019); this has resulted 
in some authors advising caution when using the PDQ and interpreting its SI in clinical 
research. One early review criticized the PDQ’s lack of items addressing self-image, sleep 
problems, sexual activity, and postural transitions, yet nonetheless concluded that the PDQ 
would usually be the most appropriate instrument for assessing HRQOL in PD (Kuspinar 
et al., 2020; Marinus, 2002). 
 
	
34 The number of questions varies between dimensions in the PDQ39; by taking the average of the 
dimensional SI’s, the PDQ39 normalizes each dimension’s contribution to the respondent’s overall 





The Morningness-Eveningness Questionnaire (MEQ) is a self-administered questionnaire 
designed to evaluate the respondent’s psychological preference for when they engage in 
certain behaviors (Di Milia et al., 2013; Kantermann et al., 2015). Said another way, the 
MEQ assesses the respondent’s morningness-eveningness preference (J. A. Horne & 
Östberg, 1977) - also known as their diurnal preference, phase of entrainment, chronotype, 
circadian phenotype, circadian typology, and, in the original MEQ and other older litera-
ture, as simply “morningness” (Di Milia et al., 2013; Kantermann et al., 2015). The MEQ 
consists of 19 questions that ask the respondent to identify their preferred time for certain 
activities such as sleeping and exercising, their perceived “best” and “worst” times of day, 
the timing of certain subjective sensations like alertness and hunger, and how they would 
react to hypothetical scenarios such as going to bed at a different time or choosing their 
ideal exercise time. The questions have between four and six potential responses, and each 
response has a predetermined score between zero and six points. The respondent’s total 
score is calculated by summing the chosen scores for all questions, with a potential range 
of 16 to 86 points divided into five categories: Definite Evening (16 - 30), Moderate Even-
ing (31 - 41), Intermediate (42 - 58), Moderate Morning (59 - 69), and Definite Morning 
(70 - 86).  
The MEQ is considered the gold standard for self-reported morningness-evening-
ness (Di Milia et al., 2013). It has been validated against physiological and cognitive indi-
cators of circadian rhythm, including body temperature (S. L. Bailey & Heitkemper, 2001; 




secretion of cortisol (S. L. Bailey & Heitkemper, 2001) and melatonin (Griefahn et al., 
2001), sleep timing (Ishihara et al., 1987), and alertness (Adan, 1991; Natale & Cicogna, 
2002). Although it has seen widespread use, been translated into multiple languages, and 
is frequently used as a benchmark against which other instruments are validated, the MEQ 
has been criticized for the author’s ambiguous rationale for selecting the final questions 
and responses, the potential multidimensionality of its ostensibly unidimensional score, 
and it’s original cutoff scores, which were based off a relatively small (n = 150) and age-
restricted (18 - 32 years old) cohort (Di Milia et al., 2013)35. To address the multidimen-
sionality of the MEQ, a “reduced MEQ” (rMEQ) was produced that contains only those 
questions shown by a factor analysis to directly relate to morningness-eveningness (Adan 
& Almirall, 1991). Other instruments, notably the Composite Scale of Morningness (CSM) 
and the Munich ChronoType Questionnaire (MCTQ), were partially derived from the MEQ 
(Di Milia et al., 2013). Despite its drawbacks, the MEQ’s frequent use in the literature, its 
role as the “gold standard” for validating other instruments, and its simplicity and ubiquity 
continue to make it a popular and valuable means of assessing respondents’ morningness-
eveningness preference. 
 
Epworth Sleepiness Scale 
The Epworth Sleepiness Scale (ESS) is a self-administered questionnaire with eight items 
covering various daily activities (e.g. driving), each ranked by the respondent on a four-
	
35 Numerous other cutoff scores have been proposed based on larger samples, other age cohorts, 




point ordinal scale according to how likely they are to doze off. The main outcome of the 
ESS is the sum of scores for all items, and represents the respondent’s degree of daytime 
sleepiness, also referred to as their Average Sleep Propensity (ASP). The ESS was devel-
oped as a simple instrument for measuring the subject’s general level of daytime sleepiness 
(Murray W. Johns, 1991)36, and was initially validated in Obstructive Sleep Apnea (OSA): 
the ESS successfully distinguished subjects with OSA from those without OSA, and after 
treatment those with OSA scored similarly to the healthy controls (M. W. Johns, 1992). 
Due to its simplicity, brevity, and prior validation, the ESS has seen widespread use in 
clinical sleep research, especially OSA, (Hirshkowitz et al., 2011), has been adapted to 
various populations - most notably children and adolescents (K. C. Janssen et al., 2017; M. 
Johns, n.d., 2015) - and has been translated into dozens of languages beyond its original 
Australian English, including Arabic (Ahmed et al., 2014), Urdu (Surani et al., 2012), Ital-
ian (Vignatelli et al., 2003), and Brazilian Portuguese (Bertolazi et al., 2009). 
Although it has been validated and continues to see widespread use, the ESS has 
several notable drawbacks that have led to criticism of its liberal application in clinical 
research, especially in the context of OSA (Omobomi & Quan, 2018; Quan, 2013). Perhaps 
the most obvious drawback is the fact that the ESS is a self-evaluation along an ordinal 
scale with no objective delineation between low, moderate, and high chances of dozing, 
which introduces considerable subjectivity in the subject’s response (Omobomi & Quan, 
2018). One of the ESS’ main advantages - the fact it can be self-administered and thus does 
	
36 The ESS’s instructions were revised in 1997 to encourage the subject to complete all questions, 




not require physician labor - also predisposes it to human error on the part of the subject 
(Omobomi & Quan, 2018), with one study examining self- vs physician-administration 
reporting that nearly a quarter of self-administered ESS’ contained an error that prevented 
full, accurate scoring (Marra et al., 2018)37. In addition to anthropogenic errors and biases 
associated with self-administered questionnaires, the ESS also exhibits a gender bias due 
to women being more likely to emphasize fatigue when reporting symptoms of OSA 
(Quan, 2013; Ye et al., 2009), an educational bias with less education being associated with 
a greater likelihood of making an error - thus preventing calculation of a score and subse-
quently under-representing less educated subjects (Marra et al., 2018; Omobomi & Quan, 
2018), and an observer bias respondents such as commercial drivers may underscore their 
sleepiness for fear of professional repercussions (Colvin & Collop, 2016; Omobomi & 
Quan, 2018). Moreover, one’s ESS score can vary across repeated administrations (Camp-
bell et al., 2018; Kendzerska et al., 2014; Omobomi & Quan, 2018), and studies examining 
its expected association with physiological measures of sleepiness (e.g. the multiple sleep 
latency test) and clinical endpoints of OSA (e.g. respiratory disturbance index) have pro-
duced inconsistent results (Fong et al., 2005; Quan, 2013). Despite these drawbacks, many 
insurance companies have made the ESS a requirement for covering clinical sleep studies, 
most of which are diagnostic screens for OSA; this requirement has been criticized due to 
the non-negligible risk of persons with (undiagnosed) OSA scoring too low on the ESS to 
qualify for a diagnostic sleep study (Quan, 2013). 
	
37 Errors included dichotomous Yes/No responses instead of an ordinal score, skipped questions, 
“cross[ed] against” questions, and inability to self-administer the survey due to illiteracy; no errors 




While the ESS is still recognized as a useful, flexible, and low-burden means of 
quickly assessing daytime sleepiness, it is increasingly recommended that it be used in 
combination with (or supplanted by) other measures, especially in the context of OSA 
(Omobomi & Quan, 2018; Quan, 2013). 
 
Mini-Mental State Examination 
The Mini-Mental State Examination (MMSE) is a 30-point questionnaire principally used 
as a rapid assessment of cognitive ability, especially screening cognitive impairment and 
dementia (Carnero-Pardo, 2014; Folstein et al., 1975). The questionnaire is filled out by an 
administrator - usually a clinician or researcher, though minimal training is required to 
administer the MMSE - who prompts the subject with questions and scores their responses 
according to predefined criteria. The MMSE consists of eight items, each assessing a spe-
cific cognitive ability and with different scoring amounts: orientation to time (5 points), 
orientation to place (5 points), registration - AKA memory encoding (3 points), attention 
and calculation (5 points), recall (3 points), language (2 points), repetition (1 point), and 
complex commands (6 points). The MMSE was first developed in 1975 as a quicker alter-
native to existing cognitive assessments38, such as the Wechsler Adult Intelligence Scale 
(WAIS), which were difficult for subjects with dementia to complete due to their length 
(Folstein et al., 1975). This was accomplished by excluding other mental functions, such 
	




as mood, to solely focus on cognitive function (Folstein et al., 1975). This original MMSE 
contained 11 items, which were eventually pared down to the current eight items. 
The MMSE is arguably the most widely used cognitive screening instrument ever 
developed, and its seminal article is amongst the most frequently health science articles 
ever published (Carnero-Pardo, 2014; Folstein et al., 1975; Nilsson, 2007). It has been 
translated into over 50 languages and adapted to various populations, such as the blind 
(Carnero-Pardo, 2014). The MMSE has been included in the main clinical practice guide-
lines published by the American Academy of Neurology (Petersen et al., 2001), the British 
National Institute for Health and Care Excellence (National Collaborating Centre for Men-
tal Health (UK), 2007), and the Spanish Sistema Nacional de Salud (Ministerio de Sanidad, 
Política Social e Igualdad, 2018), among others (Carnero-Pardo, 2014). It’s simple design 
and brief administration time have made the MMSE an attractive choice for medical and 
research organizations, and it’s widespread use facilitates replication and inter-study com-
parisons in a broad variety of contexts. Despite its popularity, the MMSE was not initially 
developed as a screening tool for dementia. For example, a third of its points concern ori-
entation, but only 10% concern memory, which is usually the first cognitive ability to be 
noticeably impaired in common dementias such as Alzheimer’s disease. It’s reliability is 
impacted by the fact that the MMSE does not have standardized instructions (e.g. the orig-
inal MMSE did not specify which words to use in the recall task), and the requirement that 
the subject be literate in the administered language restricts its generalizability, causes an 
ascertainment bias, and contributes to the MMSE’s significant educational attainment bias 




although alternatives such as the Montreal Cognitive Assessment (MoCA) are continually 
being developed and evaluated. 
 
EuroQol 5-Dimension 
The EuroQol 5-Dimension (EQ-5D) is a self-administered questionnaire consisting of five 
items scored on a three point ordinal scale39, as well as a single 0-100 Visual Analogue 
Scale (VAS). Developed by the eponymous EuroQol, an international research group 
formed in 1987 (EuroQol, 1990), the EQ-5D was specifically designed as a quick, simple, 
scalable, standardized, and disease-agnostic assessment of Health-Related Quality of Life 
(HRQOL)40 to facilitate the generation of common data-sets that can be shared and ana-
lyzed across international, clinical, and disease boundaries. The EQ-5D’s primary outcome 
is a composite “health index” score representing the impact of a respondent’s health state 
on their Quality of Life (QOL) (EuroQol, 1990). The health index is the concatenation of 
the scores of the EQ-5D’s five items, with each item representing one of five dimensions 
of health: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression 
(Rabin & Charro, 2001). For example, a health index of “13212” translates to a score of 1 
(no problems) in mobility, 3 (extreme problems) in self-care, 2 (some problems) in usual 
activities, 1 in pain/discomfort, and 2 in anxiety/depression (Rabin & Charro, 2001). 
	
39 A version with five point ordinal scales - referred to as the EQ-5D-5L - also exists 
40 HRQOL, also styled as HRQoL or HRQL, is defined as “the subjective assessment of the impact 
of disease and treatment across the physical, psychological, social and somatic domains of func-




Health indices can be converted (“valuated”) into a one-dimensional index value 
representing the respondent’s overall health state, which can then be used as a summary 
endpoint. The index value represents the value of a given health state in some context; in 
the simplest sense better health is more valuable, though the respective contributions of 
each health domain varies by population and application (Kind, 2003; Weinstein et al., 
2009). For example, the contribution of mobility impairment to QOL is likely more severe 
in athletes than non-athletes, QOL in a culture that values independence and autonomy 
would be more impacted when self-care is impaired compared to a more interconnected 
and collectivist culture, and these weights can vary between sub-populations (e.g. people 
with PD may be more sensitive to mobility impairments than someone with clinical de-
pression). Similarly, a clinician monitoring a patient’s QOL would be more interested in 
valuations based on their patient’s clinical sub-population, a public health economist allo-
cating limited resources would prefer valuations based on the general population, and a 
hospital may use valuations based on the caregiver’s - rather than the patient’s - perspective 
when assessing the efficacy of new staff policies (Kind, 2003). Numerous value sets - i.e. 
algorithms for converting a health index into an index value - have been generated for 
different clinical populations and countries using a variety of techniques. The EQ-5D’s 
VAS (EQ-5D-VAS) was the original valuation metric, though more refined methods such 
as time-trade-off and the development of standardized protocols have eclipsed VAS valu-
ation in most contexts (Kind, 2003). 
In summary, the EQ-5D is a flexible instrument with diverse applications that has 




main outcomes: a categorical health index representing the respondent’s health profile, a 
standardized index value derived from the health index using valuation sets, and the VAS, 
which represents the respondent’s valuation of their overall health state (Hurst et al., 1997). 
The EQ-5D is primarily used for assessing HRQOL by health domain - with extensive 
valuation data for adapting outcomes to specific populations of interest - though its sim-
plicity and ease of use make it suitable as a coarse measure of HRQOL in a wide variety 
of contexts. 
 
Video Analysis and Annotation 
Video annotation, the systematic identification and quantification of signals in video re-
cordings, is a broad category of observational methods with diverse scientific and non-
scientific applications. Video data is generated passively through recording a scene - be it 
a social interaction, a natural phenomenon, or a clinical assessment - and can be analyzed 
qualitatively or quantitatively. As a video is nothing more than a series of still-images cap-
tured in rapid succession, it can capture subtle, small-amplitude, and/or brief events that 
might be missed by a contemporaneous observer. These images can be quantitatively ana-
lyzed in a number of ways - e.g. profile tracing, machine vision, image analysis, etc. - 
independently from the video they were derived from, or collectively played back as a 
continuous stream of visual data from which patterns and/or events may be qualitatively 
discerned by a human observer. Herein, video annotation is discussed in the context of 
qualitatively categorizing physical movements in humans - more specifically, clinical be-




Video recordings can be easily stored and shared, allowing them to be repeatedly 
used; e.g. by different research teams seeking to replicate findings, in the evaluation of 
newer and/or alternative methods, or to consistently document a specific item of interest. 
Unlike contemporaneous observation, multiple observers can annotate the same video in a 
controlled manner fully divested from the physical, social, and temporal circumstances the 
recording was made in. For example, the inter-rater agreement of a new clinical scale could 
be estimated by having clinicians individually score the same video recording of a patient, 
thus removing the myriad circumstantial factors that could unduly influence in-person scor-
ing (e.g. different patients, different times of day, different symptomatic severity, different 
viewing perspectives/durations, etc.) (Rodby-Bousquet et al., 2014). Although it’s been 
used throughout the sciences, video annotation is particularly common in psychology due 
to its ability to objectively capture behaviors used to measure psychological processes, 
such as social interactions or behavioral tics (Gilmore & Adolph, 2017). Having access to 
both the interpretation and the subject of interpretation allows for the direct replication of 
methodologies and the rigorous assessment of their validity by others; this is necessary 
because the inherent subjectivity of the observables, their interpretations, and the methods 
of generating them cannot be fully captured with written language. 
The study of how human movement and its impairments are clinically assessed 
faces a similar problem in that the interpretation of specific ‘behavioral biomarkers’ (e.g. 
“bradykinesia”) relies on qualitative assessment on the part of the clinician, who must in-
terpret their observations in the context of some external schema (e.g. MDS-UPDRS) in 




nature of human movement and the innumerable ways it can be altered, disrupted, or im-
paired makes its evaluation a qualitative process that cannot be fully defined objectively 
with written language or mathematical formulae. Likewise, video annotation of movement 
requires a human observer to subjectively interpret the visual information in the video ac-
cording to predefined criteria. While this subjectivity introduces variance and uncertainty, 
video annotation is nonetheless well-suited to the categorization of complex behaviors - be 
they social interactions, psychological states, or physical movements - due to the remark-
able human ability to rapidly integrate contextual information. 
The process of video annotation can be grossly separated into three phases. First, 
the signal(s) of interest must be identified and rigorously defined to minimize ambiguities 
(Y. Yang et al., 2013). These definitions may incorporate subjective and objective elements 
(e.g. “walking starts with the first visible forward movement of the leading foot, or the first 
postural adjustment demonstrating the subject’s intent to begin walking”) and may be 
quantitative or qualitative in nature (e.g. “long walking is when the subject takes 10 or more 
steps while walking; if the step lengths appear uneven, annotate as long walking, uneven 
gait”). In the abstract sense, definitions bridge the gap between the objective reality of the 
video recording and the subjective perception of the human annotator, and thus should 
integrate discretely quantifiable visual criteria (e.g. “standing requires both feet to be flat 
on the ground”) into colloquial qualitative descriptions (e.g. “standing is when the subject 
is upright in a stationary vertical posture”). Ideally, definitions will also clarify ambiguous 
circumstances (e.g. “If the subject appears to be standing but you cannot verify their feet 




Second, human raters review videos to identify any events/behaviors/etc. that meet 
these predefined criteria, determine when they meet these criteria, and segment the behav-
ior accordingly (Holle & Rein, 2015). Depending on the complexity of the annotations and 
the amount of expertise required, annotators may be trained on practice videos (previously 
annotated by an experienced rater) until they meet some predetermined level of accu-
racy.  Annotations can consist of continuous periods of time (e.g. “subject walking from 
frame 100 to frame 200”) or discrete instants (e.g. “subject transitioned from standing to 
walking at frame 100”), and may include additional qualitative information or sub-catego-
rization (e.g. “subject walking with shuffling gait”). 
Third, annotations made by different raters on the same video are compared for 
agreement in both their segmentation (i.e. start/end times) and qualification (i.e. “walking 
with shuffling”); the rate of agreement can be statistically quantified, and disagreements 
may be arbitrated by a senior rater so that a “final” annotation is chosen for future use. 
Alternatively, a “primary” annotator may be selected a priori based on their experience or 
post-hoc based on statistical inter-rater reliability; the primary’s annotations are then used 
as the final data-set, and the secondary annotators are used for determining inter-rater reli-
ability (Fokkenrood et al., 2014; Orfanos et al., 2017). In order to determine agreement, 
annotations from multiple raters must be “linked” together; i.e. determined that both were 
made based on the same segment of video. This is not an issue in case-by-case data (e.g. 
two clinicians independently score a video recording of a patient performing a motor task) 




however, raters may disagree on when certain behaviors began or how they should be clas-
sified (Bakeman et al., 2009). For example, Rater A makes a single walking annotation, 
where-as Rater B believes the subject paused shortly after starting and so makes two walk-
ing annotations, one short and the other long. Rater A’s single annotation can be paired 
either with Rater B’s first annotation (due to their similar start times), Rater B’s second 
longer annotation (due to their significant overlap), or both (Holle & Rein, 2015). The 
choice is not trivial, as it limits what statistical metrics of agreement can be calculated and 
affects their interpretation. This “linking problem” remains unsolved; although there are 
algorithmic ways of automatically linking annotations in time-series data, none are always 
correct due to the sheer variety of contextual information that could influence pairing and 
the subjective manner in which the annotations were originally made. 
 
Statistical Tests and Other Analytical Considerations 
Where-as individual chapters describe the analytical procedures pertinent to their content, 
this subchapter will provide an overview of the general analytical methods, considerations, 
and practices used throughout the work described herein. Data processing and grooming 
will not be covered in this subchapter. Unless otherwise stated, all statistical analyses were 
conducted in Stata (versions 15 – 16, StataCorp, Inc., College Station, TX, USA) on a Mac 
operating system. Excel (Microsoft, Inc., Redmont, WA, USA) and MATLAB (Math-
Works Inc., Natick, MA, USA, R2018a) were used to array, groom, store, and visualize 
the data; MATLAB was also used to generate cosinor models (see Chapters 4-5).All anal-




measures of central tendency and variance; mean and standard deviation were used for 
continuous or near-continuous data41. This also involved the visualization of data, both raw 
and under different transforms (e.g. log-transform). Skewness and kurtosis were calculated 
for continuous data, including the use of skewness-kurtosis tests to dichotomize samples 
as either “normally distributed” or “abnormally distributed”. When necessary, the variance 
of different samples were compared using an equal variances test to determine the appro-
priate statistical test. Exact p-values were generated and reported where possible, and two 
thresholds were used for reporting significance: p = 0.05 was the default significance 
threshold, although p = 0.10 was used for data with poor signal-to-noise ratios and/or small 
sample sizes. For the purposes of interpretation and reporting, p ≤ 0.05 was considered 
“statistically significant” and 0.05 < p ≤ 0.10 was considered “approaching significance”. 
For the purposes of determining normality and equality of variances, a p-value of 0.05 was 
used. Significant digits were not constrained during analysis, but to improve readability the 
data were presented with two or three significant digits. 
Due to the nature of the data collected (i.e. from human subjects), outliers were 
usually identified based on participant feedback and/or researcher observations at the point 
of data collection. No outlier detection algorithms were consistently used, though some 
basic outlier criteria - such as being ≥ 3 standard deviations from the mean (for normally 
distributed data) or ≥ [ 1st/3rd quartile ] +/- [ 1.5 * interquartile range ] from the median (for 
	
41 “Near-continuous” refers to ordinal data with a large number of ranks that are conventionally 
treated as continuous for the purposes of statistical analysis; this includes, but is not limited to, 
variables such as the MDS-UPDRS total score and the MEQ total score. For the rest of this sub-




abnormally distributed data) - were used in exploratory and descriptive analyses to quickly 
evaluate the variance in the data. Potential outliers identified during post-hoc descriptive 
and exploratory analyses were evaluated on a case-by-case basis through review of study 
documents and excluded if they were deemed to be artifacts, spurious, or otherwise altered 
by a factor outside of the analytical scope of the study. Missing data was quantified and 
reported whenever possible. No missing data was imputed; however, certain samples were 
omitted from analysis due to excessive missing data that precluded accurate analysis. 
Between-group comparisons were conducted for the purposes of quantifying the 
probability that two or more samples have the same mean and distribution. Two-sample 
comparisons of continuous variables were conducted using the Student’s t-distribution; i.e. 
t-tests. Paired and unpaired t-tests were used for paired and unpaired samples, respectively. 
Welch’s t-tests or Wilcoxon Rank Sum tests (AKA Mann-Whitney U tests) were used for 
samples with unequal variances as demonstrated via an equal-variance test. The Wilcoxon 
Signed-Rank test was used for paired samples with unequal variances. For comparisons 
involving three or more samples with continuous data, Analyses of Variance (ANOVAs) 
were conducted; one-way, two-way, n-way, and repeated measures ANOVAs were used 
as needed. ANOVAs were also employed to model the effects of certain categorical/ordinal 
factors on the variable of interest, and likewise used to model the influence of continuous 
covariates on categorical variables of interest. Chi-square tests were used to identify rela-




Associations and correlations were quantified using simple and multiple-variable 
linear and logistic regressions. Linear regressions were used to model the associations be-
tween continuous variables, and logistic regressions were used for associations between 
dichotomous (dependent) and continuous (independent) variables. For associations be-
tween ordinal (dependent) and continuous (independent) variables, simple and multiple-
variable ordered logistic regressions were used. All multiple-variable regressions were pre-
ceded by simple regressions to quantify the pairwise associations between the multiple 
variables to be used. In addition, simple linear, logistic, and ordered logistic regressions 
were used extensively for exploratory analyses to identify potentially meaningful associa-
tions. 
Linear mixed-models were used to model the relationships in complex multi-level 
nested and repeated measures data (see Chapter 5 Methods). Inter-rater reliability was ini-
tially monitored by calculating simple percent agreements using annotation endpoints (i.e. 
start time, end time, and annotation value) for annotations paired by trained arbitrators (see 
Chapter 3 Methods). Percent agreement for start and end times included tolerance windows 
due to the difficulty in reliably determining the exact frame a behavior began; i.e. if two 
paired times were within 5 frames (~0.167 seconds) of each other, they were considered in 
agreement. Inter-rater reliability was formally quantified via Cohen’s kappa using different 
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The Movement Disorder Society’s Unified Parkinson’s Disease Rating Scale (MDS-
UPDRS) is the current gold standard means of assessing disease state in Parkinson’s dis-
ease (PD). Objective measures in the form of wearable sensors have the potential to im-
prove our ability to monitor symptomology in PD, but numerous methodological chal-
lenges remain, including integration into the MDS-UPDRS. We applied a structured video 
coding scheme to temporally quantify clinical, scripted, motor tasks in the MDS-UPDRS 
for the alignment and integration of objective measures collected in parallel. 
 
Methods 
25 PD subjects completed two video-recorded MDS-UPDRS administrations. Visual cues 
of task performance reliably identifiable in video recordings were used to construct a struc-
tured video coding scheme. Postural transitions were also defined and coded. Videos were 
independently coded by two trained non-expert coders and a third expert coder to derive 
indices of inter-rater agreement. 
 
Results 
50 videos of MDS-UPDRS performance were fully coded. Non-expert coders achieved a 




tasks except for Postural Stability (κ = 0.617); this level of agreement was largely main-
tained even when more stringent thresholds for agreement were applied. Durations coded 
by non-expert coders and expert coders were significantly different (p < 0.05) for only 
Postural Stability and Rigidity, Left Upper Limb. 
 
Conclusions 
Non-expert coders consistently and accurately quantified discrete behavioral components 
of the MDS-UPDRS using a structured video coding scheme; this represents a novel, prom-










Parkinson’s Disease (PD) is the second most common neurodegenerative disease, affecting 
1% of the Western population over 60 years of age (de Lau & Breteler, 2006). The gold 
standard for the evaluation of PD symptomology is the Movement Disorder Society’s Uni-




2008). A novel approach to PD symptom monitoring has emerged in Technology-based 
Objective Measures (TOMs) of movement obtained using accelerometers, gyroscopes, and 
other motion detectors housed in mobile platforms worn on the body (de Azevedo et al., 
2016; Dewey et al., 2014; Espay et al., 2016; Patel et al., 2009; Piro et al., 2016). As they 
are capable of continuously measuring movement, gait, and posture outside of the clinic, 
wearable sensors are well suited for monitoring the variable symptoms of PD.  However, 
the use of TOMs in the MDS-UPDRS is largely unexplored, and, in fact, the MDS-UPDRS 
is often used as an outcome measure for sensor validation (Johansson et al., 2018). In ad-
dition, the methodological challenges of wearable sensors remain a significant obstacle to 
their translation into routine clinical practice (Espay et al., 2016; Horak & Mancini, 2013). 
Specifically, their high resolution and sensitivity leaves them susceptible to noisy interfer-
ence. Complicated and time-consuming analytical techniques are required to derive clini-
cally meaningful endpoints from the large amounts of data they produce and the lack of 
standards has led to isolated “islands of expertise” (Lana M. Chahine & Stern, 2017; Espay 
et al., 2016, 2017; Horak & Mancini, 2013; Papapetropoulos et al., 2015; Rabuffetti et al., 
2011). These challenges are amplified in the MDS-UPDRS, as the scale’s semi-standard-
ized motor tasks introduce significant noise into the signal and its loosely structured format 
complicates interpretation. 
Human-directed behavior coding in video recordings of clinical assessments and 
functional tasks is often used to validate TOMs captured within a clinical setting (Aminian 
et al., 1999; Fokkenrood et al., 2014; Heldman et al., 2014; Lyons & Tickle-Degnen, 2005; 




of diverse datasets (e.g. TOMs and MDS-UPDRS task ratings) to a “ground-truth” time 
series of coded behaviors, which allows for greater accuracy and confidence in analyses 
between and across these data. Video coding therefore has the strong potential to enhance 
ongoing research on the use of wearable sensors for the continuous measurement of PD 
symptomatology (S. T. Moore et al., 2011; Piro et al., 2016), and, in fact, is often used to 
validate the output of prototype sensors. Nonetheless, the use of video coding to validate 
TOMs has been slowed by study-specific coding schemes, variance in the training and 
expertise of human coders, and the diversity of the definitions and methods to guide coding.  
Through a structured protocol, we have defined reliable visual cues for specific 
motor tasks in Section III of the MDS-UPDRS, and trained non-clinician coders to recog-
nize and code them in video recordings. Our objective was to construct and apply a de-
tailed, consistent and transparent video coding scheme capable of reliably generating pre-
cise timestamps of tasks and behaviors used in the MDS-UPDRS assessment for future 
alignment with TOM datasets. 
 
Methods 
Participants and Video Recordings 
25 persons with PD underwent a video-recorded administration of Section III (“Motor Ex-
amination”) of the MDS-UPDRS, as well as a five times sit-to-stand task. The tasks were 
administered by a trained medical physician who was an expert in movement disorders. 
The number of subjects, order of assessments, and the video recordings (with no audio) 




All videos were de-identified prior to transfer to the study group and all subjects gave in-
formed consent as per institutional study requirements. 
Each video recording was constructed from raw footage recorded at 30 frames per 
second by two separate cameras: a mobile Microsoft KinectÔ camera (640 x 480-pixel 
resolution) mounted on a tripod, and a stationary Microsoft KinectÔ (640 x 480-pixel res-
olution) mounted at the end of the hallway used for walking tasks. Both cameras provided 
full-body views of the subject from a front facing angle. 
 
Development of the Coding Scheme 
To facilitate consistent frame-by-frame coding of behaviors of interest, a structured Coding 
Scheme (CS) was constructed before receipt of the video recordings (Figure A.1). The CS 
contained definitions for two categories of behavior: Scripted Motor Tasks adapted from 
Section III of the MDS-UPDRS, and the sit-to-stand and stand-to-sit Postural Transitions. 
Each definition consisted of a general definition of the task or transition, a descrip-
tion of prominent visual cues identifiable in a video recording, and the specific events, 
movements, and/or stimuli coders should use to determine the task’s onset and offset 
frames. Variations of the task (e.g. left hand, right hand) and any expected deviations and 
how they should be coded were also included in the CS. Anatomical landmarks were used 
to guide identification of the onset and offset frames where possible. The full list of defi-





Coder Training Protocol 
All coding was performed using ELAN (v 5.0.0-beta for Mac iOS), a linguistic annotation 
software capable of frame-specific annotation of video. Coders were trained in the use of 
the CS (Figure A.1) and ELAN using a structured protocol and the guided coding of a 
series of training videos (Figure 3.1). Coders were required to use a predetermined config-
uration of ELAN settings to maintain consistency. The training videos ranged between 5 
and 45 minutes in duration and contained exemplars of motor behaviors in patients with 
PD, with each video focusing on a new category of behavior (Figure 3.1). Raters were 
required to achieve an accuracy of 80% before they were granted approval to independently 
code videos for use in data analysis. 
 
Figure 3.1: Flow Sheet Depicting Standardized Training Protocol Used for All Coders prior 
to participating in study 
 
Coding Process 
When coding a motor task, coders working in randomly assigned pairs individually deter-
mined its start time, its end time, and the name of the task performed. Frame-specific 
timestamps for individual behaviors within a task were generated at a resolution of ~ 





Errors of commission were identified using the following criteria: 
- Start timestamp difference between coders was greater than 0.335 seconds. 
- End timestamp difference between coders was greater than 0.335 seconds. 
- Coders identified different motor tasks were being performed. 
Additionally, one-sided codes (i.e. errors of omission) were recorded whenever only one 
coder made a code that the other coder did not.  
All videos were also coded by an expert coder (defined as a neurologist with an 
expertise in movement disorders) per the CS definitions in order to provide a measure of 
the internal validity of the definitions generated in the CS. 
 
Statistical Methods 
Descriptive statistics were generated using the raw timestamps generated across the entire 
dataset by individual coders. These included the frequency that a given motor task was 
coded, it’s average duration (Table 3.1), the average difference in start and end times be-
tween paired coders, and the frequency of coding (Table 3.2). Paired samples t-tests were 
conducted to compare the mean durations of codes made by non-expert coders and the 
expert coder as a measure of the internal validity of the CS. These were calculated using 
all codes made by all non-expert coders across the dataset and therefore did not take into 
account errors of omission or commission. 
Inter-rater agreement was calculated using Cohen’s Kappa (κ) (J. Cohen, 1960). 
The study design allowed for production of a timed-event sequential dataset capable of 




to account for errors of omission (i.e. only one coder in a pair coded a motor event) codes 
from both coders were manually linked by the expert rater with expertise in movement 
disorders. Linked codes were considered in agreement if they met two criteria: (1) both 
coders identified it as the same motor task, and (2) the segments generated by the coders 
met or surpassed the overlap threshold of 50% as calculated by the start and end time of 
the behavior codes (Holle & Rein, 2015). The frequencies of agreement for each type of 
behavior were collated into agreement matrices, from which proportions of agreement for 
each type of behavior were derived. Three matrices with overlap thresholds of 50%, 70%, 
and 90% percent overlap were constructed and used to calculate κ.  
 
Results 
25 subjects with PD each underwent two video-recorded assessments, producing a total of 
50 videos. Each video was independently coded by two trained coders using the CS, re-
sulting in a dataset of 100 coded videos. Table 3.1 summarizes the frequency of coded 
tasks within the 100 videos as well as the mean and median durations.  
 
Durations of Coded Behaviors 
Scripted Motor Tasks had a median timestamp of between 4-12 seconds while Postural 





Table 3.1: Descriptive Statistics for Coded Tasks for 100 Video Files 
















Task* Rigidity, Neck 97 4.900 (0.996) 4.853 (1.200) 4.972 (1.158) 4.900 (1.250) 
Scripted Motor 
Task Rigidity, Right Upper Limb 101 7.210 (1.754) 6.697 (1.750) 7.261 (1.862) 7.000 (1.584) 
Scripted Motor 
Task Rigidity, Left Upper Limb 98 7.470 (2.332) 7.067 (2.433) 7.459 (2.444) 6.900 (2.289) 
Scripted Motor 
Task Rigidity, Right Lower Limb 99 6.596 (1.745) 6.383 (1.909) 6.661 (1.764 6.433 (1.958) 
Scripted Motor 
Task Rigidity, Left Lower Limb 99 5.916 (1.526) 5.616 (1.683) 5.929 (1.541) 5.603 (1.742) 
Scripted Motor 
Task Finger Tapping, Right Hand 113 3.819 (2.301) 3.100 (1.934) 3.653 (2.025) 3.084 (1.717) 
Scripted Motor 
Task Finger Tapping, Left Hand 105 4.165 (2.636) 3.166 (2.633) 3.918 (1.998) 3.150 (2.558) 
Scripted Motor 
Task 
Fist Open and Close, Right 
Hand 103 5.172 (2.017) 5.067 (2.217) 5.182 (1.965) 5.000 (2.051) 
Scripted Motor 
Task Fist Open and Close, Left Hand 105 5.005 (2.180) 4.766 (2.033) 5.271 (2.966) 4.867 (1.934) 
Scripted Motor 
Task 
Pronation and Supination, Right 
Hand 106 5.695 (3.133) 4.967 (2.501) 5.859 (2.996) 4.971 (2.633) 
Scripted Motor 
Task 
Pronation and Supination, Left 
Hand 99 5.652 (2.640) 5.200 (2.232) 5.811 (2.556) 5.317 (2.225) 
Scripted Motor 
Task Toe Tapping, Right Foot 102 4.239 (1.594) 4.000 (1.642) 4.445 (1.816) 4.101 (2.117) 
Scripted Motor 
Task Toe Tapping, Left Foot 103 4.456 (1.556) 4.133 (1.667) 4.562 (1.544) 4.167 (1.699) 
Scripted Motor 





* As defined in the MDS-UPDRS Section III 
** Total number of times motor behaviors were assessed in 100 coded files (50 videos independently annotated by two Coders each) 
*** Average κ values 
 
Scripted Motor 
Task Stomping, Left Foot 101 4.462 (1.906) 3.934 (1.800) 4.582 (2.063) 3.967 (1.866) 
Scripted Motor 
Task 
Postural Tremor, Right and Left 
Hands 123 11.89 (3.293) 
12.412 




Task Kinetic Tremor, Right Hand 94 5.231 (2.166) 4.769 (1.952) 5.501 (2.154) 4.934 (2.258) 
Scripted Motor 
Task Kinetic Tremor, Left Hand 96 5.034 (1.570) 4.649 (1.950) 5.201 (1.588) 4.900 (2.000) 
Scripted Motor 
Task Postural Stability* 177 2.373 (2.110) 1.633 (1.366) 1.870 (1.222) 1.466 (0.818) 
Postural Transi-
tion Sit-to-Stand 1201 1.834 (1.150) 1.600 (0.667) 1.915 (1.304) 1.633 (0.700) 
Postural Transi-




A paired samples t-test was performed to compare mean duration between tasks 
coded by an expert coder to the raw values coded by independent, non-expert coders. Table 
3.2 reports the p values for each task; only the coded tasks Postural Stability (p=0.015) and 





Table 3.2: Comparison of Mean Coder Duration (Timestamp ss.ms) to Expert Coder for 
Scripted Motor Tasks and Postural Transitions for all 50 videos 











Scripted motor task  Rigidity, Neck [-0.660, 0.185] -1.129 50 0.264 
Scripted motor task Rigidity, Right Up-per Limb [-0.754, 0.579] -0.264 50 0.793 




-2.927 50 0.005* 
Scripted motor task Rigidity, Right Lower Limb [-0.875, 0.353] -0.855 49 0.397 
Scripted motor task Rigidity, Left 
Lower Limb 
[-0.610, 0.569] 0.070 49 0.945 
Scripted motor task 
Finger Tapping, 
Right Hand [-0.676, 1.051] 0.434 57 0.666 
Scripted motor task Finger Tapping, 
Left Hand 
[-0.865, 0.715] -0.190 51 0.850 
Scripted motor task 
Fist Open and 
Close, Right Hand [-0.716, 0.932] 0.264 51 0.793 
Scripted motor task Fist Open and 
Close, Left Hand 
[-1.242, 0.684] -0.582 52 0.563 
Scripted motor task Pronation and Supi-nation, Right Hand [-1.129, 1.714] 0.413 52 0.681 
Scripted motor task Pronation and Supi-
nation, Left Hand 
[-1.099, 0.658] -0.504 49 0.617 
Scripted motor task Toe Tapping, Right 
Foot 
[-0.449, 0.953] 0.721 51 0.474 
Scripted motor task Toe Tapping, Left Foot [-0.584, 0.566] -0.031 52 0.975 
Scripted motor task Stomping, Right 
Foot 
[-0.502, 0.581] 0.146 50 0.884 
Scripted motor task Stomping, Left Foot [-0.585, 0.841] 0.360 50 0.720 
Scripted motor task 
Postural Tremor, 
Right and Left 
Hands 
[-1.190, 1.156] -0.029 52 0.977 
Scripted motor task Kinetic Tremor, Right Hand [-0.844, 1.055] 0.223 47 0.825 
Scripted motor task Kinetic Tremor, 
Left Hand 
[-0.710, 0.736] 0.037 48 0.971 
Scripted motor task Postural Stability** [0.129, 1.148] 2.485 98 0.015* 
Postural Transitions Sit-to-Stand [-0.122, 0.182] 0.383 608 0.702 




Inter-Rater Reliability of Annotated Tasks 
We observed high levels of agreement for all Scripted Motor Tasks, with κ > 0.8, indicating 
strong agreement (Table 3.1), with the exception of Postural Stability (κ = 0.617). These 
high κ values were maintained at the more stringent 70% and 90% overlap thresholds for 
most Scripted Motor Tasks, while Postural Transitions demonstrated good agreement at 






Figure 3.2: Cohen’s κ values of IRA for individual tasks over the 50-video dataset. Each 
row and column represent an individual coded task and individual video, respectively. Each 
cell is colored to reflect the κ between the two independent coders who coded that task in 
that video. Yellow cells indicate a strong IRA as indicated by a high κ approaching 1, green 
cells a moderate IRA with κ approaching 0.5, blue cells a low IRA with κ approaching 0, 
and white cells indicate that the task was not coded by either coder in that video. 
 
Errors of Omission and Commission 
Differences in the frequency of errors were dependent on the motor activity being coded 
(Figure A.2). The most frequent error observed was a difference in the identification of the 
start time of Kinetic Tremor, Right Hand and Kinetic Tremor, Left Hand. The motor task 




the behavior. Postural Tremor, Right and Left Hands possessed the highest frequency of 
errors of omission, meaning it was only identified by one coder in a pair.    
 
Discussion 
Here we provide an analysis of a novel, detailed, and precise video coding scheme capable 
of quantifying the duration of selected motor tasks of MDS-UPDRS Section III and related 
behaviors sensitive to impairment in PD. MDS-UPDRS Scripted Motor Tasks were coded 
with a high degree of agreement between coders, as indicated by kappa values of 0.80 and 
above, with the exception of Postural Stability, which showed a moderate level of agree-
ment.  
Video coding of discrete behaviors has been extensively used in the behavioral and 
social sciences, but has only been used sparingly in the study of PD behavior. Djikstra and 
colleagues used video coding to validate multiple sensor platforms, with a focus on gait 
parameters including gait speed and distance (Dijkstra et al., 2008, 2010). Other groups 
have used force plates to define postural transitions based on force generation (Zijlstra et 
al., 2012). 
This study used anatomical landmarks and visual cues extracted from the MDS-
UPDRS’ instructions to create a detailed coding scheme defining the onset and offset times 
of motor behaviors. Using this methodology we were able to show that anatomically based 
definitions for video coding can be recognized by trained non-expert raters to a high level 
of precision. The high agreement we achieved suggests that video coding, when given suf-




As objective measures of impairment aligned to large video datasets such as this may be 
easily synchronized with other neurobiological datasets – e.g. those derived from bioimag-
ing, genomics, histology, or biomarkers – video coding may allow for the functional im-
pairments observed in MDS-UPDRS subcomponents to be more accurately related to pri-
mary measures of neuropathology in PD. Such a unified systems approach would encour-
age reproducibility, facilitate the integration of multimodal data, and allow for more pow-
erful scientific hypotheses to be generated and tested, ultimately leading to the develop-
ment of more detailed models of how they arise from PD’s neuropathology.  
Video coding studies in PD typically rely on coders with varying degrees of exper-
tise in movement and movement disorders in order to code specific movements. Moore et 
al. (2011) used video annotation to detect gait abnormalities in a group of PD patients over 
24 hours and used graduate level students with moderate expertise in movement measure-
ment to code specific movements. Similar to our findings they were able to code specific 
tasks to a high level of precision using specific definitions. In our study, we have shown 
that, with minimal training, non-expert coders can generate these timestamps in video re-
cordings of PD patients to the level of accuracy of an expert rater.  These video segments 
may now able to be individually reviewed for specific clinical indicators, such as tremor, 
or range of motion, and their timestamps aligned to TOMs generated by sensors worn dur-
ing the assessment. An example of the use of video annotation can be seen in analysis of 
postural instability.  Analysis of video coding sets such as this can provide insights into 
both the cause and possible solutions to the variability observed in quantification of this 




behavior by non-expert coders , the end time of the behavior was inconsistently recognized. 
The retropulsion test used to assess postural stability, which requires the examiner to de-
stabilize the patient with a forceful backwards pull and observe their ability to recover,  is 
difficult to consistently administer and as a result the true “end time” of this task demon-
strates subjectivity in its definition and measurement (Nonnekes et al., 2015). Like many 
UPDRS tasks, kinematics, wearable sensors, and other objective measures have been ap-
plied to quantify aspects of the retropulsion test, adding an objective measurement to en-
hance the subjective score obtained from the MDS-UPDRS. Due to its low cost, simple 
training, and reliance on objective definitions, video coding can also provide an accurate, 
consistent definition of postural instability as assessed using the retropulsion test in order 
to validate the sensor-based algorithms needed to objectively measure PD impairment. 
Quantification of task duration in this way can allow for the measurement of the variability 
of their performance, an essential clinical endpoint that can be aligned to and used to better 
understand objective physical measures of variability. 
Sub-components of task performance may reflect discrete impairments sensitive to 
a single neural control system (Curtze et al., 2015; Peterson & Horak, 2016). As a result, 
objective measures of task performance using “wearable sensors” are increasingly viewed 
as necessary to improving the precision and sensitivity with which we can monitor disease 
state (Horak & Mancini, 2013).  Body-mounted accelerometers or “wearable sensors” are 
well positioned to objectively measure these sub-components . However, the use of wear-
able accelerometers in the MDS-UPDRS is largely unexplored, and in fact the MDS-




Video annotation provides a compromise between the objective precision of wearable sen-
sors and the subjective flexibility of the MDS-UPDRS’s clinical ratings. The flexibility in 
video playback and reviewing allows for subtle characteristics of behaviors, such as sub-
components not reliably detectable during clinical assessments, to be precisely measured 
with little uncertainty in their interpretation (Bussmann et al., 1998). Although it cannot 
reliably measure amplitude or distance, video coding has granular resolution for temporal 
measurements (e.g. duration) and frequency (e.g. counting instantaneous events) far be-
yond what is available to an observer or clinician rater. While video coding falls short of 
wearable sensors in temporal precision, it avoids many of the challenges posed by wearable 
accelerometers, such as complicated analytical processes and expensive equipment, and in 
fact is frequently used to validate the outputs of prototype sensors (Heldman et al., 2014). 
Additionally, the flexibility in video playback and reviewing afforded to video coders al-
lows them to identify characteristics of behaviors, including subtle or transient movements 
not reliably detectable during clinical assessments. This  provides the opportunity for pre-
cise feature extraction necessary for machine learning algorithms. 
 
Limitations 
The technical limitations of this study are important to discuss. The assessments performed 
in this study were dependent on the equipment and personnel used for the clinical exami-
nations. For example, when assessing the reasons for the differences observed between the 
timestamps generated by the expert rater and the non-expert raters it was found that a fre-




rigidity on the left side, due to their blocking the camera’s view of the subject. Future 
studies using this methodology should take care to ensure clear and continuous lines of 
sight, and to accurately disclose the camera equipment and angles used in order to ensure 
reproducibility. The definitions used for coding in this article represent a pilot attempt to 
perform a deep classification of tasks and behaviors sensitive to PD. This remains a major 
limitation which deserves further study, with models for accurate identification of discrete 
behaviors necessary. However, they do provide insight into this methodology’s precision 
for quantifying motor behavior in PD. Lastly, the analysis methods used to evaluate relia-
bility for video coding remain important to discuss. The algorithms for linking codes be-
tween coders are not well suited to continuous coding, which will be encountered by all 
studies attempting to provide continuous measurements for discrete behaviors (Albinali et 
al., 2009; Aminian et al., 1999; Fokkenrood et al., 2014). Future work directed at advanced 
analytical methods such as Bayesian or forest plot methods may be more suitable for anal-
ysis of reliability in video coding.  
 
Future Directions 
Video coding allows for objective quantification of behaviors contained within the MDS-
UPDRS which has the potential for enhancement of clinical measurements of PD, align-
ment with sensor derived end-points and generation of improved neuropathological models 
for individual behaviors in PD. This provides multiple opportunities for clinical translation 
in PD allowing the capture of discrete behaviors in PD and objective measures of each of 




common language by which potential biomarkers may be validated, providing powerful 
objective endpoints for accompanying the MDS-UPDRS clinical assessment.  
 
Acknowledgements 
The authors wish to thank the Pfizer team members of the BlueSky Project that provided 
funding and logistical support for this work, and the Tufts team members who provided 
the MDS-UPDRS video recordings. We would also like to thank Lelia Rosenkraus, Alanna 
Cote, Riley Phelps, Michael Fedorovsky, Nancy Mendez-Lozano, Abhina Karavadra, Vic-
toria Liu for their hard work. 
 
Author Contributions 
Chris Brooks, Jaspreet Bhangu, Andrew Chang, and Gabrielle Eden were involved in re-
search project execution, statistical analysis execution, and manuscript review and critique. 
Charmaine Demanuele and Nina Shaafi Kabiri were involved in statistical analysis execu-
tion, review, and critique as well as manuscript review and critique. Michael Kelley Erb 
and Mark Moss were involved in research project conception and organization as well as 
manuscript review and critique. Kevin Thomas was involved in research project concep-






CHAPTER FOUR: VARIATIONS IN REST-ACTIVITY RHYTHM ARE 
ASSOCIATED WITH CLINICALLY MEASURED DISEASE SEVERITY IN 
PARKINSON’S DISEASE 
Published in: Chronobiology International 
Authors 
Chris Brooksa* 












a Department of Anatomy and Neurobiology, Boston University School of Medicine, Bos-
ton, MA, USA 




c Department of Physical Medicine and Rehabilitation, Harvard Medical School, Boston, 
MA 
d Early Clinical Development, Pfizer Inc., Cambridge, MA, USA 
e Department of Psychiatry, Tufts University School of Medicine, Boston, MA, USA 
* Corresponding author at: Department of Anatomy and Neurobiology, Boston University 
School of Medicine, 650 Albany Street, Rm. X-140, Boston, MA 02118, USA. E-mail 
address: crbrooks@bu.edu (C. Brooks) 
 
Abstract 
The continuous, longitudinal nature of accelerometry monitoring is well-suited to captur-
ing the regular 24-hour oscillations in human activity across the day, the cumulative effect 
of our circadian rhythm and behavior. Disruption of the circadian rhythm in turn disrupts 
rest-activity rhythms. Although circadian disruption is a major feature of Parkinson’s dis-
ease (PD), rest-activity rhythms and their relationship with disease severity have not been 
well characterized in PD. 13 PD participants (Hoehn & Yahr Stage [H&Y] 1 – 3) wore a 
Philips Actiwatch Spectrum PRO continuously for two separate weeks. Rest-activity 
rhythms were quantified by fitting an oscillating 24-hour cosinor model to each participant-
day of activity data. One-way ANOVAs adjusted for demographics revealed significant 
variation in the amount (MESOR, F = 12.76, p < 0.01), range (Amplitude, F = 9.62, p < 
0.01), and timing (Acrophase, F = 2.7, p = 0.05) of activity across H&Y Stages. Those with 
higher H&Y Stages were significantly more likely to be active later in the day, where-as 




than those who did not change H&Y Stage. Being active later in the day was also signifi-
cantly associated with higher scores on the Movement Disorder Society’s Unified Parkin-
son’s Disease Rating Scale (MDS-UPDRS) Section III (motor symptom severity, p = 0.02), 
Section II (self-reported impact of motor symptoms on daily living, p = 0.01), and Total 
Score (p = 0.01) in an adjusted linear regression model; significant associations between 
MDS-UPDRS scores and activity levels were observed only in the unadjusted model. 
These findings demonstrate that continuous actigraphy is capable of detecting rest-activity 
disruption in PD, and provides preliminary evidence that rest-activity rhythms are associ-










The circadian rhythm is thought to be associated with underlying neurodegenerative pro-
cesses and is increasingly recognized as a major component of Parkinson’s disease (PD) 




tor and non-motor symptoms, circadian biomarkers such as melatonin and body tempera-
ture exhibit a depressed diurnal amplitude, and the neurological processes underlying cir-
cadian rhythm are altered by the dopaminergic treatments used to mitigate parkinsonian 
symptoms (Baumann-Vogel et al., 2017; Gros & Videnovic, 2017; K. Suzuki et al., 2007; 
van Someren et al., 1996). Circadian disruption is associated with a myriad negative se-
quelae, including metabolic, cardiac, and endocrine syndromes, mental and neuropsychi-
atric disorders, and sleep disruption (Korshunov et al., 2017; Vetter, 2018). 
Actigraphy, the process of monitoring activity using body-worn sensors, has been 
used to study circadian disruption through altered sleep patterns in multiple populations, 
such as adolescents (Arora & Taheri, 2015) and shift workers (Hulsegge et al., 2019). Alt-
hough actigraphy has the disadvantage of inferring behavior through movement, it permits 
continuous and longitudinal measurement that would be infeasible with methods such as 
clinical scales and polysomnography. Actigraphy also provides an objective measure of 
behavior in place of self-report motor and sleep diaries, which are often considered subjec-
tive in nature (Horak & Mancini, 2013). Due to their small size and capacity to continu-
ously record activity for days to weeks at a time, actigraphy has seen increasingly extensive 
use in PD research (Espay et al., 2017; M. Suzuki et al., 2017) to objectively quantify motor 
symptoms (Johansson et al., 2018), measure sleep disruption (Baumann-Vogel et al., 
2017), and provide objective measures of gait and balance during motor tasks (Zampieri et 
al., 2010).  
Without exogenous zeitgebers (e.g. regular light-dark cycles), the human circadian 




Czeisler et al., 1999), which would gradually desynchronize it from the 24-hour day. A 
combination of exogenous cues – e.g. light and social interaction – and endogenous mech-
anisms – e.g. clock gene feedback loops – continuously entrain the circadian rhythm, ef-
fectively synchronizing it with the environment. However, artificial zeitgebers such as 
light-emitting technology and readily accessible social media, which are ubiquitous in 
modern societies, can desynchronize the circadian rhythm from the calendar day (Vetter, 
2018). In addition, the timetables and obligations of our modern industrial society often 
diverge from natural light-dark cycles and thus can disrupt biological rhythms. The contin-
uous, longitudinal nature of actigraphic monitoring is well-suited to capturing such dis-
turbances, both through sleep disruption and through assessment of Rest-Activity Rhythms 
(RAR), the regular 24-hour oscillation in human activity across the daily sleep-wake cycle. 
RAR can be parametrically modelled by fitting a sine-cosine function with a 24-hour pe-
riod to time-series accelerometry data, allowing the average, range, and phase-shift of ac-
tivity to be quantified. Actigraphic evaluation of RAR in neurodegenerative disease is not 
a new approach – actigraphy has been used to monitor changes in the stability of RAR in 
Alzheimer’s disease (van Someren et al., 1996) – and the continuing advancement and 
ubiquity of wearable sensors has enabled larger and more detailed datasets to be produced. 
Herein we continuously assessed RAR using wrist-worn actigraphy in persons with 
PD collected over two full weeks in a prospective study. Our objective was to further char-
acterize circadian disruption in PD and determine its associations with disease severity, 
with the broader aim of developing a methodological and statistical model to characterize 





Materials and Methods 
Participants 
This paper is a retrospective analysis of an observational study performed in 2016 whose 
primary objective was to evaluate the feasibility of an electronic application (app) for re-
porting quality of life and disease symptom outcomes. The participants, 5 older healthy 
controls (not included in this paper’s analysis) and 15 persons with a diagnosis of idiopathic 
PD (Hoehn & Yahr Stage 1 – 3), were enrolled on a “first come first serve” basis so long 
as they met criteria. All participants underwent in-home and in-lab activity monitoring with 
a Philips Actiwatch Spectrum PRO and a network of BioSensics PAMSys devices (only 
persons with PD were included in this analysis). Herein we present an analysis of the 
Philips Actiwatch data, specifically aimed at extracting rest-activity rhythms from the lon-
gitudinal and continuous actigraphic recordings. 
A single Philips Actiwatch recording accelerometry at 32 Hz was worn by partici-
pants on the wrist of their symptomatically least-affected side for two seven-day at-home 
periods. The recording weeks were separated by an average of 36.31 days (standard devi-
ation = 4.80, range = [28 - 49]). Participants were instructed to wear the devices as often 
as possible except when they would be submerged in water (e.g. showering, swimming). 
Participants were also instructed to maintain their normal routine and behavior, and asked 
to complete electronic quality of life and motor diaries, while wearing the sensors at-home. 
All participants gave their written informed consent before participating in the study 




Declaration of Helsinki (World Medical Association, 2013). Each at-home recording pe-
riod was followed by an in-lab visit where participants underwent clinical assessments. 
Perceived daytime sleepiness was assessed using the Epworth Sleepiness Scale 
(ESS), quality of life was assessed using the Euro-QoL 5-Dimension (EQ-5D) instrument 
and the Euro-QoL Visual Analogue Scale (EQ-5D-VAS), perceived severity of parkin-
sonian symptoms was evaluated with the Parkinson’s Disease Questionnaire, 8-Point 
(PDQ8), and disease state was assessed using the Movement Disorder Society’s Unified 
Parkinson’s Disease Rating Scale (MDS-UPDRS). The MDS-UPDRS was administered 
by one of three trained neurologists during the participant’s in-lab visit immediately before 
each week of recording; participants were assessed while ON medication. Demographics, 
including daily intake of levodopa medication (in milligrams), were obtained from the par-
ticipants through self-report. Overall cognitive function was assessed using the Mini-Men-




Tri-axial accelerometry data from the Philips Actiwatch was downloaded using the Philips 
Actiware 5.0 and transformed into Activity Counts (AC) binned into 15-second epochs42. 
The AC time-series was segmented into days (n = 5760 epochs per day). In order to max-
imize available data, days were defined as starting with the 18:00:00 – 18:00:15 epoch and 
	
42 Actiware uses a proprietary algorithm to automatically extract AC from raw accelerometry data, 




ending with the 17:59:45 – 18:00:00 epoch (due to scheduling, participant recording began 
in the late morning to late afternoon). For clarity, models will be referred to by their starting 
day (e.g. Sunday cosinors start at 18:00:00 and end at 17:59:45 on Monday). Oscillating 
sin-cosine models with periods of 24-hours (a “cosinor model”) were fitted to the daily AC 
time-series using the least squares method (cheart, 2008; Nelson et al., 1979). The cosinor 
produces three parameters that characterize the participant’s rest-activity rhythms: the Mid-
line Estimating Statistic of Rhythm (MESOR) represents the midline of the fitted cosinor 
function, that is the average AC across the model’s sample (i.e. a day) and about which the 
cosinor function oscillates; Amplitude (Amp) is equal to difference in the average peak (or 
trough) of the cosinor function and it’s midline; Acrophase (Acro) is the relative phase-
shift of the peak amplitude from the reference time marking the start of the cosinor function 
(in this case, 18:00). Cosinor models were generated for all of those days with no more 
than 15% missing data (i.e. 864 epochs or 3.6 hours), which was usually caused by the 
participant removing the Actiwatch. 
 
Baseline and Clinical Characteristics 
Before the primary analysis, descriptive statistics were generated for the baseline variables 
collected at enrollment (Age, Sex, Handedness, BMI, MMSE Score, and Levodopa In-
take)43 and clinical endpoints collected after each week of in-home recording (ESS, PDQ8, 
	
43 Circadian rhythm undergoes a forward phase-shift with increasing age and has a slightly longer 
period in men; chronic circadian disruption is associated with increased BMI and impaired cogni-
tion; while there is little evidence implicating handedness as a modulator of circadian rhythm, it 





EQ-5D, MDS-UPDRS, and H&Y Stage). To determine if clinical characteristics signifi-
cantly varied between the two in-home recording weeks, paired sample t-tests were con-
ducted for continuous variables (ESS, EQ-5D-VAS, and MDS-UPDRS Section Scores) 
and Wilcoxon Mann-Whitney rank-sum tests were conducted for non-continuous variables 
(PDQ8, EQ-5D , and H&Y Stage).  
Participants were sorted into sub-groups by their H&Y Stage. Participants whose 
H&Y Stage changed between the two weeks were defined as their own groups: either H&Y 
Stage 1/2 (for those who were rated at Stage 1 and Stage 2) or H&Y Stage 2/3 (for those 
who were rated at Stage 2 and Stage 3). No participant’s H&Y Stage changed by more than 
one between the two weeks. While some participants were evaluated by multiple neurolo-
gists during the study due to scheduling and availability, all participants who changed H&Y 
Stage were evaluated by the same neurologist at both time points. To determine if baseline 
characteristics significantly varied by H&Y Stage, one-way Analyses of Variance (ANO-
VAs) were conducted for the analysis of continuous variables (Age, BMI, MMSE Score, 
and Levodopa Intake) and Pearson’s chi-square analyses were conducted for categorical 
variables (Sex and Handedness). 
 
Rest-Activity Rhythm 
Cosinor rhythmometry was performed in MATLAB v9.4 (MathWorks Inc., Natick, MA, 
R2018a). Data were arranged and visualized in Microsoft Excel v16.16.7 (Microsoft Inc., 
Redmond, WA) and analyzed using Stata/SE v15.1 (StataCorp LLC, Texas, USA). The 




as Average (± Standard Deviation) for continuous data and Number (Percent) for categor-
ical, ordinal, and dichotomous data. 
Univariate analysis of cosinor parameters and their association with clinical varia-
bles was calculated using one way ANOVA and linear regression. Bivariate models were 
subsequently performed between cosinor parameters and baseline characteristics. Associ-
ations with continuous variables (age, BMI, MMSE score, ESS score, and daily levodopa 
intake) were quantified with simple linear regressions, and for dichotomous variables (sex 
and handedness) odds ratios were calculated using simple logistic regressions. 
The primary analytical question was whether the participant’s rest-activity rhythm 
significantly varied by disease severity, as measured by H&Y Stage sub-group and by 
MDS-UPDRS Sections. For the former, one-way ANOVAs were conducted for each of the 
cosinor parameters (MESOR, Amplitude, and Acrophase) with H&Y Stage as the inde-
pendent grouping variable. Simple linear regressions were used to measure the degree of 
association between each cosinor parameter and each MDS-UPDRS Section, including To-
tal Score.  
 ANOVAs and regressions except for bivariate associations with baseline and clin-
ical characteristics were performed twice: once in an unadjusted model with no predictors 
besides H&Y Stage or MDS-UPDRS score, and then repeated in a model adjusted by age, 







Two participants were excluded at the beginning of analysis due to excessive missing data, 
resulting in an analytical sample of 13 participants. Out of a total possible 182 participant-
days (14 in-home study days * 13 participants), 58 (31.87%) participant-days were ex-
cluded from the cosinor analysis due to greater than 15% missing data within a given day 
(Table A.1). Across all participants, the greatest proportion of excluded participant-days 
was on Monday (n = 24, 92.31%). This could be ascribed to being the day participants 
began and ended study activities with an in-lab visit, resulting in much of the day usually 
not being recorded. The next greatest proportion of excluded participant-days was on Sat-
urday (n = 10, 38.46%), with Thursday having the least excluded participant-days (n = 2, 
7.69%). Across all days, H&Y Stage 3 had the highest percent excluded (n = 17, 40.48%) 
and H&Y Stage 2 the lowest (n = 10, 23.81%). 
 
Baseline Characteristics 
The participant’s age, sex, hand dominance, BMI, cognitive status, and daily levodopa in-






Table 4.1: Demographic characteristics of the final analytical cohort and outcomes of statistical tests by H&Y Stage.  
 
H&Y Stage 1/2 H&Y Stage 2 H&Y Stage 2/3 H&Y Stage 3 All 
Comparison of Means Between H&Y 
Stages 
 





 62.00 (-) 61.5 (4.72) 59.33 (9.24) 59.67 (3.79) 60.62 (5.20) F(3, 9) = 0.14 p = 0.94 
Sex (Male) 
◊




















800.00 (-) 501.04 (441.17) 683.33 (395.99) 400.00 (173.21) 542.79 (358.68) F(3, 9) = 0.44 p = 0.73 
Abbreviations: ANOVA (Analysis of Variance), BMI (Body Mass Index), H&Y (Hoehn and Yahr), kg (kilogram), mg (milligram), 
MMSE (Mini-Mental Status Examination), PD (Parkinson’s Disease). 
Age, BMI, MMSE, and Levodopa Intake provided in Mean (Standard Deviation); Sex and Hand Dominance provided in: Number (%). 
  
†
 Summary statistics are provided in Mean (Standard Deviation); between-group comparison made with a One-Way ANOVA 
◊






Clinical Characteristics, Change Across Study Weeks 
The participants did not significantly vary in their MDS-UPDRS scores between the two 
weeks (p = 0.26 - 0.68; Table 4.2). Although some participants transitioned between H&Y 
Stages between the two weeks, this was not significant across the sample (p = 0.17). Pa-
tient-reported disease state, quality of life, and daytime sleepiness did not significantly vary 
between the two weeks (PDQ8: p = 0.84, EQ-5D: p = 0.90 – 0.97, ESS: p = 0.92). Six of 
the 13 participants presented with unilateral tremor (as identified by MDS-UPDRS Item 
3.17 “Resting Tremor”) – four on the left side, two on the right side (data not shown). The 
remaining seven participants presented with no resting tremor in their limbs. No partici-




Table 4.2: Clinical and quality of life characteristics of the final analytical cohort and out-
comes of statistical tests between the two week-long recording periods.  
 Week 1 Week 2 All Weeks 
Comparison of Means Be-
tween Weeks 
 n = 13 n = 13 n = 26 
Paired t-test or Wilcoxon 
Mann-Whitney Rank-Sum 
Test 
Hoehn & Yahr Stage ◊ 2.46 (0.52) 2.15 (0.55) 2.31 (0.55) z = 1.38 p = 0.17 
MDS-UPDRS Section I † 9.69 (6.76) 10.15 (6.89) 9.92 (6.69) t = -1.07 p = 0.31 
MDS-UPDRS Section II † 10.08 (5.48) 11.15 (8.09) 10.62 (6.79) t = -0.94 p = 0.37 
MDS-UPDRS Section III † 22.23 (8.81) 23.23 (11.61) 22.73 (10.11) t = -0.43 p = 0.68 
MDS-UPDRS Section IV † 4.54 (2.40) 5.15 (3.46) 4.85 (2.94) t = -1.10 p = 0.29 
MDS-UPDRS Total Score † 46.54 (18.55) 49.69 (23.97) 48.12 (21.06) t = -1.17 p = 0.26 
PDQ8 (Total Score) ◊ 6.00 (4.20) 6.62 (4.89) 6.31 (4.48) z = -0.21 p = 0.84 
EQ-5D (Total Score) ◊ ‡ 6.25 (1.36) 6.42 (1.93) 6.33 (1.63) z = 0.12 p = 0.90 
EQ-5D-VAS † ‡ 79.58 (13.56) 79.42 (19.97) 79.50 (16.69) t = 0.03 p = 0.97 
ESS (Total Score) † ‡ 7.75 (3.31) 7.67 (3.92) 7.71 (3.54) t = 0.10 p = 0.92 
Abbreviations: CI (Confidence Interval), ESS (Epworth Sleepiness Scale), EQ5D (Euro-Quality 
of life, 5 Dimension), MDS-UPDRS (Movement Disorder Society’s Unified Parkinson’s Disease 
Rating Scale), PD (Parkinson’s Disease), PDQ8 (Parkinson’s Disease Questionnaire, 8-point), 
VAS (Visual Analogue Scale). 
† Summary statistics are provided in Mean (Standard Deviation); between-group comparison 
made with a paired t-test 
◊ Summary statistics are provided in Number (%); between-group comparison made with a Wil-
coxon Mann-Whitney Rank-Sum Test 
‡ Week 2 data for one participant was not included for these assessments due to data loss, and 




Rest Activity Rhythm, Association with Baseline Characteristics 
Bivariate linear regressions (Table A.2) demonstrated a significant association between 
higher MESOR and lower age (p < 0.01, Coef. = -1.83 AC/year), lower BMI (p < 0.01, 
Coef. = -1.88 AC/kg/m2), lower MMSE score (p < 0.01, Coef. = -3.41 AC/point), increased 
daily levodopa intake (p < 0.01, Coef. = 0.02 AC/mg levodopa/day), being female (p < 
0.01, Male Odds Ratio = 0.95), and being left-handed (p < 0.01, Right Hand Odds Ratio = 
0.95). A greater range of activity (Amplitude) was significantly associated with lower age 
(p < 0.01, Coef. = -1.71 AC/year), lower BMI (p < 0.01, Coef. = -1.67 AC/kg/m2), lower 
MMSE score (p < 0.01, Coef. = -4.11 AC/point), lower ESS score (p = 0.04, Coef. = -0.96 
AC/point), increased daily levodopa intake (p < 0.01, Coef. = 0.02 AC/mg levodopa/day), 
being female (p < 0.01, Male Odds Ratio = 0.95), and being left-handed (p < 0.01, Right 
Hand Odds Ratio = 0.95). A forward-shifted Acrophase was significantly associated with 
a lower MMSE score (p = 0.02, Coef. = -16.12 minutes/score) and a higher daily levodopa 
intake (p < 0.01, Coef. = 0.08 minutes/mg levodopa/day). 
 
Rest-Activity Rhythm, Association with MDS-UPDRS, Unadjusted 
Bivariate linear regressions demonstrated that an increased MESOR was significantly as-
sociated with a higher Section I score (p = 0.05, Coef. = 0.56 AC/score) and Section IV 
score (p < 0.01, Coef. = 3.16 AC/score) in Week 1, a higher Section IV score (p < 0.01, 
Coef. = 3.27 AC/score) in Week 2, and a lower Section III score (p = 0.03, Coef. = -0.35 




weeks. A higher range of activity (Amplitude) was significantly associated with a higher 
Section I score (p < 0.01, Coef. = 0.75 AC/score), Section IV score (p < 0.01, Coef. = 2.84 
AC/score), and a higher Total Score (p = 0.04, Coef. = 0.21 AC/score) in Week 1, a higher 
Section IV score (p < 0.01, Coef. = 3.25 AC/score) in Week 2, and a higher Section I score 
(p = 0.04, Coef. = 0.49 AC/score) and a higher Section IV score (p < 0.01, Coef. = 3.02) 
in a sample containing both weeks. A forward-shifted Acrophase was significantly associ-
ated with a higher Section I score (p < 0.01, Coef. = 5.18 minutes/score) in Week 1, a 
higher Section I score (p < 0.01, 6.40 minutes/score), higher Section II score (p < 0.01, 
5.68 minutes/score), higher Section III score (p < 0.01, 3.45 minutes/score), and higher 
Total Score (p < 0.01, 2.13 minutes/score) in Week 2, and a higher Section I score (p < 
0.01, 5.78 minutes/score), higher Section II score (p < 0.01, 4.80 minutes/score), higher 
Section III score (p < 0.01, 2.45 minutes/score), and higher Total Score (p < 0.01, 1.75 





Table 4.3: Cosinor parameters** of the final analytical cohort***, tabulated by Study Week and by H&Y Stage, and the outcomes 







































































































































































































































F(3, 57) = 
8.94 
p < 































F(3, 59) = 
4.92 
p < 
































F(3, 120) = 
11.10 
p < 


















































































F(3, 57) = 






3:05 p = 0.22 
Coef. = 
0:29 p = 0.76 
Coef. = 
4:52 p = 0.40 
Coef. = 
1:09 p = 0.11 













F(3, 59) = 























































Summary statistics are provided in Mean (Standard Deviation) 
**MESOR and Amplitude are reported in AC for mean and standard deviation, and in AC per UPDRS score for regression coefficients. Note that Acro-
phase is reported in hour:minute for mean and standard deviation, and in minute:second per UPDRS score for regression coefficients. 
***The sample analyzed contained n = 61 cosinor participant-days and degrees of freedom of F(6, 54) for Week 1, n = 60 and degrees of freedom of 
F(6, 53) for Week 2, and n = 121 and degrees of freedom of F(6, 114) for both Weeks combined. 
Abbreviations: AC (Activity Count), ANOVA (Analysis of Variance), CI (Confidence Interval), Coef = [Regression] Coefficient, H&Y (Hoehn and 
Yahr), MDS-UPDRS (Movement Disorder Society’s Unified Parkinson’s Disease Rating Scale), MESOR (Midline Estimating Statistic Of Rhythm). * = 




Rest-Activity Rhythm, Variation by H&Y Stage 
In the models unadjusted for baseline and demographic characteristics (Table 4.3; Figure 
4.1), significant variation in mean and range, but not timing, of activity was consistently 
observed across H&Y Stages for the first week (MESOR: F[3, 57], F = 11.17, p < 0.01; 
Amplitude: F[3, 57], F = 8.94, p < 0.01; Acrophase: F[3, 57], F = 2.19, p = 0.10), the second 
week (MESOR: F[3, 59], F = 5.47, p < 0.01; Amplitude: F[3, 59], F = 4.92, p < 0.01; 
Acrophase: F[3, 59], F = 1.25, p = 0.30), and across both weeks of recording (MESOR: 
F[3, 120], F = 13.52, p < 0.01; Amplitude: F[3, 120], F = 11.10, p < 0.01; Acrophase: F[3, 
120], F = 2.62, p = 0.05). MESOR and Amplitude remained significantly different between 
H&Y Stages after adjustment of the model for age, sex, ESS score, daily levodopa intake, 
and BMI (p < 0.01; Table 4.4; Figure 4.1). Acrophase was not significantly different be-
tween H&Y Stages during Week 1 (F[8, 53], F = 0.83, p = 0.48) in the adjusted model, 
although it achieved significance in Week 2 (F[8, 51], F = 3.92, p = 0.01) and across both 




Figure 4.1: Modelled values for MESOR (top), Amplitude (middle), and Acrophase (bot-
tom) for each Hoehn & Yahr Stage generated from one-way ANOVA models. The left col-
umn shows values from unadjusted models and the right column shows values from models 
adjusted for age, sex, ESS score, daily levodopa intake, and BMI. Significant differences be-







Rest-Activity Rhythm, Association with MDS-UPDRS, Adjusted 
Adjustment for baseline characteristics (age, sex, BMI, handedness, daily levodopa intake, 
MMSE score, and ESS score) eliminated all of the significant bivariate associations ob-
served between MDS-UPDRS Sections and MESOR/Amplitude, with the exception of 
MESOR remaining significantly and negatively associated with Section III scores across 
both weeks (p = 0.05, Coef. = -0.36 AC). The associations between Acrophase and Section 
I for Week 1 and both Weeks became non-significant after adjustment (Week 1: p = 0.88, 
Coef. = 0.30 minutes; Both Weeks: p = 0.16, Coef. = 2.55 minutes). Acrophase remained 
significantly and positively associated with Section II for Week 2 (p < 0.01, Coef. = 4.80 
minutes) and across both Weeks (p < 0.01, Coef. = 3.73 minutes), with Section III for Week 
2 (p < 0.01, Coef. = 5.40 minutes) and across both Weeks (p = 0.02, Coef. = 0.85 minutes), 
and with the Total Score for Week 2 (p < 0.01, Coef. = 1.93 minutes) and across both 





Table 4.4: Cosinor parameters** of the final analytical cohort***, tabulated by Study Week and by H&Y Stage, and the outcomes 
of one-way ANOVAs conducted by H&Y Stage, and linear regressions conducted by MDS-UPDRS score across all participants, 






































































0.30 p = 0.29 
Coef. = -
0.33 p = 0.16 
Coef. = 
1.18 p = 0.18 
Coef. = 






















0.01 p = 0.99 
Coef. = -
0.14 p = 0.66 
Coef. = -
0.53 p = 0.11 
Coef. = 
1.34 p = 0.36 
Coef. = -























0.10 p = 0.70 
Coef. = -
0.02 p = 0.94 
Coef. = -
0.36 p = 0.05* 
Coef. = 
1.09 p = 0.13 
Coef. = -




































































0.35 p = 0.19 
Coef. = 
0.31 p = 0.29 
Coef. = 
0.06 p = 0.80 
Coef. = 
0.97 p = 0.28 
Coef. = 






















0.08 p = 0.87 
Coef. = -
0.21 p = 0.49 
Coef. = -
0.45 p = 0.15 
Coef. = 
0.29 p = 0.84 
Coef. = -























0.14 p = 0.59 
Coef. = -
0.08 p = 0.71 
Coef. = -
0.20 p = 0.26 
Coef. = 
0.76 p = 0.29 
Coef. = -







































































0:18 p = 
0.88 
Coef. = 
1:49 p = 
0.41 
Coef. = -
1:38 p = 
0.36 
Coef. = 
1:23 p = 
0.84 
Coef. = -
0:01 p = 
0.98 


















7:21 p = 
0.01* 
Coef. = 
4:48 p < 
0.01* 
Coef. = 
5:24 p < 
0.01* 
Coef. = 
5:45 p = 
0.51 
Coef. = 























2:33 p = 
0.16 
Coef. = 
3:44 p < 
0.01* 
Coef. = 
0:51 p = 
0.02* 
Coef. = 
6:03 p = 
0.23 
Coef. = 
1:17 p = 
0.01* 
Summary statistics are provided in Mean (Standard Deviation) 
**MESOR and Amplitude are reported in AC for mean and standard deviation, and in AC per UPDRS score for regression coefficients. Note that Acro-
phase is reported in hour:minute for mean and standard deviation, and in minute:second per UPDRS score for regression coefficients. 
***The sample analyzed contained n = 61 cosinor participant-days and degrees of freedom of F(6, 54) for Week 1, n = 60 and degrees of freedom of 
F(6, 53) for Week 2, and n = 121 and degrees of freedom of F(6, 114) for both Weeks combined 
Abbreviations: AC (Activity Count), ANOVA (Analysis of Variance), CI (Confidence Interval), H&Y (Hoehn and Yahr), MDS-UPDRS (Movement 





This study has found that rest-activity rhythms, quantified via rythmometric cosinor anal-
ysis of actigraphy data, vary with disease severity in PD and are associated with clinical 
ratings of disease state. MESOR and Amplitude, which measure the average and range of 
activity, did not increase linearly with H&Y Stage but were instead significantly higher in 
participants whose H&Y Stage changed over the study period. Participants with more se-
vere and burdensome symptoms (i.e. higher MDS-UPDRS Sections I, II, and III scores) 
were less active on average and had a smaller range of activity; however this association 
became non-significant once demographic covariates were accounted for. A consistent re-
lationship was observed between the timing of activity (Acrophase) and increased disease 
severity as assessed by both H&Y Stage and by MDS-UPDRS scores, which remained 
significant after including covariates in the model.  
 
Rest-Activity Rhythms are Associated with Disease Severity in PD 
Circadian disruption of molecular, neurological, and behavioral systems is increasingly 
recognized as a major component in PD with implications for symptom management and 
the development of therapeutic interventions (Fifel & Videnovic, 2019; Videnovic & 
Golombek, 2017). Although actigraphy has been widely used to characterize both the hall-
mark motor impairments and non-motor symptoms (i.e. sleep disruption) in PD (Artusi et 
al., 2018; Horak & Mancini, 2013; M. Suzuki et al., 2017), objective measures of rest-
activity rhythms in PD are scarce. Relative to healthy controls, persons with PD have lower 




sleep resulting in sleep disruption (Madrid-Navarro et al., 2018; Niwa et al., 2011; White-
head et al., 2008). Our results generally support these findings, as we observed a consistent 
negative association between MDS-UPDRS Sections I - III and average activity and range 
of activity. Although the depression of rest-activity rhythms may worsen with increasing 
disease severity (Fifel & Videnovic, 2019), reported associations between activity levels 
and MDS-UPDRS scores have been inconsistent (Madrid-Navarro et al., 2018; Niwa et al., 
2011). A significant positive association between Section IV (Motor Fluctuations) and am-
plitude of activity was reported by Whitehead et al. (2008), where-as we observed a nega-
tive non-significant association. Our use of the revised MDS-UPDRS versus Whitehead et 
al.’s use of the original UPDRS may explain this. Our results are consistent with Niwa et 
al.'s (2011) finding that activity amplitude is negatively associated with MDS-UPDRS Sec-
tion III (Motor Exam). However, Madrid-Navarro et al. (2018) found no significant asso-
ciations between range of activity and any MDS-UPDRS Section. 
Curiously, the association between disease severity and activity did not extend to 
H&Y Stages: rather, participants whose H&Y Stage changed over the course of the study 
had higher activity than those who remained in the same Stage (clinically, participants who 
received two separate H&Y Stages approximates a cohort with a variable disease state, or 
a cohort with disease severity straddling the division between the two stages). This may 
indicate that amplitude of activity is affected by fluctuations in disease state in addition to 
its overall severity. However, it is uncertain if this is a genuine trend, or the result of normal 
but unaccounted for inter-individual heterogeneity in rest-activity rhythms, which remain 




Madrid-Navarro et al., 2018). Small sample sizes may amplify the effects of such inter-
individual variances, which highlights the need for future studies including larger cohorts. 
 
Biological Implications of Rest-Activity Rhythms 
Dopamine is integral to the neuropathology of PD (Fahn, 2008; Hornykiewicz, 1966; Kalia 
& Lang, 2015; Videnovic & Golombek, 2013); it’s depletion due to dopaminergic cell 
death in the substantia nigra pars compacta is considered the primary cause of PD’s char-
acteristic motor symptoms, and the main therapeutic strategies focus on mitigating its se-
quelae (either directly through dopamine agonists or indirectly through deep brain stimu-
lation). Given that dopamine exhibits circadian rhythmicity with a diurnal morning peak in 
cerebrospinal fluid (Poceta et al., 2009) and is involved in multiple circadian regulatory 
systems – e.g. light adaptation in the retina (Witkovsky, 2004) and clock gene expression 
in the dorsal striatum (Hood et al., 2010) – it has been hypothesized that pathological do-
paminergic depletion would inevitably impair the neural regulation of the circadian rhythm 
(Videnovic & Golombek, 2017). Furthermore, hypocretin-positive cell loss – a neuropa-
thological characteristic of narcolepsy – occurs in the hypothalamus in PD proportional to 
disease progression (Thannickal et al., 2007), and the concentration of hypocretin in cere-
brospinal fluid has been associated with loss of muscle atonia in REM sleep (Bridoux et 
al., 2013) and excessive daytime sleepiness (Wienecke et al., 2012). 
Although actigraphy cannot directly measure these biological markers, it is capable 
of monitoring rest-activity rhythms as an estimate of circadian rhythm (Ancoli-Israel et al., 




interacting biological (e.g. sleep drive, temperature, heart rate) and environmental (e.g. 
work schedule) influences (Vetter, 2018). Rest-activity rhythms therefore provide a gener-
alized measure of circadian integrity in an ecologically valid “real life” setting (J. A. Mitch-
ell et al., 2017), with the acknowledgement that they are the product, not a direct measure, 
of circadian rhythm (Vetter, 2018). By quantifying the gross output of a complex systems, 
one trades the biological specificity of biomarkers for the generalizability of a simple be-
havioral outcome: did their rest-activity rhythm change? Actigraphic rhythmometry has 
been applied in this way in healthy (J. A. Mitchell et al., 2017), geriatric (Hopkins et al., 
2017), and neurodegenerative populations (Musiek et al., 2018) using both parametric (i.e. 
cosinor) and non-parametric models to monitor gross behavioral change. Generally, older 
age and neurodegenerative diseases are associated with a reduced amplitude of activity and 
greater fragmentation of rest-activity rhythms within and across days. These trends are 
thought to reflect impairment of the neural control mechanisms that synchronize circadian 
and behavioral cycles to each other and to the environment, either due to normal aging, 




This analysis has several limitations that should be considered when interpreting our find-
ings. First, our analytical model assumes that all of the participants follow a similar rest-
activity rhythm, therefore any observed differences may be attributed to covarying charac-




times, with the exception of one outlier, fell between 5:18 PM and 10:12 AM; however it’s 
possible that some of our observed results may be due, in part, to normal inter-individual 
variations in circadian and circaseptan rest-activity patterns. Second, our small sample size 
limits the power of our statistical tests and restricts our ability to interpret the results. For-
tunately, this analytical model can be easily applied to larger cohorts in order to replicate 
the observed effects. Third, the two weekly data-sets were merged for this analysis. This 
was done to compensate for the sporadic missing data (~32.14% of participant-days are 
missing) and requires the assumption that there is no true difference in participant rest-
activity rhythms between the two weeks. To ensure no bias was introduced into actigraph-
ically derived circadian rhythm data, imputation was not employed. Finally, we lack valu-
able lifestyle and health information about our participants, notably their employment and 
social obligations that could affect their rest-activity rhythms (e.g. Friday-night social 
events). Opportunities for future research may lie in the inclusion of other factors that could 
alter their rest-activity patterns, such as sleep disorders or use of substances known to affect 
sleep behavior (e.g. alcohol, marijuana, stimulants, prescribed medications, etc.), or in the 
application of algorithms to detect specific behaviors in actigraphy, such as rest tremor 
during sleep. While we observed no difference between men and women in their daytime 
sleepiness as assessed by the ESS (data not shown), it may be prudent to include this in 






This study demonstrates that rest-activity rhythms are associated with disease severity and 
fluctuations in symptom intensity. RAR as measured by actigraphy was able to provide 
important insights into neurobiological behavior of participants with PD demonstrating as-
sociations with phase shifting to later in the day and overall decreases in activity by disease 
severity. Circadian disruption is a critical non-motor aspect of PD that requires the integra-
tion of molecular, neural, pathological, and behavioral research to effectively understand 
and treat (Fifel & Videnovic, 2019; Vetter, 2018). Actigraphically monitored rest-activity 
rhythms are an objective and easily scalable measure of circadian rhythmicity that lever-
ages the innate advantages and growing use of actigraphic monitoring in PD. In combina-
tion with gold-standard clinical assessments, diagnostic biomarker panels, and in vivo bi-
oimaging, actigraphically measured rest-activity rhythms may enhance our ability to inter-
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Abstract 
In order to prepare for regular daily behaviors such as eating and sleeping, many animals 
rely on their circadian (“about day”) rhythm, a complex “system of systems” that continu-
ously entrains biological processes with each other and the environment. Although humans 
predominantly entrain to solar time, individual persons vary in the precise timing of circa-
dian-influenced events, such as sleep timing and physical activity, due to endogenous and 
exogenous factors. Innate differences in the timing of individual circadian rhythms relative 
to a common environmental cue are known as chronotypes, ranging from earlier than av-
erage (Morningness) to later than average (Eveningness). Furthermore, individual behavior 
is often constrained by social constructs such as the seven day week: the regular shift be-
tween different work and rest days gives rise to chronic circadian disruption such as social 
jet lag (SJL) and sleep debt, as one’s circadian rhythm lags behind abrupt “sociogenic” 
changes in behavioral rhythms. The impact our social calendar has on our circadian rhythm 




preferred on work days. However, current gold-standard methods such as polysomnogra-
phy (PSG) are ill-suited to the type of long-term monitoring needed to collect behavioral 
rhythms across the week. Our aim in this study was to employ objective actigraphic mon-
itoring across multiple continuous weeks of out-of-clinic normal behavior in order to iden-
tify consistent “about weekly” – i.e. circaseptan – patterns in rest-activity rhythm and sleep 
characteristics, including evaluating the agreement between self-reported and objective 
measures of circadian timing. 24 young male volunteers (mean age 23.46 years) wore a 
Philips Actiwatch for four weeks while going about their normal lives. Chronotype was 
primarily assessed through self-report on the Morningness-Eveningness Questionnaire. 
Sleep characteristics were derived using Actiware; daily rest-activity rhythms were mod-
elled using a basic 3-parameter cosinor function. Linear mixed models were employed to 
account for the nested, repeated-measures design, and included random effects to account 
for the considerable variability expected from uncontrolled in situ recordings. We observed 
that both Eveningness and Morningness Chronotypes were more active and slept later on 
the weekends than on weekdays. Significant between-Chronotype differences in sleep tim-
ing and duration were observed within individual days of the week, especially during tran-
sitions between weekends and the work-week. Moreover, Chronotypes significantly varied 
in their circaseptan rest-activity and sleep rhythms: e.g. Morningness Chronotypes gener-
ally adapted their sleep duration, timing, and quality between weekends and weekdays 
quicker than Eveningness Chronotypes. Our results contribute to a growing body of evi-




observational studies of human behavior, especially when chronotype, sleep behavior, 











The circadian rhythm is the regular periodic oscillation in behavior and physiological pro-
cesses synchronized with the geophysical 24 hour solar day (“circadian” = “about day”). 
Organized as a distributed yet coordinated “system of systems”, the circadian rhythm is an 
interconnected and hierarchical network of periodic molecular, genetic, neurological, and 
physiological processes embedded in cells, tissues, organs, and neural control networks 
that synchronize the body’s myriad biological and homeostatic functions to each other and 
to their environment (M. H. Hastings et al., 2014). Functionally, the circadian rhythm pre-
pares biological systems for expected behavioral states; for example, core body tempera-
ture in humans peaks during the afternoon and reaches its nadir during the early morning, 




rhythm has a period of approximately 24.2 hours and, in isolation, would gradually drift 
out of synchrony with the solar day (Burgess & Eastman, 2008; Czeisler et al., 1999). 
However, a combination of exogenous cues – predominantly light – and endogenous bio-
logical mechanisms receptive to these cues – e.g. translational-transcriptional feedback 
loops – continuously entrain the circadian rhythm via the hypothalamic Suprachiasmatic 
Nucleus (SCN), effectively synchronizing our internal biological rhythms to each other and 
their environment.  
While the biology and period of the circadian rhythm are generally consistent be-
tween individuals, the phase (i.e. timing) of the circadian rhythm can vary greatly from 
person to person. This can be seen in the colloquialisms of “morning larks” and “night 
owls”, respectively referring to those who prefer to go to sleep and wake up earlier than 
normal or later than normal. In the chronobiology literature, these concepts are referred to 
as chronotypes, which may refer to a general phenotype (e.g. Morningness) or to a specific 
measurement of circadian timing  (e.g. sleep mid-time) relative to a sample or population 
(Vetter, 2018). Chronotypes are dependent on several intrinsic and environmental factors, 
most notably genetic predisposition, age, sex, and the amplitude, timing, and concentration 
of environmental light exposure (Roenneberg et al., 2015). Every person has an innate pre-
ferred chronotype, which predictably shifts earlier or later across the lifetime depending on 
their age and sex, and which can be acutely modulated by changes in their behavior and 
environmental zeitgebers (German: “time giver”, i.e. a stimulus capable of entraining the 




Ideally, an individual’s innate circadian chronotype and rhythm are tightly coupled 
with both their expressed behavioral chronotype and the solar day; i.e. requires minimal 
day-to-day resynchronization and which doesn’t impinge upon behavioral rhythms (e.g. 
eating, sleeping). However, artificial zeitgebers such as light-emitting technology can shift 
the circadian rhythm independently of the solar day (Vetter, 2018). The timetables and 
obligations of our modern industrial society often diverge from natural light-dark cycles 
(e.g. shift work, jet lag), and our seven day work week imposes arbitrary changes in be-
havioral timing that can further decouple one’s circadian rhythm from their environment 
(e.g. waking up for work vs. sleeping in on the weekend). These disruptions vary in severity 
and frequency by chronotype. For example, both adults and schoolchildren tend to sleep 
longer, later, and poorer on weekend nights (“2005 Sleep in America Poll – Adult Sleep 
Habits and Styles,” 2015; Bei et al., 2014; Crowley & Carskadon, 2010; Taylor et al., 
2008). This effect becomes more pronounced in those with a later chronotype since their 
preference to go to sleep later conflicts with their social obligations (i.e. work). When this 
obligation is removed on rest days, they “sleep in” to make up the sleep deficit accumulated 
during the workweek (Vitale et al., 2015). The biological cost of these circadian disruptions 
may include increased risk of cardiovascular and metabolic disease, obesity, and depres-
sion (Korshunov et al., 2017).  
This habitual discrepancy in sleep timing between work and rest days is common 
form of circadian disruption known as Social Jet Lag (SJL) (Leypunskiy et al., 2018; 
McMahon et al., 2019; Vetter, 2018; Wittmann et al., 2006; Wong et al., 2015). SJL arises 




systems; while the distribution of chronotypes in the general population is broad, ranging 
from extreme eveningness to extreme morningness, the distribution of work schedules is 
far more compact and constrained by artificial factors such as economics, logistics, law, 
and culture (Roenneberg et al., 2015). The result is that most of the population is forced to 
adapt to a social/work schedule too early or too late for their natural chronotype, and then 
revert back to their natural preference once social constraints are removed on rest days. 
While all chronotypes can develop SJL, Eveningness chronotypes are significantly more 
likely to do so (Roenneberg et al., 2019; Takahashi et al., 2018; Wittmann et al., 2006; 
Zerbini et al., 2020). Looking across multiple weeks, this periodic transition between social 
and biological “time zones” and the SJL it entails may be described as a circaseptan 
(“circa” = about “septan” = seven) rhythm of circadian disruption. 
SJL and chronotypes are measured by proxy, usually via changes in the timing of 
sleep (itself a systemic behavioral output regulated in part by the circadian rhythm) across 
the week (Roenneberg et al., 2019; Vetter, 2018). While sleep disruption has been tradi-
tionally assessed using in-clinic polysomnography (PSG) as it offers the highest resolution 
and accuracy for sleep measurements, controlled laboratory settings cannot replicate in situ 
sleep behavior for several reasons: the unfamiliar setting, the myriad instruments, and the 
controlled environment each have poorly understood effects on sleep (Roenneberg et al., 
2015). Moreover, while controlled sleep studies have greatly advanced our knowledge of 
sleep’s structure and neurological substrates, they have given relatively little insight into 




rhythm in situ (Roenneberg et al., 2015). In other words, well-controlled in-laboratory stud-
ies lack “ecological validity”; they offer unparalleled resolution and specificity, yet this 
narrow scope inherently limits their generalizability and therefore our ability to translate 
their findings into clinical and functional applications (Andrade, 2018; Roenneberg et al., 
2015; Vetter, 2018). 
Actigraphy, the use of wearable accelerometers to continuously measure physical 
behavior, is increasingly used to monitor sleep behavior in one’s normal environment as 
an alternative to in-clinic polysomnography (Ancoli-Israel et al., 2015). While actigraphy 
has the disadvantages of inferring sleep via decreased movement, increased risk of missing 
data due to subject non-compliance, and is a non-specific measure susceptible to back-
ground noise, it is capable of continuous longitudinal measurement that would be infeasible 
with polysomnography and thus has greater ecological validity (Espay et al., 2016; Ibáñez 
et al., 2018; Roenneberg et al., 2019). In addition to its metabolic, symptomatic, and kine-
matic applications, actigraphic data can also be used to model the diurnal fluctuations in 
physical activity known as rest-activity rhythms (RAR), providing an additional approach 
to objectively assess changes in circadian rhythm (Meyer-Rochow & Brown, 1998). 
Herein we present sleep and circadian data derived from actigraphy collected con-
tinuously from a cohort of young adult male volunteers across a full month in situ to gen-
erate a multi-week accelerometry data-set; this study included at-home self-report assess-
ments and in-clinic polysomnography, genetic testing, and cortisol/melatonin assays, 
which are discussed elsewhere (Marshall et al., 2020 (under review)). Our objectives were 




characteristics derived from the same data-set, their variation across days of the week and 
self-reported chronotype, and concordance between self-reported and actigraphically as-
sessed measures of circadian timing and chronotype. 
 
Materials and Methods 
Participants 
24 healthy volunteers underwent in-home actigraphic monitoring for two 14-day in-home 
periods separated by a 3-day sleep lab phase (Friday evening – Monday morning). Partic-
ipants wore five Philips Actiwatch Spectrum sensors recording at 32Hz during the in-home 
period – one on each wrist and ankle (secured by watch-bands) and one on the anterior 
torso (secured by Tegaderm [3M, Minnesota, USA]). While at-home, participants were 
instructed to wear the devices as often as possible except when they would be submerged 
in water and to maintain their normal routine and behavior while wearing the sensors. Only 
the actigraphic data collected from the Philips Actiwatch Spectrum worn on the non-dom-
inant wrist is analyzed and discussed in this paper; other results from this study are dis-
cussed in Marshall et al., 2020 (under review). 
Only volunteers who met the following criteria were offered enrollment into the 
study: Male; Between 18 and 40 years old (inclusive); English fluency; Non-smoker (in-
cluding both cigarettes and nicotine vaping); Body Mass Index (BMI) < 30 kg/m2; No self-
reported history of sleep, psychological, neurological, or addictive disorders; Not a shift-
worker; Does not change time zones frequently or have a highly irregular sleep schedule; 




claustrophobic; Does not have a pacemaker; No allergy to nickel or skin adhesive; and Not 
dependent on or abusing a substance within the previous six months. All participants gave 
their informed consent before participating in the study (BUSM IRB H-33035). 
 
Demographics and Clinical Endpoints 
Age, sex, BMI, and handedness were obtained through self-report during the first visit. 
Participants also completed several self-report instruments: the Epworth Sleepiness Scale 
(ESS) to evaluate daytime sleepiness, the Pittsburgh Sleep Quality Index (PSQI) to evalu-
ate sleep quality, and the Morningness-Eveningness Questionnaire (MEQ) to evaluate 
chronotype (J. A. Horne & Östberg, 1977). Participants were separated into two groups 
based on their MEQ scores: those with an MEQ score above 52 were assigned to the Morn-
ingness group, and the remainder were assigned to the Eveningness group. This division 
was based on the observation of a bimodal distribution in MEQ scores, with participants 
clustering around two peaks at MEQ scores of ~40 and ~60, and were was implemented in 
order to maximize the contrasts between Chronotypes. Since these peaks were close to the 
MEQ’s baseline cutoffs (41/42 and 58/59), the clusters of participants with similar chro-
notypes would’ve been split between multiple groups per the MEQ’s cutoffs, which would 






Accelerometry from the Philips Actiwatch was extracted as “Activity Counts” (AC) and 
binned (“epoched”) in 15-second epochs (Brooks et al., 2020); raw accelerometer data (i.e. 
voltage) from the Philips Actiwatch is inaccessible and can only be extracted by conversion 
to AC. The AC algorithm Actiware uses to do this is proprietary, though it may be based 
off of the Zero Crossing Method (ZCM) algorithm – which reports the number of times the 
accelerometer’s voltage crossed a predetermined threshold in a given epoch as that epoch’s 
AC – due to ZCM’s high sensitivity when classifying sleep and subsequent popularity in 
sleep scoring algorithms (Fekedulegn et al., 2020). Using Actiware 5.0’s built-in segmen-
tation algorithm, epoched AC data were then temporally segmented into different behav-
ioral “intervals”: either Active, Rest (from which one Sleep interval per Rest interval can 
be derived), or Excluded (i.e. for periods with no data, such as when the Actiwatch was not 
being worn). The segmentation algorithm for differentiating Active from Rest Intervals is 
based solely off activity levels, but further information about how the segmentation algo-
rithm works is unknown as it is also proprietary (Chow et al., 2016). Active and Excluded 
Intervals were omitted from further analysis, and the remaining Rest Intervals were filtered 
so that only those containing overnight Sleep Intervals would be analyzed. Specifically, 
sleep characteristics were derived only from Sleep Intervals that started between 1800 and 
0600 and which were determined to not be false positives (i.e. short, idle periods misiden-
tified by the algorithm as sleep) by manual review. 
While we cannot access the AC algorithm, segmentation algorithm, or the raw ac-




Company, Inc., 2006). Briefly, it calculates a “Total AC” – more generally referred to as a 
“sleep score”  (Fekedulegn et al., 2020) – for each epoch by summing the weighted ACs 
of that epoch and those of adjacent epochs using this formula:  
Total AC for Epochn (En) = (En-8 * 0.04) + (En-7 * 0.04) + (En-6 * 0.04) + (En-5 * 0.04) + (En-4 * 0.2) 
+ (En-3 * 0.2) + (En-2 * 0.2) + (En-1 * 0.2) + (En * 4) + (En+1 * 0.2) + (En+2 * 0.2) + (En+3 * 0.2) + (En+4 
* 0.2) + (En+5 * 0.04) + (En+6 * 0.04) + (En+7 * 0.04) + (En+8 * 0.04) 
Note: the number of epochs summed and their respective AC weights is different for each 
epoch length; this formula is for the 15-second epochs used in this analysis. 
If an epoch’s Total AC is less than or equal to a predetermined “Wake Threshold 
Value”, it is classified as Asleep; otherwise, it’s classified as Awake. Actiware then applies 
one of two Sleep Interval detection algorithms, using either continuous periods classified 
as Asleep or sustained periods of immobility to define the Sleep Interval. Which algorithm 
is used and some of its parameters are manually customizable. We used the sustained im-
mobility algorithm with the following parameters: Wake Threshold Value = 20 (epochs 
with Total AC greater than this value are classified as Awake); Immobile Minutes Onset = 
10 (the beginning of a given Rest Interval’s Sleep Interval is defined as the first epoch of 
the first continuous series of epochs this many minutes long where no more than one epoch 
has ≥ 1 AC); Immobile Minutes Offset = 10 (the end of a given Rest Interval’s Sleep In-
terval is defined as the last epoch of the last continuous series of epochs this many minutes 
long where no more than one epoch has ≥ 1 AC); Enhanced Sleep Statistics = Off (if On, 
this modifies several sleep characteristics using correction factors derived from PSG and 
other Rest intervals in the recording; we chose not to use this because what corrections are 




(If On, this only allows only one Rest Interval ≥ 3 hours – specifically the longest – to be 
defined in a single 24-hour period); Minor Rest Interval Sensitivity = Medium (a lower 
sensitivity will detect fewer Rest Intervals); Minor Rest Interval Minimum = 40 (Rest In-
tervals must be at least this many minutes long).  
 
Sleep Characteristics 
Sleep characteristics quantifying the timing, duration, and quality of sleep were generated 
for each Rest Interval with a valid overnight Sleep Interval: measures of sleep timing in-
cluded Sleep Onset time (SON), Sleep Mid-time (SMID), and Sleep Offset time (SOFF); 
measures of duration included Sleep Onset Latency (SONL), Sleep Offset Latency 
(SOFFL), Sleep Period (SP), Time in Bed (TiB), Total Sleep Time (TST), and Wake After 
Sleep Onset (WASO); and measures of sleep quality included Sleep Efficiency (SE), Per-
cent Sleep Time (PST), Fragmentation Index (FI), Average AC per minute during sleep 
(ACm), and Maximum AC per minute during TiB (AC Max). 
SON and SOFF approximate the start and end of sleep, and are defined by the Im-
mobile Minutes Onset/Offset options, respectively, as described above; SMID is simply 
the mean of SON and SOFF. SONL is the time difference between the start of the Rest 
Interval and the start of the Sleep Interval (i.e. how long it took to fall asleep); SOFFL is 
likewise the difference between the end of the Sleep Interval and the end of the Rest Inter-
val (i.e. how long it took to wake up). SP is equal to the duration of the Sleep Interval (i.e. 
SP = SOFF - SON), and TiB is equal to the duration of the Rest Interval (i.e. TiB = SP + 




durations of all Asleep/Awake epochs in the SP, respectively (i.e. SP = TST + WASO). SE 
is a percentage measure of general sleep quality where SE = TST / TiB, and PST is a similar 
characteristic calculated by dividing TST by SP; i.e. PST does not include SOFFL or 
SONL. Due to their similarities in calculation and interpretation, SE and PST are often 
conflated with each other in the literature (Berger et al., 2005; Fekedulegn et al., 2020). FI 
is a percentage measure of how likely a person is to transition between Asleep and Awake 
during their SP, and is calculated (Mini Mitter Company, Inc., 2006) as: 
Fragmentation Index = ([number of mobile bouts] + [number of immobile bouts ≤ 1 minute]) / 
[number of immobile bouts]  
…where a “bout” is a continuous series of epochs of the same type, and where epochs with 
≥ 1 AC are considered “mobile”. Higher FI is indicative of frequent night-time arousals 
and/or increased somnolescent movement. ACm is equal to the total number of AC de-
tected during the Sleep Interval (i.e. SP) divided by its duration, and AC Max is equal to 
the greatest number of AC observed in a 15-second epoch during the Rest Interval (i.e. 
TiB).  
 
Rest-Activity Rhythm (RAR) Characteristics 
The raw epoch-by-epoch AC time-series for each participant-day was fit to a basic 3-pa-
rameters cosinor model (Cornelissen, 2014) – a modified sine-cosine function with a period 
of 24 hours frequently used to model human RARs – and three parameters that characterize 
the participant’s RAR were produced. The Midline Estimating Statistic of Rhythm 




the entire day and about which the cosinor function oscillates. The Amplitude (Amp) is 
equal to difference between the average peak of the cosinor function and its MESOR. The 
Acrophase (Acro) represents how phase-shifted the individual’s RAR is relative to the 
other participants. Cosinors were only generated for at-home days with at least 20 hours 
and 24 minutes (4896, or 85%, of the 5760 15-second epochs in a day) of successful actig-
raphy data capture; participant-days that contained any time spent in the mid-study week-
end sleep clinic were excluded. The time periods cosinors were applied to were selected to 
provide sufficient data coverage for modelling; since participants typically began the study 
in the mid-to-late afternoon, we modelled cosinors on 24-hour periods running from the 
epoch starting at 18:00:00 through the epoch starting at 17:59:45 the next day, for a total 
of 5760 epochs (or 24 full hours) per cosinor model. This allowed us to ensure that each 
overnight sleep period was fully encapsulated within a single cosinor model and that each 
participant’s sleep and RAR characteristics were paired within each of their study days for 
analysis; specifically, sleep characteristics were paired to the cosinor parameters they oc-
curred within. Since sleep periods and our cosinor intervals straddle midnight and therefore 
overlap two calendar days, we refer to individual days by the name of the following calen-
dar day in this article for simplicity: e.g. results presented under “Saturday” consist of Fri-







Two endpoints were calculated to estimate sociogenic circaseptan disruption – chronic dif-
ferences in sleep behavior, timing, and quality resultant from social obligations and the 
work week: (1) Social Jetlag (SJL) is the absolute difference between one’s average SMID 
on before-work nights (i.e. Sunday through Thursday nights) and on before-rest nights (i.e. 
Friday and Saturday nights), and (2) Sleep Debt is the absolute difference in average SP 
between before-work and before-rest nights (Wong et al., 2015). Where-as SJL quantifies 
the difference in sleep timing between weekends and workdays, Sleep Debt quantifies the 
difference in sleep duration.  
 
Statistical Analysis 
Descriptive statistics were generated for all variables; unless otherwise stated, all descrip-
tive values reported herein are “mean (standard deviation)” for continuous variables and 
“number (%)” for dichotomous, ordinal, and categorical variables. Measures of central ten-
dency consisted of means and medians for normally and non-normally distributed varia-
bles, respectively. Processed data were organized and arrayed using Excel 16.16.13 for 
Mac (Microsoft, Inc., Redmont, WA, USA). All statistical analyses were performed in 
Stata 16.0 for Mac (StataCorp, Inc., College Station, TX, USA). Normality of distributions 
was evaluated using skewness-kurtosis tests, and equality of variances between groups was 
evaluated using equal-variances test. Two-sample comparisons were conducted using two-




normally distributed samples with unequal variances, and Wilcoxon rank-sum tests for 
non-normally distributed samples with a significance threshold of p = 0.05.  
 In order to account for nesting, repeated measures, and the random effects of be-
tween-participant and between-day variability, Linear Mixed Models (LMM) were em-
ployed to evaluate the variance of sleep and RAR Characteristics between the primary fac-
tors of interest (i.e. Chronotype and Day of the Week). Three LMMs were used: two one-
way models containing only either the Chronotype factor or the Day of the week factor, 
and a two-way model containing both factors. LMMs were fit using maximum likelihood 
and an independent covariance structure in a nested design, with Day nested within Study 
Week nested within Participant. Continuous variables for Age, BMI, and Date (specifically 
“days since the first participant’s first day”) were included as covariates. Holidays observed 
in Boston, MA, USA, including school vacations and final exam dates (Boston University 
Medical Campus Academic Calendar, 2015)44, were flagged with a dummy variable (“Spe-
cial Day”) that was included in the model. Although these days likely change the schedule 
and therefor the RAR and sleep of individuals relative to “normal days”, their effects are 
also likely not uniform; therefore an interaction between Date and the Special Day dummy 
variable was included in the model to account for the unique fixed effects of individual 
Special Days.  
The significance of between-group differences in the LMMs was assessed with 
Wald tests using linear combinations of marginal linear predictions via the Stata contrasts 
	
44 Halloween, Thanksgiving, Thanksgiving Break, Last Day of Classes, Fall Final Exam Study Pe-




command (Stata 16.0, StataCorp). The amount of variance attributable to each level of 




Participant Demographics and Self-Report 
Descriptive statistics for demographics and self-reported measures, including between-
Chronotype comparisons, are presented in Table 5.1. 24 healthy male participants com-
pleted the study; based on their MEQ scores, 15 participants were assigned to the Evening-
ness group (MEQ: 59.44 [2.96]) and 9 participants to the Morningness group (MEQ: 39.8 
[7.23]). All demographic and self-report measures were normally distributed (p > 0.05), 
with the exception of Age in the Eveningness Chronotype (p = 0.03). Although the MEQ 
scores across the entire sample were normally distributed (p = 0.15), dividing the sample 
into Chronotypes appeared to improve the normality within each group (p > 0.81). Further-
more, MEQ scores and self-reported normal sleep timings on weekends and weekdays were 
significantly different between the two Chronotypes (p < 0.01). BMI and self-reported 
sleep quality (via the PSQI and ESS) were not significantly different between Chronotypes 
(p > 0.43). The difference in age appeared to approach significance (p = 0.09), with Morn-
ingness being older on average; this is expected since Chronotype generally shifts toward 
Morningness as one ages (Foster & Roenneberg, 2008; Roenneberg, 2004). Together, these 
observations of improved normality, differences in sleep timing, and lack of differences in 




greatest differences were observed in measures expected to be sensitive to Chronotype (i.e. 
sleep timing and Age), with other measures (i.e. BMI and sleep quality) not achieving sig-
nificance (Table 5.1). 
 
Missing Data 
In order to be considered “valid” and eligible for analysis, a participant-day required both 
a cosinor model and an overnight sleep period. With perfect compliance, the study design 
allowed for a maximum of 672 participant-days (24 participants * 28 days) of recorded 
data. In total, 505 (75.15%) valid participant-days were collected (Table A.3). The 
Eveningness Chronotype had more valid participant-days overall, with 308 (73.33%), alt-
hough the Morningness cohort had a higher rate with 197 (78.17%) valid participant-days. 
Valid participant-days were generally more frequent during the work-week, especially in 
the week immediately following the sleep clinic stay. Lastly, 111 (21.98%) of all valid 






Table 5.1 – Participant demographics and self-reported sleep timing and quality, presented by Chronotype and including the p-
value of between-Chronotype tests. 
Demographic Characteristics 
by MEQ Chronotype 
All Participants 
(n = 24) 
Evening Chronotype 
(n = 15) 
Morning Chronotype 
(n = 9) 
Between-Group 
Comparisons 
Measure Average (Standard Deviation) Two-Sample Test  p-value 
Age (Years) RS 23.46 (4.77) 22.20 (4.55) ‡ 25.56 (4.61) 0.0853 * 
Body Mass Index (Kilogram/Meter2) TT 24.33 (3.00) 24.72 (2.60) 23.68 (3.65) 0.4250 
Epworth Sleepiness Scale (Score) TT 5.46 (2.43) 5.47 (2.72) 5.44 (2.01) 0.9833 
Pittsburgh Sleep Quality Index (Score) TT 3.71 (2.01) 3.93 (1.94) 3.33 (2.18) 0.4913 
Usual Sleep Time, Weekday (Time) TT 23:44 (0:55) 00:13 (0:46) 22:57 (0:28) 0.0002 ** 
Usual Sleep Time, Weekends (Time) TT 01:03 (1:02) 01:34 (0:52) 00:12 (0:38) 0.0004 ** 
Usual Wake Time, Weekdays (Time) WTT 07:49 (1:09) 08:20 (1:08) 06:57 (0:29) 0.0005 ** 
Usual Wake Time, Weekends (Time) TT 09:11 (1:21) 09:54 (1:07) 08:00 (0:45) 0.0002 ** 
Social Jet Lag, Self-Reported (Hours) TT 1.40 (1.01) 1.69 (1.11) 0.94 (0.58) 0.0929 * 
Sleep Debt, Self-Reported (Hours) TT 0.52 (0.49) 0.58 (0.57) 0.41 (0.32) 0.4091 
Morningness-Eveningness Questionnaire 
(Score) WTT 47.17 (11.37) 39.80 (7.23) 59.44 (2.96) < 0.0001 ** 
* p-value 0.05 < 0.10 
** p-value < 0.05 
‡ Significantly abnormal distribution (skewness-kurtosis test, p-value < 0.05) 
TT T-Test: Both Chronotypes were normally distributed (skewness-kurtosis test, p-value > 0.05) and had equal variances (equal variances 
test, p-value > 0.05); the between Chronotype comparison was conducted with an independent samples t-test. 
WTT Welch’s T-Test: Both Chronotypes were normally distributed (skewness-kurtosis test, p-value > 0.05) and had significantly different 
variances (equal variances test, p-value < 0.05); the between Chronotype comparison was conducted with a Welch’s independent samples 
t-test. 
RS Rank Sum: At least one Chronotype was non-normally distributed (skewness-kurtosis Test, p-value < 0.05); the between Chronotype 




Variance in Linear Mixed Models (LMM) 
The variance components of each variable at each nested level (i.e. Day of the Week nested 
in Study Week nested in Participant) were estimated in the univariate LMM (Table A.4). 
When averaged across all variables within a nested level, the highest average variance 
component of 56% was observed at the Day of the Week level, and the lowest average 
variance component of 8% was observed at the Study Week level; i.e. the highest predicted 
variance was observed between-Day within-Participant and -Week, and the lowest variance 
was observed between-Week within-Participant and -Day. The greatest variance compo-
nents of individual variables were observed in MESOR at the Participant level (55%), 
SOFF at the Study Week level (24%), and SOFFL at the Day level (86%). SE had the 
highest residual (i.e. unaccounted for in the model and not attributable to any specific 
nested tier) variance component of 39%. 
 
Rest-Activity Rhythm (RAR) and Sleep Characteristics (SC) 
Significant one-way (i.e. between-Chronotype, across-Day) differences were observed in 
individual RAR and SC variables in the unmodeled raw data (Table A.5): MESOR (p = 
0.0090), Amp (p = 0.0040), Acro (p < 0.0001), SON (p < 0.0001), SMID (p < 0.0001), 
SOFF (p < 0.0001), and FI (p = 0.0070); both TiB and TST approached significance (p = 
0.0867 and p = 0.0878, respectively). 
One-way comparisons were conducted for individual variables via Wald tests be-




or between-Day. Significant between-Chronotype across-Day differences were observed 
in the “time of day” variables: Acro (p = 0.0329), SON (p = 0.0062), SMID (p = 0.0084), 
and SOFF (p = 0.0370), with Eveningness having later values (Figure A.4; Table A.6A). 
Additional significant differences were observed in a larger number of RAR and 
SC variables in the between-Day across-Chronotype one-way LMM (Figure A.5; Table 
A.6B)45: MESOR (p = 0.0356), Amp (p = 0.0007), Acro (p = 0.0003), SON (p < 0.0001), 
SMID (p < 0.0001), SOFF (p < 0.0001), TST (p = 0.0140), and PST (p = 0.0348). To 
summarize, weekends (Friday 18:00 – Sunday 18:00) had higher activity, later timing of 
activity, later sleep times, and longer sleep periods with less time spent awake. TiB (p = 
0.0979), SOFFL (p = 0.0578), and SE (p = 0.0957) appeared to approach significance. 
Significant within-day between-Chronotype differences (Figure 5.1, Table 5.2) 
were observed in the two-way LMM: SMID (p = 0.0243) and SOFF (p = 0.0095) on Sun-
days; Acro (p = 0.0162), SON (p = 0.0022), SMID (p = 0.0142), TiB (p = 0.0367), and 
TST (p = 0.0291) on Mondays; SMID (p = 0.0405) on Tuesdays; SON (p = 0.0210) and 
SMID (p = 0.0210) on Thursdays; and Acro (p = 0.0101), SON (p = 0.0003), SMID (p = 
0.0028), TiB (p = 0.0275), and TST (p = 0.0304) on Fridays. Lastly, SON (p = 0.0116), 
TiB (p = 0.0263), and TST (p = 0.0180) were jointly significant for Chronotype and Day 
of the Week (Table 5.2).
	
45 All between-Day across-Chronotype p-values reported in-text are joint p-values derived from 
joint Wald tests conducted across all seven Days. Two-sample Wald tests were used to compare 





Table 5.2 – Predicted marginal means (standard error) for each Chronotype-Day, the p-values of the between-Chronotype within-
Day Wald tests, and the p-values of the joint Wald tests. 





































































































































p-value 0.1894 0.0875 * 0.4290 0.7767 0.4197 0.9523 0.3727 
Morning-




























































































































































































Figure 5.1: Predicted marginal means (standard error) of cosinor parameters (MESOR, Amplitude, and Acrophase) and sleep 
timings (Sleep Onset, Sleep Mid, Sleep Offset) by-Chronotype and by-Day of the Week derived from the by-Day by-Chronotype 
two-way linear mixed model. Between-Chronotype Wald tests were conducted within each Day for all variables; ** indicates p-



































In this study, we used data from a single wrist-worn actigraphy device to identify signifi-
cant differences in Rest-Activity Rhythm (RAR) and Sleep Characteristics (SC) across the 
seven-day week and between Morningness and Eveningness Chronotypes. We found that 
certain RAR and sleep characteristics varied significantly between Chronotypes, and that 
these differences were often dependent on day of the week. 
 
Sleep and Activity Timing Significantly Varies across the Week 
We observed substantial changes in SC across the week in both Chronotypes, especially 
during the “transitions” that separate work from rest days (i.e. Friday/Monday). As might 
be expected, the strongest between-day differences were observed in the timing of activity 
and sleep; both Chronotypes woke up and were active later during the weekend (Friday 
and Saturday nights) than during the work-week (Sunday – Thursday nights), suggesting 
that “sleeping in” was not limited to a specific Chronotype in our sample (Figure 5.1, Table 
5.2, Table A.6). Significant day-to-day changes in SMID and SOFF were observed at the 
transitions between work and rest days for both Chronotypes. Although both Chronotypes 
went to bed earlier during the work week, Morningness participants adjusted to the work 
week more quickly, achieving significantly earlier bedtimes within one day. In contrast, 
Eveningness participants took on average an extra day before their SON were significantly 
earlier than on the weekend. Interestingly, Eveningness transitioned to their later weekend 
SON on Thursday night, where-as Morningness began going to bed later on Friday night. 




Where-as Morningness shifted within one day, Eveningness gradually went to bed earlier 
each day from Sunday through Tuesday, then later with each day through the weekend. 
In summary, both Chronotypes conform to a similar circaseptan rhythm across the 
week – i.e. sleep timing advances on weekends – and that this pattern is most consistent in 
their SOFF. When transitioning between weekends and weekdays, Morningness adjust 
their SON quicker than Eveningness, who shift incrementally throughout the week. These 
results may be due to the fact that SOFF are the most directly constrained by the work-
week, where-as individual preference plays a larger role SON; i.e. SON is more sensitive 
to Chronotype than SOFF. 
Morningness had significantly greater TiB and TST than Eveningness on Sunday 
and Thursday nights (Figure 5.1; Table 5.2). These differences are attributable to Chrono-
type-specific variations in SON and SOFF: Thursday night’s due to the later Eveningness 
SON without a comparable advance in SOFF, and Sunday night is likewise explained by 
the significantly earlier Morningness SON. Both Chronotypes experienced a significant 
and comparable decrease in SOFFL from Sunday morning to Monday morning, perhaps 
attributable to work constraints as with SOFF (i.e. less freedom to “sleep in”).  
Eveningness had significantly higher SE on Friday night relative to Thursday night, 
potentially due to their resumption of their preferred sleep schedule. In contrast, Morning-
ness had significantly lower SE on Saturday night relative to Friday night. The unexpect-
edly similar advances in sleep timing on the weekend for both Chronotypes may be at-
tributable to the fact that the social schedule during the work week is more closely aligned 




night social events) resulted in phase-advance of sleep timing in Morningness participants 
beyond their preferred sleep schedule, resulting in decreased sleep quality. Eveningness 
participants, however, may experience improved SE on the weekend for the same reason. 
However, note that other measures of sleep quality – WASO, PST, and FI – did not signif-
icantly decrease during the weekend for Morningness, although Eveningness WASO and 
PST significantly decreased on Saturday nights relative to Friday nights. 
 
Measuring and Interpreting Circaseptan Rhythms 
Technological advances have enabled continuous monitoring of authentic, uncontrolled, 
and out-of-lab behavior. Wearable devices such as the Actiwatch used in this study allow 
chronobiologists to collect ecologically valid data, better interrogate the complex interac-
tions between circadian cycles and environmental factors, and potentially identify targets 
for interventional therapy. However, this introduces new problems: which methods are the 
most reliable and functional, which measures are the most relevant and informative, iden-
tifying unknown systemic biases or false assumptions, and ensuring methodological and 
analytical consistency to allow for replicability and meta-analysis. Our study highlights 
some of the more pragmatic obstacles to this approach, specifically the large amount of 
variance observed, the need to account for as many environmental factors as possible, and 
participant compliance. 
Due to the unconstrained nature of continuous monitoring, our main analytical goal 
was to account for as much variance as possible and isolate the desired signal: RAR and 




within Participant – was specifically chosen to detect circaseptan rhythms. Analogous to 
an electroencephalographic technician deriving an event-related potential from the average 
of hundreds of trials synchronized to a reference time, we derived circaseptan rhythms from 
the average of many Participant-Weeks “synchronized” to the standard seven-day week. 
This allows random variability to “average out”, where-as effects that are constant across 
all weeks (e.g. sleeping in on the weekend) remain. While the results in this article are 
primarily discussed in reference to individual days, these outcomes collectively represent 
the average pattern across the average week; i.e. circaseptan rhythms. 
We derived variance components for each of the three nested levels in our design. 
The largest variance components were observed at the Day level for all variables, with the 
exception of MESOR and SON whose largest variance component was at the Participant 
level (Table A.4). This means that RAR and sleep characteristics varied more between 
Days within a Participant than they did between Participants, and implies that the largest 
contributors of variance were at the Day level; in addition to normal between-Day varia-
bility, this variance may be attributable to weather, illness, personal events such as birth-
days or travelling, and so on. Likewise, Participant-level variance may be explained by 
normal individual variability and unaccounted for between-Participant factors, such as liv-
ing situation, employment, or commute. Although we cannot definitively attribute variance 
to individual factors, variance components allow us to infer the what factors different meas-
urements may or may not have in common. For example, the large Participant-level vari-
ance component seen in SON suggests that individual preference is more influential on the 




SOFF implies that external day-specific factors (e.g. work) may be more important for 
predicting when one wakes up.  
Our results support the concept that Day of the Week is a significant factor that 
alters timing of sleep and activity, and therefore should be accounted for when assessing 
them across multiple days. More generally, study designs must properly account for the 
social calendar their participants will exist in, whether it’s office employees at a 9-to-5 job, 
nurses on 12-hour shifts, or oil-rig workers on a four week rotation, especially when the 
observation period includes both rest and work days (Roenneberg et al., 2019; Vetter, 
2018). This extends to the natural calendar, i.e. season and daylight hours. Given the wide-
spread control the circadian rhythm has on our physiology and behavior, we argue that 
most studies of human biology should account for these calendar factors as well, especially 
observational studies with long data collection periods. 
 
Circadian Disruption in Modern Societies 
Circadian disruption is the sustained desynchronization of the circadian rhythm from its 
environment (Vetter, 2018), and is a significant and widespread burden upon modern in-
dustrialized societies (Colten & Altevogt, 2006). Epidemiological studies quantifying its 
full extent are scarce (D. R. Hillman & Lack, 2013) due its multifaceted and vaguely de-
fined nature (Vetter, 2018); however, epidemiological studies of sleep disruption (which is 
closely linked to circadian disruption) estimated that over a third of Americans suffer from 
insufficient sleep (Liu et al., 2016), a similar proportion of Australians suffer from sleep 




~1.5 hours less than recommended (Léger et al., 2011). Moreover, retrospective analyses 
of Swedish and Finnish cohort studies suggest that sleep duration has declined by as much 
as 18 minutes/night over a period of ~30 years (Kronholm et al., 2008; Rowshan Ravan et 
al., 2010), and the prevalence of sleep disruption is expected to continue rising in propor-
tion to at-risk populations (Ferrie et al., 2011). Numerous health issues have been linked to 
circadian disruption, including metabolic disease (Potter et al., 2016), cardiovascular dis-
ease (Portaluppi et al., 2012), neuropsychiatric disorders (Musiek & Holtzman, 2016), neu-
rodegenerative diseases (Colten & Altevogt, 2006; Videnovic, Lazar, et al., 2014), and 
disruption of the endocrine system (Bedrosian et al., 2016; Vetter, 2018). Generalized 
symptoms of acute circadian disruption (e.g. fatigue and impaired attention) have contrib-
uted to the occurrence of fatal accidents (Gottlieb et al., 2018) - the rate of which has in-
creased in the United States of America (USA) over the past decade (Murphy et al., 2018) 
– and has been implicated in numerous high profile accidents and catastrophes such as the 
Three Mile Island disaster, the Chernobyl disaster, the Exxon Valdez oil tanker spill, the 
Space Shuttle Challenger disaster, and the Union Carbide disaster in Bhopal, India (Colten 
& Altevogt, 2006; RAND Corporation, 2016). Insufficient sleep has also been linked with 
seven of the fifteen most common causes of death in the USA (RAND Corporation, 2016) 
and is associated with worse academic performance in schoolchildren and undergraduates 
(Okano et al., 2019). The broad extent of sleep and circadian disruption is believed to have 
a significant economic impact. In 2002, the total economic cost (in terms of lost produc-




estimated at $226 billion in the USA alone (Stewart et al., 2003). 14 years later, one inter-
national model (RAND Corporation, 2016) estimated that cost had increased to ~$350 bil-
lion.  
Clearly, there is a need for a better understanding of the causes and consequences 
of circadian disruption in order to inform the development of new therapies and policies 
for curtailing it and its deleterious impacts on human society. However, there is a lack of 
consensus regarding the spectrum of changes to the circadian rhythm, which range from 
normal intra- and inter-individual variability (e.g. behavior and chronotype, respectively), 
to adaptive changes in response to the environment (e.g. seasonal changes in sunlight), to 
short-term disturbances caused by acute challenges (e.g. jet lag), to chronic disruption cre-
ated by sustained desynchrony between the circadian rhythm and environmental cues (e.g. 
SJL) (Vetter, 2018). Any discussion of circadian disruption must account for the fact that 
the circadian rhythm is innately adaptive; i.e. it constantly receives and integrates internal 
and external zeitgebers to optimize the timing and coordination of biological processes. 
For example, the gradual day-to-day change in sunrise time is a constant challenge that the 
circadian rhythm easily adapts to with minimal systemic effects (i.e. we are not jet lagged 
every morning). However, a significant change in sunrise time (e.g. due to normal jet lag) 
can overwhelm the circadian rhythm’s adaptability and result in a period of disruption be-
fore the organism is fully resynchronized to their new environment. Therefore any discus-
sion of circadian disruption must distinguish between healthy adaptation, normal varia-




This extends to the impact on the biological mechanisms of circadian rhythm: which mol-
ecules, cells, tissues, organs, and/or systems are affected by adaptation and disruption, by 
how much, how consistently, how are disruptions borne and distributed by each level of 
organization and its sub-components, etc. In other words, the circadian rhythm is a system 
of systems; inferring its integrity by studying its overall function is analogous to determin-
ing the health of an individual by their height alone. 
Our data contribute to the considerable evidence indicating our circadian rhythm 
adapts to the socially-defined seven-day week. Although our sample was small and demo-
graphically constrained, we incorporated relevant factors (e.g. chronotype, holidays) and 
triangulated the circadian rhythm using multiple approaches (i.e. objective monitoring and 
subjective self-report) and endpoints (i.e. RAR, sleep, and biomarkers (see Marshall et al., 
2020 [under review]) to produce a more comprehensive model of sociogenic disruption. 
This model enabled us to estimate the variance attributable to between-Day, between-
Week, and between-Individual effects, which can be used to generate hypotheses targeting 
specific factors for future work; residual variance components likewise provide an estimate 
of how much “background noise” can be expected in certain endpoints, which can aid in 
the informing power analyses. 
Moreover, our work emphasizes the highly integrated nature of our biology and our 
society. Sleep and RAR are systemic outputs that represent the cumulative effects of our 
conscious decisions, circadian rhythm, social environment, and natural zeitgebers like sun-




may be the cumulative product of the intersection between our social calendar and biolog-
ical rhythms; e.g. there is a well-documented circaseptan rhythm in suicides and heart at-
tacks associated with the transitions between work- and rest-days (F. Halberg et al., 2005; 
Refinetti et al., 2007; Rogot et al., 1976). Given that blood pressure exhibits a circaseptan 
rhythm with a peak on Mondays (Murakami et al., 2004), and that transitions between 
“social time zones” (i.e. stress of returning to work after the weekend) increases psychoso-
cial – and subsequently physiological – stress, the weekly rhythm in heart attack fatalities 
may be attributable to the compounded risks borne from biogenic and sociogenic factors 
(Ayers et al., 2014; Wallert et al., 2017). The presence of a circaseptan rhythm in urinary 
17-ketosteroid secretion (Franz Halberg et al., 1965), the approximately circatrigintan 
rhythm of menstruation, and circannual rhythms in cortisol secretion (Morgan et al., 2017) 
and the duration of nocturnal melatonin secretion (Stothard et al., 2017) suggest the pres-
ence of endogenous infradian rhythms that exist independently of, and thus may become 
misaligned with, our social calendars. For example, human birth-rates exhibit a profound 
circannual rhythm, but the amplitude has dramatically decreased since the industrial revo-
lution (Foster & Roenneberg, 2008). This change was undeniably driven by sociocultural 
factors (e.g. artificial lighting, insulation from seasons, transition to industrialized mass 
production, implementation of standardized time tables, etc.), but it is unknown if this was 
because the circannual rhythm in birth-rate is purely an emergent property of human culture 
with no biological basis, or because the effect of its biological drive has since been eclipsed 




ard work schedules have rendered moot our need to wake with the rising sun, or how arti-
ficial lighting has largely abolished our circannual rhythm in nocturnal melatonin secretion 
(Stothard et al., 2017). In summary, circadian disruption associated with the seven-day 
week is only one of the myriad ways in which our behavior is shaped by a combination of 
intrinsic biological and extrinsic social factors, and serves as a microcosm for studying the 
nature, breadth, and extent of these factors. 
 
Limitations 
The study discussed in this article had several limitations. The high level of variability 
observed between Participants and Days was a natural consequence of the uncontrolled 
nature of continuous monitoring. We were able to mitigate this by accounting for random 
effects at the Participant and Day level in our linear mixed model, but this nonetheless 
limits interpretability of results. This study employed a “basic” 3-parameter cosinor to 
model RARs; while computationally accessible, the basic cosinor assumes symmetrical 
rhythms with an idealized cosine waveform. Human RARs are more “block-like” than si-
nusoidal, with prolonged periods of activity and torpor of different length during the day 
and night, separated by relatively rapid transitions in activity level. We plan to use the 
“extended” 5-parameter cosinor model (Marler et al., 2006) in future work, which includes 
additional parameters to model the rise/fall time and the ratio of sustained activity versus 
torpor. Sleep characteristics were generated with Actiware, which has many customizable 




our results to other sleep data. The study population was recruited from a limited demo-
graphic, consisting mainly of medical and graduate students from the Boston area. While 
this minimized variance from factors such as age or sex, this is not a representative sample 
of the population and further limits generalizability. This study required participants to 
wear additional devices and complete daily diaries at-home, as well as a one-weekend stay 
in a sleep lab halfway through the study period; although the sleep lab visit was excluded 
from all analysis in this article, participant behavior may have been altered by the additional 
devices, in-home diary, or on days adjacent to their stay in the sleep lab. Lastly, we did not 
collect detailed information on their work schedule during the study, their observation of 
holidays (official, personal, or otherwise), or other changes in their day-to-day schedule; 
this required us to assume the cohort had a uniform and consistent weekly schedule 
throughout the study period, and deviations from this assumption likely contributed to 
some of the residual variance in our models. 
 
Conclusion 
Our observations support the growing literature describing chronic circadian disruption in 
modern societies. Phenomena such as SJL, sleep debt, and “sleeping in on the weekend” 
emerge from the mismatch between social and circadian rhythms, whereby individuals os-
cillate between their preferred chronotype on rest days and a socially enforced chronotype 
on work days analogously to crossing time zones (Vetter, 2018). The behavioral shift is 
immediate, where-as the circadian rhythm “lags behind” and requires time to resynchro-




associated with acute cognitive, homeostatic, and metabolic deficits (Roenneberg et al., 
2012; Vetter, 2018); unlike jet lag, SJL and similar phenomena presents a challenge at 
consistent, periodic intervals (i.e. weekly). As a result, sociogenic circadian disruption is a 
unique challenge to our modern societies that will require widespread data collection, care-
ful identification of relevant factors, improved methodological consistency and replicabil-





CHAPTER SIX: DISCUSSION 
Summary of Main Outcomes 
Circadian disruption in humans is widespread in modern industrialized societies due to a 
combination of sociogenic and pathological factors. In order to translate scientific studies 
into clinical applications, researchers must be able to accurately quantify and classify cir-
cadian disruption, distinguish between disruption and normal variance, and identify poten-
tial therapeutic targets. This requires the use of observational approaches that emphasize 
ecological validity, employ synergistic methodologies, to challenge our assumptions, and 
to strive to detect and account for the myriad environmental factors that shape our circadian 
rhythm. Most importantly, researchers must reach a consensus on how to standardize the 
scientific evaluation of circadian disruption: its definition, its assessment, its reporting, and 
its interpretation. This harmonization is not only for the benefit of chronobiology, but also 
for the study and treatment of pathologies such as Parkinson’s disease (PD) for whom cir-
cadian disruption is a major feature. This is not unique to circadian disruption; as technol-
ogy continues to improve, methodological diversity increases, and powerful new tech-
niques emerge, scientific work must be consolidated, standardized, and clearly reported 
lest the field miss the forest for the trees. 
A key element in this approach is the integration of diametric methods, such as 
qualitative self-report with quantitative measurement, subjective evaluation with objective 
mensuration, cross-sectional evaluation with longitudinal monitoring, and controlled ex-
periments with naturalistic observation. In Chapter 3, this philosophy was applied by inte-




its assessment via the Movement Disorders Society’s Unified PD Rating Scale (MDS-
UPDRS). This work showed that behaviors used in the standard evaluation of PD can be 
systematically defined using key anatomical, visual, and behavioral references to enable 
their identification and precise temporal quantification in video recordings to a level of 
detail so that naive raters without prior clinical experience can achieve high inter-rater re-
liability. 
Amongst the challenges of studying circadian disruption is attributing its etiology 
to discrete factors and causes. While circadian disruption is increasingly recognized as a 
major feature of PD, relatively little work has been done to characterize its relationship 
with PD’s clinical severity, or to what degree PD’s circadian disruption is attributable to 
pathology or unrelated factors. In Chapter 4, depression and fragmentation of rest-activity 
rhythms (RAR) in PD were detected via continuous actigraphic monitoring, which further 
revealed an association between RAR disruption and motor severity and Hoehn and Yahr 
stage (H&Y). 
Misalignment between our biological rhythms and our artificial timetables gives 
rise to phenomena such as Social Jet Lag (SJL), sleep debt, “sleeping in on the weekend”, 
and “a case of the Mondays”. As these occur on a weekly period - potentially due to our 
use of a seven-day week and/or an endogenous seven-day biological rhythm - they can be 
described as circaseptan rhythms of circadian disruption. An interim analysis found that 
persons with PD experienced more sleep fragmentation across the week, but retained the 
“half-week” or “semicircaseptan” rhythm observed in controls. This implies a common 




a product of the seven-day week. To test this, the same general methodology used in Chap-
ter 4 was applied to a population of young, healthy adults with the intent of characterizing 
the potentially sociogenic circadian disruption observed in the PD cohort. This worked 
revealed strong circaseptan effects in RAR and sleep related to transitions between week-
days and weekends (i.e. when people’s behavioral timing shifts due to a change in sched-
ule), which were further influenced by their self-reported chronotype. These sociogenic 
and endogenous factors must be quantified and accounted for in order to advance our un-
derstanding of, and capacity to minimize, circadian disruption in humans. 
 
Methodological Considerations 
Much of our knowledge of chronobiology derives from controlled experiments designed 
to manipulate the circadian rhythm and measure it in isolation. Technological advance-
ments have led to the development of wearable devices capable of measuring circadian 
indicators, such as body temperature, sleep, and movement. By measuring authentic (i.e. 
uncontrolled) human behavior longitudinally, researchers can observe how rhythmic pro-
cesses - well understood in isolation - are impacted by the myriad intricacies of life. This 
approach inherently produces highly variable data, and is dependent on well-structured 
analytical models, integration of secondary lifestyle information to account for individual 
differences, and the application of sociological theories on human behavior to minimize 




This subchapter will discuss methodological considerations relevant to the studies 
and topics covered in earlier chapters. In particular, the importance of methodological har-
monization and clarity, the beneficial integration of synergistic measures, the necessity of 
mitigating unconventional biases, and notable methodological obstacles will be explored 
in the context of this manuscript’s contents and applied more generally to human observa-
tional research (especially chronobiological) writ large. 
 
Methodological Diversity: Objective, Subjective, Quantitative, and Qualitative Ap-
proaches 
As scientists, we strive to measure natural phenomena as objectively and quantitatively as 
possible. Much of the effort in scientific research is expended in pursuit of developing, 
assessing, refining, validating, and disseminating novel methods for measuring observables 
of interest to generate and test hypotheses. Observation is fundamentally the acquisition of 
information from some system, and since every measurement will always have some 
amount of uncertainty, the methods employed by scientists are incredibly specialized and 
rely on strategies tailored to the signal of interest and its context. However, as a method 
becomes more context-dependent and constrained by a conceptual framework, the number 
of prerequisite assumptions needed for the valid interpretation of its outputs increases. Put 
simply, the cost of specialization is a loss of generalizability. A natural application of this 
knowledge is to incorporate both powerful, specialized methods and more non-specific, 
generalizable methods in parallel, so that their respective strengths can compensate for 




was able to more accurately predict future risk of Parkinson’s disease (PD) using a combi-
nation of two potential biomarkers - hyposmia46 and reduction in dopamine (DA) trans-
porter (DAT) binding - than either individually (Lana M. Chahine & Stern, 2017; Danna 
Jennings et al., 2017). Both hyposmia and a reduction in DAT binding can be detected with 
high sensitivity, but have poor specificity for PD due to their myriad potential causes. How-
ever, since there is little overlap in their potential causes, their integration into a single 
model can greatly improve their combined specificity by filtering out false positives (e.g. 
hyposmia secondary to respiratory illness) and “triangulating” the common factor of inter-
est; i.e. PD. Predictive accuracy can be further increased through the inclusion of additional 
biomarkers such as constipation and cognitive dysfunction (Lama M. Chahine et al., 2016; 
D. Jennings et al., 2014), which also allows for individual biomarkers to be weighted as 
risk factors relative to their predictive power (Berg et al., 2015; Lana M. Chahine & Stern, 
2017). It has been acknowledged that an effective approach to detecting prodromal PD will 
likely require a diverse array of biomarkers sensitive to specific symptomatic (both motor 
and non-motor) and pathological components, requiring a combination of quantitative, 
qualitative, subjective, and objective methods (Artusi et al., 2018; Espay et al., 2017). 
Chapter 3 similarly employed a constellation of complementary methods to trian-
gulate specific endpoints. Instead of integrating prodromal biomarkers to improve speci-
ficity, video annotation was applied to quantify the duration of clinical behaviors in com-
bination with subjective clinical evaluations, with the goal of establishing a unified clinical 
	




dataset that could be aligned with objective actigraphic monitoring. By integrating subjec-
tive, objective, and quantitative measures, this “multimodal” dataset can characterize these 
behaviors in detail and allow for equitable comparisons between normally incompatible 
methods: e.g. the duration of a sit-to-stand can be precisely quantified through annotation, 
which can then be related to a clinical rating via the MDS-UPDRS, and used to segment 
objective actigraphic accelerometry for use in algorithm development or machine learning. 
This unified approach provides essential information that contextualizes and bounds the 
often difficult-to-discern key features of interest in actigraphy data, facilitating analysis 
and informing interpretation more efficiently than actigraphy alone. 
Chapter 4 employed multimodal measures to assess sleep and rest-activity rhythm 
(RAR) disruption in persons with PD, whose multifaceted symptoms and multi-system 
pathological insults require a similarly diverse methodology to comprehensively assess. 
Consider sleep disruption, a major non-motor symptom in PD that can be quantified with 
polysomnography (PSG) through objective markers such as sleep stage progression and 
number of awakenings. Daytime sleepiness is another common non-motor symptom in PD 
caused, in part, by previous sleep disruption. Although there are objective, quantifiable 
events that cause daytime sleepiness (e.g. midsleep awakenings, i.e. sleep disruption), it 
manifests as a qualia, an experiential perception (Lou et al., 2009) that can only be subjec-
tively assessed, usually through self-report on a questionnaire. In this context, subjectivity 
means that the signal of interest is dependent on some contextual perspective, such as the 




experienced disrupted sleep may be so accommodated to daytime sleepiness that they con-
sistently rate themselves as having less daytime sleepiness than another person who re-
cently developed the same level of sleep disruption. While there is no biological difference 
between these hypothetical subjects, the impact on quality of life would be greater in the 
latter subject since their subjective perception is more severe. 
This highlights the critical and fundamental importance of selecting the appropriate 
methods to balance accuracy, relevance, burden, validity, and translatability. Consider the 
myriad ways a researcher could measure the sleep quality of PD patient: they could record 
how well they slept every morning in a diary, infer sleep quality through the number of 
conscious awakenings by instructing the patient to press a button on their phone whenever 
they wake up, have an experienced sleep clinician observer assign a score based on stand-
ardized criteria, monitor them with wearable sensors to quantify some behavioral or phys-
iological correlate of sleep like physical activity or respiration rate (respectively), or have 
them spend the night in a sleep lab with polysomnography (PSG) to directly monitor 
sleep/wake status via brain activity, the neurological primogenitor of sleep, alongside myr-
iad physiological correlates. 
These methods vary along different axes: subjective (e.g. clinical evaluation) to 
objective (e.g. actigraphy), qualitative (e.g. sleep quality diary) to quantitative (e.g. number 
of awakenings), low burden (e.g. passive monitoring in-home with actigraphy) to high bur-
den (e.g. PSG), coarse (e.g. self-report) to precise (e.g. clinical scale), and systemic (e.g. 
brain activity) to system-specific (e.g. respirations). Sleep diaries are subjective because 




perceived quality of sleep. Marking midsleep awakenings is quantitative because it’s meas-
uring the quantity of awakenings, and objective because the subject always presses the 
button when they wake up. An expert rating based on standardized criteria is subjective 
because the expert must interpret their observations to determine which criteria are met, 
qualitative because they have to assign a score, and also quantitative because the score is - 
in part - based on quantitative metrics like “number of awakenings”. Measuring respiration 
rate with a wearable respiration belt is objective (because it’s observed via an artificial 
sensor) and quantitative (as it’s derived from the number of respirations), but it may not be 
as precise as other methods since it reflects a single biological system that can be influenced 
by many different factors beyond sleep. It is also less burdensome as it does not require the 
subject or researcher to actively measure breathing, and is thus less susceptible to issues of 
compliance and human error. PSG is also objective and quantitative, but instead of meas-
uring one biomarker of sleep, it assesses many (e.g. movement, respiration, heart rate, cor-
tical activity, etc.); this allows one to triangulate the data (a la the previous PD prodromal 
biomarker example) (Lana M. Chahine & Stern, 2017; Espay et al., 2017) and arrive at a 
more accurate outcome than just measuring respirations alone, albeit at the cost of high 
subject burden due to the myriad instruments and monitors placed on them and the need to 
stay in an unfamiliar environment (i.e. sleep lab). 
In theory, one might consider always using PSG due to its systemic scope, objective 
nature, and quantitative measures - and in fact PSG is considered the “gold standard” (i.e. 
most accurate and reliable) method for assessing sleep. In reality, the burden, cost, logis-




are used in some situations. If a scientist is, for example, conducting a quick exploratory 
study to determine if a certain population has enough sleep disruption to merit a large-scale 
project, then a sleep diary will probably suffice: it can be easily distributed, is cheap, does 
not require extensive analysis or post-processing to interpret, and - while it is less accurate 
and susceptible to more confounds than PSG - a high level of accuracy isn’t essential in a 
prospective exploratory study. 
Do not mistake this as an argument against the validity of subjectively evaluated 
data or an indictment of qualitative scales; rather, this highlights the importance of choos-
ing “the right tool for the job”. In other words, seemingly inferior methods - on account of 
their subjectivity, coarseness, etc. - still have valid applications to which they are well-
suited. For example, a questionnaire can capture qualitative data on mood and a thermom-
eter can capture quantitative data on body temperature. While one could theoretically be 
inferred from the other - given sufficient knowledge of mood-related changes in thermoreg-
ulation - this is not feasible in practice because one is a subjective report of perception, and 
the other an objective measurement of a physical property. While mood can theoretically 
be reduced to a series of neurochemical processes, their specific nature, the ability to pre-
cisely quantify them, and the knowledge to translate these biomarkers into a mood that can 
be subjectively verified is currently beyond our ability. Pragmatically, it is much easier to 
simply have the subject complete a structured questionnaire. Philosophically, the episte-
mological incompatibility of physical biology and intangible consciousness precludes their 




sciousness (from which subjective evaluation originates) arises from quantifiable biochem-
ical processes (which can be objectively measured) is unknown and can’t be artificially 
recreated. Put simply, subjective evaluations are the product of an inscrutable “black box” 
of consciousness, whose internal mechanisms cannot be accurately replicated or objec-
tively measured. Until we can do so (and perhaps not even then), subjective evaluation and 
qualitative self-report will continue to be powerful and ubiquitous methods. 
 
Mixed Methods Research and Data Triangulation – Actigraphy and Polysomnography 
We applied the above-mentioned principles to create a multimodal battery of methods to 
triangulate sleep and circadian disruption in PD (see Chapter 4) and in young healthy men 
(see Chapter 5). Specifically, objective and quantitative measures (e.g. actigraphy, PSG) 
were integrated with subjective and qualitative approaches (e.g. sleep questionnaires) to 
capture as much data and contextual information as possible. 
Although PSG is currently the most direct and reliable means of assessing sleep, it 
entails significant costs and burden on both the clinicians and patients (M. Mitchell & 
Werkhaven, 2020). Patients are required to sleep in an unfamiliar environment outside of 
their homes and are often responsible for arranging travel to the clinic, which can be a 
significant logistical barrier to some. Trained technicians are needed to set up, monitor, 
and score the PSG, and the necessary specialized equipment and facilities are both expen-





Actigraphy has been found to have a sleep-detection accuracy of ~80-90% in com-
parison to in-laboratory PSG, though this varies slightly by population (Ancoli-Israel et al., 
2003; Fekedulegn et al., 2020; Marino et al., 2013; M. T. Smith et al., 2018). However, 
actigraphy’s ability to effectively detect sleep - and whether its efficacy is sufficient to 
yield valid data - is still debated (Goldstone et al., 2018). Epoch-by-epoch sensitivity is 
considered very good relative to PSG (i.e. ≥ 90%), yet the specificity of epoch-by-epoch 
sleep detection over the last 20 years has remained constant at approximately 50% (Gold-
stone et al., 2018). Although derived metrics (e.g. sleep characteristics) usually have better 
agreement between actigraphy and PSG than epoch-by-epoch sleep detection, the specific-
ity of derived metrics is lower in sleep periods with more wake time. Furthermore, there is 
scant literature describing the intricacies of sleep algorithms and how certain sleep charac-
teristics are calculated, leading to confusion and inconsistent reporting in the literature 
(Berger et al., 2005; Fekedulegn et al., 2020; M. T. Smith et al., 2018). Increased method-
ological transparency may contribute to a better understanding of how sleep characteristics 
are generated. improve the validity and consistency of their interpretation and application 
in future studies, facilitate their iterative refinement with improved algorithms, call atten-
tion to underused sleep characteristics, and provide the information needed to develop (and 
disseminate) novel sleep characteristics tailored to specific applications (Fekedulegn et al., 
2020). 
Ultimately, actigraphy is a compromise between biological assessment and subjec-
tive self-report. It is an objective measurement that is still significantly cheaper and less 




longitudinally in ecologically valid environments. Moreover, it eschews the inherent im-
precision of subjectively self-reporting sleep, the inaccuracy of which is further com-
pounded by the fact that sleep is an unconscious behavior, and the tendency for subjects to 
fill out diaries after significant time has passed. However, it is limited by the lack of a direct 
biological measure, instead inferring sleep through reduced physical activity, and cannot 
sample qualitative data such as sleep quality or perceived tiredness. Nonetheless, these 
drawbacks can be greatly mitigated by the inclusion of complementary measures - namely 
PSG and self-report sleep diaries - allowing internal validation of their common measures 
(e.g. sleep timing) and data triangulation to inform more accurate interpretations (Madrid-
Navarro et al., 2018). 
For example, the work presented in Chapter 5 used a combination of demographic 
and objective data to inform the division of the sample into Morningness and Eveningness 
cohorts. Since chronotype represents one’s default phase-alignment with external zeit-
gebers, only measures of circadian timing (e.g. acrophase of RAR, sleep timing) would be 
expected to vary significantly between the cohorts in an unbiased sample. Thus after com-
paring and finding no difference in non-timing endpoints (e.g. age, BMI) between the co-
horts, it was concluded that there were no significant demographic confounds related to 
chronotype that would need to be accounted for in statistical analysis and interpretation. In 
addition, the use of the Morningness-Eveningness Questionnaire (MEQ) to determine 
chronotype was further supported by deriving chronotype from other sources (specifically 




verifying that these outcomes were also significantly different between MEQ-defined 
Morningness and Eveningness cohorts. 
Triangulation can also be accomplished by characterizing certain aspects or sub-
components within a single measure (e.g. actigraphy). For example, Chapter 5 character-
ized general “sleep quality” using several different measures algorithmically derived from 
actigraphy: Sleep Efficiency (SE), Wake After Sleep Onset (WASO), Percent Sleep Time 
(PST), and Fragmentation Index (Frag). After observing a weekend decrease in SE in the 
Morningness cohort, its potential causes were considered. SE is the ratio of Total Sleep 
Time (TST) to total Time in Bed (TiB), therefore a lower SE could be caused by additional 
time spent awake and/or a greater Sleep Onset/Offset Latency (SONL/SOFFL, respec-
tively). PST is a similar metric that omits SONL/SOFFL and only considers the time spent 
awake between the time of Sleep Onset (SON) and the time of Sleep Offset (SOFF). A 
significant decrease in PST on weekends in the Morningness cohort was not observed, 
which led to the conclusion that the additional time spent awake that contributed to the 
lower SE occurred within the sleep period. However, a significant increase in WASO – 
which would be expected if a person spent more time awake at night – was not observed. 
Since WASO is an absolute sum and SE is a ratio, a change in the latter but not the former 
suggests that the cohort had similar WASO throughout the week, and thus a decrease in 
TST is the likely cause of the observed decrease in SE. 
Despite these applications, the value of multimodal data triangulation was unfortu-
nately only recognized in hindsight. The analyses throughout Chapter 4 and 5 were com-




sleep. While it is practically infeasible to measure all of the possible factors that could 
influence RAR and sleep, due to their being systemic behavioral outputs of the interactions 
between the individual’s natural and social environments and their biological circadian 
rhythms, many of the most influential factors can be readily assessed through self-report. 
For example, subjects were assumed to work a uniform Monday - Friday daytime schedule 
due to a lack of information on their vocation and work schedule. Subjects were not in-
structed to record deviations from their normal routine or asked to report on noteworthy 
events that could have potentially affected their sleep and activity (e.g. “woke up early to 
catch flight”), requiring the assumption that such instances never occurred. National holi-
days and other “special” days that usually elicit a change in behavior (e.g. day off from 
work) were accounted for in Chapter 5, though this entailed the assumption that all subjects 
uniformly observed and reacted to these special days because these data were not col-
lected47. Other influential factors that were not collected include timing and amount of 
substance use (especially caffeine, alcohol, and other stimulants/depressants), long-dis-
tance travel (especially across time zones), living conditions (e.g. shared bed), meal content 
and time of consumption, exposure to artificial light48, and changes in daily routine be-
tween work and rest days (e.g. using an alarm clock only on work days).  
The inclusion of even a few of these factors may dramatically alter the outcomes of 
statistical analyses; for example, most of the bivariate associations between MDS-UPDRS 
	
47 This was somewhat mitigated by treating each special day as a random effect (see Chapter 5, 
Methods) 
48 This includes the use of specialized screens to filter out blue light, which has the most influence 




scores and RAR cosinor metrics reported in Chapter 4 were accounted for by the inclusion 
of demographic (age, sex, BMI, handedness) and clinical (daily levodopa intake, MMSE 
score, and ESS score) covariates. It is possible that the remaining significant associations 
could be attributable to some of the aforementioned factors, especially those related to en-
vironmental conditions and work and rest schedules. Longitudinal and multi-site studies 
(who sample across long duration or distances, respectively) would especially benefit from 
the inclusion of local day/night cycles, which vary by time of year and geographic location, 
and which could be represented by those variables, sunrise/sunset times, and/or day:night 
ratio. A subtle yet significant confound can occur if the sample is distributed across a time 
zone: while everyone shares the same social time, individuals at different longitudes and 
(to a lesser extent) latitudes will have different local sunrise and sunset times. Since humans 
entrain primarily to solar time, the phase-of-entrainment relative to social time will steadily 
advance as one travels from west to east across a time zone (Roenneberg et al., 2007). The 
effect is proportional to differences in local sunrise/sunset times, which can vary by up to 
an hour in most time zones; e.g. on June 21, 2020 the sun rose 51 minutes later (~3.5% of 
a day) in Indianapolis, Indiana than it did in New York City, New York, despite both being 
located in the Eastern Standard Time (EST) time zone. Therefore samples taken across 
large geographic distances should avoid unnecessary variance by accounting for differ-
ences in local solar time, as well as other changes in social time (most notably daylight 




Ultimately, observational circadian studies greatly benefit from the relatively 
straightforward collection of ancillary data about the subject and their environment. In ad-
dition to allowing researchers to better characterize their dataset, identify novel factors, and 
draw more nuanced conclusions, it contributes to the methodological harmonization of the 
field by advancing toward a standardized array of influential covariates and high-value 
endpoints, which can be expanded to include relevant population-specific factors (e.g. 
levodopa use in PD, which can cause sleep disruption via night-time dyskinesias).  
 
Mixed Methods Research and Data Triangulation – Actigraphy and Video Annotation 
While automation is clearly more efficient and reliable in known systems that can be algo-
rithmically defined, video annotation’s value lies in its ability to classify ambiguous and/or 
context-dependent visual information (Bussmann et al., 1998). This is possible because 
humans possess the remarkable ability to rapidly evaluate and accurately classify many 
kinds of visual information that remain algorithmically challenging to contemporary com-
putational approaches (e.g. facial recognition software). More specifically, humans can 
flexibly integrate contextual information and use it to inform their judgments; for example, 
a person can correctly recognize that a fold-out lawn-chair and an antique handcrafted 
wooden chair are both in fact chairs despite their distinct appearances, but would likely not 
identify a toilet or a throne as a “chair” based on their contextual knowledge of their func-
tional uses. These properties make human raters much more adaptable, accurate, and flex-




open-ended, and contextually dependent behaviors, such as social interactions and natural 
physical movements. 
Video annotation is a valuable hybrid approach that implements both subjective 
and objective techniques to qualitatively classify and temporally quantify behavior; i.e. it 
implements data triangulation to accurately characterize ambiguous and/or context-de-
pendent behaviors. Furthermore, the fine control of video playback and granularity of 
“frame-by-frame” review allows for subtle characteristics not reliably detectable in real-
time to be precisely visualized with maximal clarity in their presentation (Bussmann et al., 
1998; W. G. Janssen et al., 2002). This level of control gives video annotation a temporal 
resolution far beyond what is available to a contemporaneous observer and allows brief 
and instantaneous events to be fully reviewed; however, spatial features (e.g. amplitude or 
distance) cannot be easily quantified by annotators without objective techniques (e.g. kin-
ematics). Although the temporal resolution of video annotation falls short of quantitative 
measures of movement (e.g. 125 Hz actigraphy has ~8 millisecond resolution, where-as a 
60 frames per second (FPS) video has ~17 millisecond resolution), it avoids many of the 
challenges posed by wearable accelerometers and similar methods - such as expensive 
equipment, visualization software, and post-processing/filtering. Moreover, raw video data 
provides an unaltered visual representation unobtainable with accelerometry, allowing for 
the easy verification of the data: e.g. one could easily verify that a given subject is in a 
video by watching the video, but one cannot do the same by looking at just an accelerom-
etry waveform. Because of its rich visual content and minimal abstraction, video recordings 




algorithms (Heldman et al., 2014). It’s important to note that, in these scenarios, the algo-
rithms are being validated against the definitions and criteria used by the annotators to 
classify behavior; i.e. in the absence of an objective ground truth, the accuracy of the quan-
titative algorithm is validated against the accuracy of qualitative video annotation. 
While the work presented in Chapter 3 was specifically aimed at assessing the fea-
sibility and reliability of video annotation, it was implemented in the first place to bridge 
the gap between the subjective clinical gold standard - the MDS-UPDRS - and an objective 
measure of the physical behaviors it assesses. By using video annotation, the MDS-
UPDRS’ clinical behaviors were accurately and reliably temporally delimited in such a 
way that they could be readily aligned to objective accelerometry collected in parallel. This 
effectively created an internally consistent dataset composed of discrete instances of clini-
cal behaviors and postural states. Each instance has an associated duration, demographic 
information (e.g. sex), clinical scores from the MDS-UPDRS, objective actigraphy and its 
associated endpoints (i.e. derivatives like sleep characteristics, and other sensors like tem-
perature) and general study metadata associated with the behavior or subject (e.g. date of 
observation, self-reported quality of life), all manually reviewed and temporally aligned. 
Such datasets are powerful tools that allow for equitable and valid comparisons between 
normally incompatible approaches, leveraging data triangulation to contextualize the sub-
ject of interest with multiple modalities. For example, a machine learning algorithm could 
be trained to predict the clinician’s score on the Finger Tapping task using accelerometry 




Although video annotation is not required to create aligned multimodal datasets, it 
is well-suited to validating sensor-derived postural segmentation and behavioral detection 
algorithms (Czech & Patel, 2019; W. G. Janssen et al., 2002): postures and most behaviors 
are gross movements readily identifiable in video, subjective bias can be minimized 
through clear predefined criteria as demonstrated in Chapter 3, and disagreements can be 
thoroughly arbitrated as the video is a permanent, immutable record. While the MDS-
UPDRS remains a common feature in validation studies due to its ubiquity and recognition 
as the gold standard assessment of disease severity, it is not well-suited for validating sen-
sor-derived symptomatic scores (e.g. bradykinesia): the scoring - while guided by clear 
criteria - often relies on the clinician’s subjective interpretation of transient symptoms, the 
scores are assigned in real time with no opportunity to “rewind” and review an ambiguous 
clinical presentation, and the most commonly used endpoints (i.e. section scores and total 
score) are meant to reflect overall disease severity and integrate a broad array of symptoms 
beyond what’s being evaluated. Ultimately, no MDS-UPDRS data is lost through the in-
clusion of wearable sensors and video recording, but their quantitative nature can help con-
textualize and validate subsequent analyses of scores from the MDS-UPDRS and other 
clinical assessments (Criss & McNames, 2011; Goetz et al., 1997; Lyons & Tickle-Degnen, 
2005; S. T. Moore et al., 2011). 
 
Maximizing Data Integrity and Value to the Scientific Community 
Both PD’s pathology and the circadian rhythm are complex, dynamic systems that benefit 




used to assess them are sensitive to myriad extraneous factors that must be considered, 
controlled, and accounted for throughout the scientific process. In addition to ensuring 
sound experimental design, drawing reasonable conclusions from the results, and objec-
tively considering previous data, the scientific method demands methodological rigor and 
replicability. 
Of paramount importance is the need to reach a scientific consensus on what 
measures should be employed to assess circadian disruption, it’s associated factors, and 
it’s short- and long-term effects on health and wellbeing (Vetter, 2018). Currently, the 
study of circadian disruption is plagued by inconsistent terminology and insufficient meth-
odological detail, resulting in discrepancies between peer-reviewed articles in how they 
generate, present, and interpret their findings (Fekedulegn et al., 2020; Vetter, 2018). Be-
yond the complications this introduces to scientific communication, such heterogeneity 
limits the power of systematic reviews and meta-analyses by forcing them to reconcile 
methodological inconsistencies and account for them in their interpretation. 
In order to achieve consensus, different models and methodological paradigms 
must be replicated, evaluated, and compared; to do so requires abundantly detailed and 
transparent methodological reporting. For example, there are several algorithms that are 
commonly used to derive sleep characteristics from actigraphy. These are described in de-
tail in Chapter 2; briefly, raw accelerometry must be condensed into epochs through con-
version into some intermediate metric (e.g. AC, ENMO), then these epochs are behavior-
ally classified (i.e. sleep, rest, active, etc.) using a sleep scoring algorithm to identify and 




be derived. Designing the method of data collection and implementing the first two steps - 
epoching and sleep scoring - entails myriad technical decisions (Ancoli-Israel et al., 2015; 
Fekedulegn et al., 2020): 
- What sampling frequency should be used? 
- Where will the device be placed on the subject? 
- Will the data be transformed to minimize the effect of non-normal distribution 
and variability (e.g. log transform) 
- Which epoch-level endpoint should be used? 
- What epoch duration should be used? 
- Will gravity be accounted for? How (e.g. gyroscope, ENMO)? 
- Will off-body non-wear periods be identified? How (e.g. manual review, sub-
ject self-report)? 
- How much missing data will be tolerated before the actigraphy is considered 
invalid for analysis? 
- What is the threshold for distinguishing rest from active states? 
- Which sleep-scoring algorithm should be used? 
- Should the algorithms parameters be tailored to the specific population being 
assessed? For example, should the sleep threshold be higher in PD to account 
for their nighttime tremor increasing their baseline activity? 




Acknowledging that there is a lack of consensus on the optimal answers to these 
questions, this disagreement can be attributed to, in part, the lack of methodological trans-
parency in peer-reviewed articles assessing sleep through actigraphy. Although many such 
articles provide answers to some of these questions, few provide sufficient detail to accu-
rately replicate their algorithmic pipeline (Fekedulegn et al., 2020). This lack of detailed 
reporting leads to “islands of expertise” (Espay et al., 2016), the relatively independent and 
often redundant iterative development of techniques that grow increasingly incompatible 
with other “islands” due to the lack of communication and collaboration. Espay and col-
leagues (2016) applied this term specifically to the producers of “technology-based objec-
tive measures” (which includes actigraphy) as part of a larger acknowledgement (Johans-
son et al., 2018) of the need to improve reporting and standardization of actigraphy derived 
measures in PD research (including motor, clinical, and physical activity in addition to 
sleep characteristics); however, this concept is just as applicable to the iterative process of 
methodological refinement in research. For example, the FI is a common sleep character-
istic that is often interpreted to represent the frequency of sleep/wake transitions throughout 
the night; i.e. it is a measure of how likely a person is to transition between sleep and wake 
epochs throughout the night (Fekedulegn et al., 2020; Natale et al., 2014). While it is widely 
reported, there exist multiple variations purporting to be “fragmentation index” or analo-
gous metrics that are derived using different formulas (Fekedulegn et al., 2020; Mini Mitter 
Company, Inc., 2006). Further confusion is introduced by “spin-off” metrics derived from 
FI, such as the rest fragmentation (kRA) and activity fragmentation (kAR) indices (Lim et al., 




(Moser et al., 2009), to infer sleep fragmentation. Without context, “sleep fragmentation 
index” could potentially refer to any one of these metrics. 
The need to promote abundantly detailed and transparent methodological reporting 
is by no means limited to actigraphy, but is vital for all aspects of study design. While 
frequently acknowledged as a limitation (including for the work presented herein), sam-
pling and recruitment biases are nonetheless a significant and widespread confound in ob-
servational circadian research that must be accounted for and, whenever possible, mitigated 
(Di Milia et al., 2013). Unfortunately, the practical constraints of deadlines and budgets 
often leads to “convenience sampling” in modern human subjects research, where subjects 
are enrolled as quickly as possible from easily accessible populations (e.g. a study on 
“healthy adults” recruiting undergraduate students from the laboratory’s university). Alt-
hough the judicious use of appropriate inclusion/exclusion criteria can mitigate the effect 
of convenience sampling by homogenizing the sample (albeit at the cost of generalizabil-
ity), and post-hoc analysis can potentially account for demographic differences between 
the cohort and the general population, a convenience sample may differ from the general 
population in ways not accounted for by the researchers. For example, alcoholics were 
screened out in Chapter 5, but a cohort of young males is nonetheless significantly more 
likely to drink to excess than the general population and this must be considered when 
generalizing Chapter 5’s results. 
The work presented herein was not immune to this bias, as the data presented in 
Chapter 5 was obtained from a sample consisting largely of graduate students enrolled at 




and thus increased the confidence of conclusions drawn from it, the lack of a representative 
sample worked to negate the primary strength of observational research by limiting the 
generalizability of its conclusions. This is not to say that observational circadian research 
should not be conducted on specific sub-populations - in truth circadian function and dis-
ruption varies widely across demographic factors such as age, chronotype, and vocation 
(Roenneberg et al., 2019; Vetter, 2018) - but that a convenient sample should not be as-
sumed to be a representative sample. Especially now, in this period of methodological con-
solidation and theoretical harmonization, large representative samples are needed in both 
the general population and specific subpopulations to provide accurate baseline data to 
inform future research in observational circadian research. Beyond making informed study 
design decisions, this also requires clear reporting of the process by which subjects were 
selected and recruited, the inclusion/exclusion criteria used to screen them, and the ra-
tionale for these choices in the context of the study’s primary research questions. 
Missing data is another serious hindrance to observational circadian research, pri-
marily due to the reliance on methods such as actigraphic monitoring that are susceptible 
to subject non-compliance (Fuster-García et al., 2013). Considerable missing data was en-
countered in Chapters 4 and 5, the large majority of which was attributable to subject non-
compliance. Although data imputation was considered, it was ultimately decided that it 
was too unreliable and that the relatively small size of the dataset would introduce unnec-
essary stochastic bias. Data imputation is common in actigraphy, though conventional im-
putation methods entail assumptions regarding the distribution of missing data that actig-




(Brooks et al., 2020; Herrmann et al., 2014; Jang et al., 2020). There is also no consensus 
on the amount of missing data that can be tolerated before a given period of actigraphy 
should be discarded entirely. Chapters 4 and 5 implemented 15% threshold (i.e. 3.6 
hours/day) for the purposes of identifying eligible days for cosinor analysis. After failing 
to identify a consistent reference threshold in the scientific literature, 15% was chosen as 
it could flexibly accommodate the amount of missing data and participant non-compliance 
expected to occur due to study protocols (e.g. removal for bathing). 
Although there is scant information regarding the treatment of missing data in co-
sinor analysis49, there has been some exploratory work in other applications of actigraphy. 
For example, the minimum amount of “wear time” needed to assess daily physical activity 
ranges from 2 - 16 hours (Herrmann et al., 2013); a wear time of 12+ hours, based on a 
2014 meta-analysis (Herrmann et al., 2014), has recently become more common (Amagasa 
et al., 2019; Kaufman et al., 2019; Mazzoni et al., 2017). Missing data must be character-
ized in detail in scientific reporting50: it’s amount, distribution across the sample, potential 
causes, and treatment (i.e. imputed or omitted). Not only is this valuable information that 
can inform future work and meta-analyses (Johansson et al., 2018), it can be applied to 
better understand the causes of missing data and mitigate its frequency and severity 
(Herrmann et al., 2014; Morgenthaler et al., 2007). 
 
	
49 Cosinor analysis has been described as “robust” to missing data because it does not require equi-
distant samples (Cespedes Feliciano et al., 2017) 




Sociogenic Circadian Disruption 
Our behavioral rhythms - and therefore our physiology and health - are subtly influenced 
by factors conventionally taken for granted. Our circadian rhythm is, in many ways, anal-
ogous to the social calendar in form and function. According to the French sociologist, 
Émile Durkheim: “A calendar expresses the rhythm of the collective activities, while at the 
same time its function is to assure their regularity.” In the same way, our circadian rhythm 
is the product of the “collective activities” of our myriad biological processes, and simul-
taneously serves to “assure their regularity” with respect to each other and the geophysical 
day. Both provide a common, regular temporal reference that can be used to minimize 
waste and optimize efficiency; both were derived from the astronomical properties of our 
planet and sun; and both are a constant pressure that shapes our daily lives and subtly af-
fects our minute-to-minute behavior. 
Circadian disruption is the sustained desynchronization of the circadian rhythm 
from its environment, although it has also been referred to as circadian misalignment, cir-
cadian desynchrony, and chronodisruption, among other terms, in the literature (Vetter, 
2018). The widespread circadian disruption extant in modern industrialized societies can 
be partially attributed to interference caused by social calendars, mores, and expectations 
that shape our behavioral schedules independently of the biological circadian rhythm and 
the geophysical day. Chapter 4 reported variations in sleep and RAR metrics that appeared 
to be associated with distinct times of the week, which were characterized as “sociogenic” 
based on the socially defined nature of the calendar week. Sociogenic circadian disruption 




especially the calendar and the “rhythm of collective activities” it regulates. The work in 
Chapter 5 explicitly aimed to detect these sociogenic effects in a larger, more uniform sam-
ple and found distinct, regular changes in sleep and RAR associated with transitions be-
tween weekends and the work-week. Analysis of variance components in each nested tier 
of Chapter 5’s linear mixed models - Participant, Week, and Day - identified consistently 
large variances at the Day level across RAR and sleep characteristics, suggesting that the 
most influential factors on sleep and RAR patterns may be at the Day level: e.g. weather, 
exercise opportunities, inconsistent weekly schedules, etc. 
There is abundant evidence of the deleterious effects associated with rhythmic so-
ciogenic factors. For example, there is a well-documented weekly rhythm in heart attack 
with its peak on Mondays (Rogot et al., 1976), and cardiovascular mortality has been ob-
served to increase on regularly occurring socially significant occasions, such as holidays 
(Wallert et al., 2017) and major sporting events (Wilbert-Lampen et al., 2008), although 
similar increases in mortality have been observed in singular periods of social disturbance, 
such as in the weeks following earthquakes (Takegami et al., 2015). Other socially influ-
enced infradian rhythms have been found in the timing of human activity vis-à-vis the nor-
mal morning increase in power grid burden occurring ~1 hour later on weekends (Stowie 
et al., 2015) and a similar delay in peak social media usage (Leypunskiy et al., 2018). Other 
notable infradian rhythms potentially influenced by social factors include an increase in 
the mortality rate of acute subarachnoid hemorrhages increasing during the work-week 
(Turin et al., 2010), a circaseptan rhythm in blood pressure with its peak on Monday (Mu-




et al., 2005; Refinetti et al., 2007). Myocardial Infarction (MI) with Non-Obstructive Cor-
onary Arteries (MINOCA) events were observed to be more common on Mondays and 
early mornings (Nordenskjöld et al., 2019); curiously, unlike normal MI’s, the frequency 
of MINOCA’s was not associated with holidays. Collectively, these may be caused by 
sudden increases in psychosocial stress associated with significant social events (e.g. holi-
days), behavioral transitions (e.g. weekend to work week), and their subsequent physiolog-
ical stress (Ayers et al., 2014; Wallert et al., 2017). 
Circadian disruption is not a new phenomenon, but modern technology has vastly 
increased the number of ways it may occur. Before the development of steam engines, for 
example, no human had the means to travel far enough in one day to experience jet lag; 
now it is a common occurrence for much of the population (Roenneberg et al., 2015). Ca-
lendrical abnormalities and social customs such as daylight savings time and holidays, re-
spectively, present challenges to our circadian rhythm that risk acute disruption (Fritz et 
al., 2020; Kitamura et al., 2016; Wallert et al., 2017). Artificial lighting has a clear con-
founding effect that interferes with the circadian rhythm’s ability to synchronize to photic 
zeitgebers, and has made it dramatically easier to extend daytime behaviors into the night 
and further decoupled social and biological time. For example, there are many “time-ag-
nostic” professions whose schedules are almost entirely determined by social factors, in-
cluding first responders, military personnel, medical specialists, and shift-workers at 24/7 
jobs. Competitive fields, such as professional sports and post-graduate education, may en-




schedule. At a macro scale, human birth-rates have historically exhibited a strong circan-
nual trend that has all but evaporated: birth-rates fluctuated by ~60% across the year in pre-
industrial human societies, where-as modern industrialized nations experience an ampli-
tude of ~0%-5% (Foster & Roenneberg, 2008). 
Modern human societies are more secluded from natural zeitgebers than ever be-
fore. Through the development of shelter, artificial lighting, social calendars, industriali-
zation, electronics, globalization, rapid long-distance transportation, and near-instantane-
ous communication, human society has increasingly sequestered itself from the natural cy-
cles present on Earth that shaped the biological rhythms of our global ecosystem and there-
fore our own species. While our behavior is still dominated by the rising and setting of the 
sun, our technological advancement has led to our societies becoming more insulated from 
natural zeitgebers. The rhythm of human society is increasingly determined by logistical 
(e.g. international shipping), economic, sociopolitical (e.g. work-week), geographic, pro-
fessional (e.g. shift-work), and other artificial pressures. The increasing independence of 
our society from natural cycles (e.g. tidal, solar, and seasonal) results in a discrepancy be-
tween our social, behavioral, and circadian rhythms from which circadian disruption can 
arise. 
 
Circaseptan Rhythms and Disruption 
Socially motivated changes in the phase of behavioral rhythms across the seven-day week 
give rise to circaseptan rhythms of circadian disruption. Social Jet Lag (SJL), the difference 




most obvious example of sociogenic circaseptan disruption. Most adults in industrialized 
countries experience at least one hour of Social Jet Lag (SJL) (“2005 Sleep in America Poll 
– Adult Sleep Habits and Styles,” 2015; Roenneberg et al., 2003, 2015). This delay in sleep 
times on rest versus work days is commonly observed (Monk et al., 2000; Roenneberg et 
al., 2003) and can cause circadian phase delays of up to 1 hour (Crowley & Carskadon, 
2010; C.-M. Yang et al., 2001) that may take several work days to overcome (Crowley et 
al., 2015; Taylor et al., 2008). This mild forward phase-shift leads to increased daytime 
sleepiness and fatigue (Taylor et al., 2008), consequently impairing attention, mood 
(Dinges et al., 1997), memory consolidation (Karni & Sagi, 1993), vigilance, and poten-
tially contributing to an increased risk for accidents (Bonnet & Arand, 1995) and cardio-
vascular disease (Gallerani et al., 2017) following rest-work transitions. While these out-
comes are caused by disruptions associated with discrete parts of the week (specifically the 
transition between different “social time zones”, i.e. work and rest days), it is unclear 
whether it is purely a product of abrupt changes in behavioral rhythms (e.g. sleep timing) 
and significant events (e.g. work-related stress) caused by the week, or if they can be par-
tially attributed to the misalignment of an innately circaseptan biological rhythm with the 
social week exacerbates the sociogenic disruption (Reinberg et al., 2017). In the same way 
the circadian rhythm predisposes us to be active during sunlight hours in the 24-hour day, 
an innately circaseptan biological rhythm may predispose us to being more active on cer-
tain days of the week. 
Humans likely adopted the seven-day week based primarily on cultural and social 




outcomes associated with weeks of different lengths. Ancient Bayblon implemented a lunar 
calendar divided into four seven-day weeks - the oldest historical evidence of a calendar 
week - and the first non-lunar calendar week appeared in Judea; both included a specific 
“sabbath” or “rest day” dedicated to spiritual and ceremonial activities (Zerubavel, 1989). 
Perhaps the most famous antecedent of the seven-day week in American society is the story 
of God’s creation of the earth as told in the Book of Genesis: 
 
“And on the seventh day God ended His work which He had done, and He rested on the seventh day 
from all His work which He had done.” (Genesis 2:2, New King James Bible) 
 
Although it is implicit that the modern week was derived from these historical prec-
edents, it is nonetheless possible that the adoption of the seven-day week was encouraged 
by an innate biological circaseptan rhythm through its influence on infradian rhythms in 
human behavior (i.e. work/rest days). Humanity’s inquisitive, greedy, and self-preserving 
nature ensures that our societies are continually adapting to external pressures by explor-
ing, testing, and revising strategies to protect themselves and improve their fitness. For 
example, prehistoric humans spontaneously formed cities in response to new farming tech-
nology and the food surplus they created, as this gave them an immense benefit by allowing 
specialization and non-agricultural pursuits, and these cities spontaneously formed self-
governing coalitions (i.e. states) to protect their shared interests. During World War II, the 
adoption of “total war” policies and the societal cost it entailed led to dramatic changes in 




of “victory gardens” to supplement rationed food supplies. At the time of writing this man-
uscript in 2020, ingrained social touch customs such as the handshake are rapidly being 
replaced with contactless gestures due to the increased risk of viral transmission associated 
with the global Coronavirus Disease 2019 (COVID-19) pandemic. Human sociocultural 
mores are enduring yet adaptable, and this extends to our calendars as well.  
For most of human history, societal time structures and their subsequent rhythms 
have been dictated by biological (e.g. circadian rhythm) and natural (e.g. day/night cycle) 
factors. While artificial considerations such as simplicity, economic efficiency, compati-
bility with other societies, and the cost of revising an existing system undoubtedly influ-
enced calendar development throughout history, the increased energy made available by 
the industrial revolution greatly expanded our productive capacity and thus the influence 
of these artificial factors. In the interest of efficiency, industrialization efforts built upon 
and standardized pre-existing systems: since the week was the cultural standard in much 
of the world in the 19th century, it became the basis for the standard modern calendar. As-
suming it exists, an innate biological circaseptan rhythm likely influenced the adoption of 
the seven-day week in human societies, but has since been supplanted by an artificial cal-
endar dependent on non-biological factor: why check the sun’s position in the sky when 
you can look at your watch? While a circaseptan rhythm and the seven-day week are equiv-
alent in duration, the day-to-day activities and normal behaviors across the week are now 
primarily informed by wholly artificial considerations: i.e. work schedules. In other words, 




the industrial revolution, nor that it possesses the same properties such as adapting to sea-
sonal differences in the day/night cycle. 
 
Origin of Circaseptan Rhythms 
It has been proposed that circaseptan rhythms observed in tidal zone organisms, such as 
the beach beetle (Chaerodes trachyscelides), derive from the lunar-driven tidal cycle, and 
that this may be the origin of circaseptan rhythms in non-tidal animals (Meyer-Rochow & 
Brown, 1998). Tides are regular oscillations in local water level along coastlines driven 
primarily by the gravitational force exerted by the moon. Individual tidal cycles (i.e. high 
tide to the next high tide) occur every ~12.4 hours due to the combined rotation of the earth 
and the revolution of the moon about the earth - for a given location, high tides generally 
occur when the moon is directly overhead and directly underfoot, and low tides occur when 
the moon is perpendicular to the location’s ground plane. Tidal dynamics are complex, 
being affected not only by local conditions (e.g. atmospheric pressure, temperature) and 
geography (i.e. coastline shape), but also by the sun. Despite its distance, the sun’s im-
mense mass allows its gravity to exert a force roughly half as influential as the moon’s 
gravity. This is most noticeable during spring and neap tides. Twice during the lunar cycle, 
the earth, moon, and sun align in syzygy, once with the moon between the earth and sun 
(i.e. a new moon), and ~14.5 days later when the earth is between the moon and sun (i.e. a 
full moon). During these syzygies, the gravitational pulls of the moon and sun both work 
along the same axis, exaggerating the amplitude of high and low tides; these are known as 




when the moon is at quadrature (i.e. orthogonal to the sun relative to the earth) and the 
lunar-solar gravitational reinforcement is at its weakest, resulting in reduced tidal ampli-
tude. 
The authors of the aforementioned C. trachyscelides study observed a circaseptan 
rhythm in their physical activity (Meyer-Rochow & Brown, 1998). They further noted that, 
since C. trachyscelides forages in the debris zone left by the ebb tide, and since the debris 
zone would gradually shift up and down a beach between each neap and spring tide, they 
would be subject to a natural evolutionary pressure to anticipate and follow these shifts. As 
previously explained, a single cycle of spring tide --> neap tide --> spring tide takes ap-
proximately 14 days to complete; this makes it a circadiseptan rhythm, with the accelera-
tion, deceleration, and eventual reversal of the tidal cycle’s maximum extent occurring 
every 7 days - i.e. a circaseptan rhythm. Therefore, the weekly increase in C. trachyscelides 
activity may be a byproduct of their natural chronobiological adaption to the circaseptan 
harmonic of the naturally occurring circadiseptan rhythm of neap and spring tides. Thus, 
while natural circaseptan rhythms do not have an obvious astronomical correlate capable 
of entraining them, they may have ultimately originated from the lunar cycle via the regular 
circadiseptan oscillation in tidal amplitude caused by the moon’s rotation around the earth 
relative to the sun. While this may indicate a potential biological origin of the circaseptan 
rhythms, it does not account for how such a rhythm could be biologically preserved and 
transferred to humans (via evolution, symbiosis, or otherwise). Given that the majority of 




rhythm, it is possible that this played a role in the sociocultural development of a seven-
day calendar unit regardless of the presence of a biological correlate. 
 
Scientific and Clinical Considerations 
In order to improve resiliency to the negative effects of sociogenic circadian disruption, we 
must be able to reliably detect it, precisely measure its magnitude, thoroughly characterize 
its nature, and quantify its risks and their associations with its negative outcomes, both 
acute (e.g. fatigue) and chronic (e.g. risk factors for diseases). While it is clear that systemic 
changes in the ordering of our social calendars is needed to prevent sociogenic circadian 
disruption (), the nature and extent of these changes are unknown. Until then, more con-
ventional therapeutic interventions are needed to mitigate the deleterious effects of circa-
dian disruption. 
Much like “lifestyle diseases” such as obesity and metabolic disorders, circadian 
disruption can be minimized through practical changes to one’s lifestyle. SJL is a wide-
spread form of chronic sociogenic circadian disruption caused by the seven-day week and 
associated with numerous negative health outcomes. Much like obesity, it is a product of 
one’s behavior (acknowledging also the genetic, metabolic, and neurological systems pro-
moting that behavior) and is best remedied through behavioral modification. In addition to 
maintaining a constant sleep schedule, daytime exercise and consistent day-to-day RAR’s 
provides a stabilizing effect that strengthens the amplitude of the SCN’s latent rhythms and 
improve mood and performance in Alzheimer’s disease (Pévet, 2016); note that circadian 




Amongst the numerous topics of debate in this emerging field is the degree to which 
sociogenic factors can directly influence the biological circadian rhythm, as opposed to 
indirectly (e.g. via sleep). Although social calendars and behaviors may influence a per-
son’s chronotype, these “social zeitgebers” do not appear capable of independently entrain-
ing human circadian rhythms (Roenneberg et al., 2007, 2015), and evidence suggests that 
the human circadian rhythm is entrained primarily by the solar calendar (i.e. sunrise/set) 
rather than the social calendar. For example, humans have created arbitrary “time zones” 
that unify relatively broad ranges of longitude with a common clock, yet local sunrise time 
is a continuous function of longitude irrespective of time zones; e.g. the sun may have risen 
in New York City but not in Columbus, a city in the same time zone but ~9° farther west. 
A study examining self-reported sleep times and chronotypes in Germany found that indi-
viduals who lived farther west woke up later than more easterly individuals in the same 
time zone; i.e. their clocks showed the same time. This effect was inversely proportional 
to population density, as. people in cities were less entrained to solar time, which the au-
thors theorized was due to light pollution (Roenneberg et al., 2007). The greater importance 
of solar time versus social time for circadian entrainment is further supported by case stud-
ies of blind workers, who have free-running circadian rhythms (due to their insensitivity to 
light) despite functioning within a social calendar (i.e. work) (Arendt et al., 1988). In other 
words, social time can influence the phase of the circadian rhythm (and thus disrupt it), but 
it is not enough to entrain the circadian rhythm by itself (Roenneberg et al., 2007). 
Methodologically, the study of circadian disruption benefits from data triangulation 




are well-suited to basic biological research, where-as human subjects lend themselves well 
to translational research. This holds especially true for chronobiology given the presence 
of numerous artificial zeitgebers (e.g. artificial lighting), widespread use of circadian-mod-
ifying substances (e.g. caffeine and alcohol), and other anthropogenic confounds extant in 
modern human populations (e.g. social media). Moreover, the sheer number of potential 
confounds limits the generalizability of basic research to functional applications. Observa-
tional studies attempt to maximize ecological validity - i.e. minimize observational and 
experimental biases - to more accurately measure authentic circadian disruption as it exists 
in the modern milieu, replete with artificial zeitgebers and innumerable potentially con-
founding variables. Thus observational studies are often epidemiological or translational 
in nature, relying on gross systemic outputs of the circadian rhythm (e.g. sleep timing) in 
combination with environmental factors (e.g. presence of artificial zeitgebers) and/or in-
terventions (e.g. sleep medication) to characterize a given population’s circadian rhythm, 
its disruption in a given context, and potential correlates amongst the behavioral (e.g. sleep 
timing), biological (e.g. body temperature), cognitive (e.g. reaction time), and/or psycho-
logical (e.g. perceived sleepiness) outcomes of interest (Vetter, 2018). 
In addition to factors and covariates mentioned earlier in this Chapter (see Method-
ological Considerations), the work presented in Chapter 5 reinforces the importance of 
accounting for chronotype in observational circadian research and contributes to its utility 
as a circadian endpoint in clinical and epidemiological studies. DLMO is generally consid-
ered to be the gold standard marker of one’s biological chronotype (Arendt & Skene, 2005; 




plasma samples collected in frequent intervals to prevent short-term changes (from, e.g., 
exposure to artificial light) from “masking” the underlying circadian rhythm. As the pro-
cess of sampling and processing of samples for DLMO is burdensome, time-consuming, 
and expensive, self-reported chronotype (e.g. via questionnaires like the MEQ) has become 
more common. Alternatively, sleep timing on rest days has been used as low-cost low-
burden behavioral proxy for inferring chronotype (Vetter, 2018). This approach benefits 
from its cost-effectiveness, ease of implementation, and applicability to remote in-home 
monitoring for capturing ecologically valid sleep behavior, with the significant caveat that 
sleep is a complex systemic behavior only partially mediated by the circadian rhythm. In 
other words, sleep timing represents a behavioral output influenced by the circadian 
rhythm, where-as DLMO is a physiological signal directly regulated by the central oscilla-
tor and so can be expected to more accurately reflect the circadian phase (Vetter, 2018). 
When assessing chronotype in humans, chronobiologists must weigh the accuracy and bi-
ological validity of DLMO sampling against the utility and ecological validity of question-
naires and sleep timing. The MEQ was employed in Chapter 5 due to the logistical diffi-
culties of sampling DLMO while monitoring subjects during their “normal life”. Regard-
less of whether sleep timing is assessed either subjectively through self-report (e.g. MEQ) 
or quantified through objective measures (e.g. DLMO, actigraphy), it is essential that chro-
notypes are derived from sleep timing on rest nights. This is because external factors, such 
as waking up early to go to work, will change when a person sleeps, where-as one can 
adhere to their preferred, “chronotypical” sleep timing when there are no restrictions on 




Lastly, it should be noted that there is a profound historical sex bias in chronobi-
ological research: for example, only 1 in 5 peer-reviewed articles employing mouse models 
of circadian rhythm included female mice (Kuljis et al., 2013). This systemic bias is exac-
erbated by the mounting evidence of significant sexual dimorphism in circadian biology; 
e.g. sex-specific modification of circadian rhythm in the embryo, differences in SCN vol-
ume, physiology, and cytoarchitecture between the sexes, and the presence of androgener-
gic and estrogenergic receptors on neurons in central circadian regulators, including the 
SCN (M. Bailey & Silver, 2014; Kuljis et al., 2013). Between-sex differences have also 
been observed in humans; e.g. women have larger and longer SCN’s relative to total brain 
volume. 
 
Circadian Disruption in Parkinson’s Disease 
Circadian disruption and sleep dysregulation are critical non-motor symptoms of PD that 
require the integration of molecular, neurological, and behavioral research to effectively 
understand and treat (Fifel & Videnovic, 2019; Vetter, 2018). Much like PD’s other symp-
toms, the breadth and severity of circadian disruptions are heterogenous. Although sleep 
and circadian disruption (amongst other non-motor symptoms) have received considerably 
less attention than PD’s hallmark motor symptoms until recently, they were described in a 
patient with advanced PD by James Parkinson in his seminal work, “An Essay on the Shak-





“In this stage, the sleep becomes much disturbed. The tremulous motion of the limbs occur during 
sleep, and augment until they awaken the patient, and frequently with much agitation and alarm. ... 
It now seldom leaves [a patient] for a moment; but even when exhausted nature seizes a small por-
tion of sleep, the motion becomes so violent as not only to shake the bed-hangings, but even the 
floor and sashes of the room. ... [The patient’s] attendants observed, that of late the trembling would 
sometimes begin in his sleep, and increase until it awakened him: when he always was in a state of 
agitation and alarm.” 
 
Parkinson described sleep disruption as a consequence of the motor symptoms in 
particular, though there now exists a burgeoning appreciation that the breadth and diversity 
of sleep disruptions in PD is considerable and is caused by non-motor factors (i.e. the 
pathological disturbance of the circadian rhythm). Etiologically, sleep disruptions have 
been separated into three broad categories: sleep disruption as a consequence of PD’s neu-
ropathology and symptoms, sleep disruption as a consequence of dopaminergic medication 
and its side effects, and sleep disorders that frequently co-occur with PD (Claassen & 
Kutscher, 2011). The first category includes Excessive Daytime Sleepiness (EDS; de-
scribed by Parkinson as “constant sleepiness” and “extreme exhaustion”), which may orig-
inate from intrinsic the degeneration of central sleep regulators such as the raphe nucleus 
and locus coeruleus, and/or secondarily by sleep fragmentation caused by urinary inconti-
nence, motor symptoms, etc. (Videnovic, Lazar, et al., 2014). Parkinson’s observations 
(1817) fall in this category. Next, dopaminergic medications (e.g. levodopa) can induce 
insomnia and reduce time spent in NREM when incorrectly dosed (Brunner et al., 2002; 




tremor, and medications for other symptoms and comorbidities (e.g. depression) can fur-
ther interfere with sleep regulation (Huete & Varona, 1997; Jindal, 2009). Lastly, REM 
Behavioral Disorder (RBD), Restless Leg Syndrome (RLS), and Obstructive Sleep Apnea 
(OSA) are more prevalent in persons with PD than those without PD (Claassen & Kutscher, 
2011); determining the causal relationship between these disorders and PD - i.e. whether 
one causes the other - is a major objective of current clinical research. 
Dopamine has been identified as a promising research target for exploring the rela-
tionship between the pathology and circadian disruption of PD (Videnovic, Lazar, et al., 
2014; Videnovic, Noble, et al., 2014). The depletion of dopamine throughout the CNS and 
particularly in the basal ganglia is a hallmark symptom of PD and thought to be the primary 
cause of PD’s motor symptoms; moreover, dopamine is a major neurotransmitter in the 
circadian rhythm, and several symptoms have been linked to dopamine loss and dysregu-
lation in PD (see Chapter 4; Discussion). 
 
Limitations 
The work presented in this manuscript should be considered in the context of several lim-
itations and assumptions. While these have been described in greater detail throughout the 
Chapter, they will be briefly summarized here. The use of small sample sizes recruited 
through “convenience sampling” contributed to the high variance in the data and limited 
their generalizability, especially in Chapter 4. The Actiwatch used throughout Chapters 4 




a proprietary algorithm to epoch and behaviorally segment the data, which greatly re-
stricted analytical options for deriving RAR and sleep characteristics. A significant amount 
of missing data primarily attributable to subject non-compliance was also encountered; in 
combination with limited sampling periods of two to four weeks (in Chapters 4 and 5, 
respectively), this weakened statistical power and increased variance. The basic cosinor 
model, while common in the literature, is overly simplistic and can only approximate hu-
man RAR, which are more “block-wave” than sinusoidal. Due to methodological con-
straints, several contextual factors known to influence circadian and circaseptan rhythms 
were not accounted for, most notably employment, weekly work schedule, use of depres-
sants and stimulants, exercise and mealtimes, and “one-off” events that deviated from the 
subject’s normal rhythm. 
 
Future Directions 
The work described in this manuscript has highlighted several promising avenues for future 
research. First, the significant methodological challenges encountered due to inconsistent 
and opaque reporting in the literature is a significant hindrance to the field – progress de-
mands methodological consolidation, theoretical harmonization, abundantly transparent 
reporting, and the generation of publicly available datasets to facilitate collaboration and 
data triangulation – and future work will strive to promote these principles alongside the 
rest of the field. Second, future work will focus on the refinement of the methodological 




reducing missing data through improving subject compliance, and the integration of syn-
ergistic methods to create more robust and comprehensive statistical models. Third, the 
search for potential biological correlates of infradian rhythms will be aided through iden-
tification of infradian trends in unconventional data, including social (e.g. social media 
usage), demographic (e.g. birth rates), epidemiological (e.g. causes of death), commercial 
(e.g. media engagement), and civil (e.g. power consumption) data. This also entails the 
detailed characterization of RAR and sleep characteristics in distinct populations and en-
vironments, such as those with different levels of light pollution (e.g. urban v. rural), to 
identify significant factors that contribute to circadian disruption, and the integration of the 
sociological perspective to aid in contextualizing and interpreting chronobiological out-
comes. 
Our future work will be guided by the knowledge that our lives, our behavior, our 
society, and our health are shaped by factors we all-too-often take for granted - most nota-
bly the seven-day week - and fueled by the remarkable abundance of data available to 
humanity in the information era. 
 
Conclusion 
The circadian rhythm is a distributed yet interconnected system of systems that coordinates 
the timing of biological processes by integrating exogenous and endogenous signals via a 
self-regulating, adaptive network present at every level of biological organization, from 
cells to cities. Although we have greatly improved our knowledge of the circadian rhythm’s 




in modern societies are less well understood. Moreover, the ubiquity of circadian rhythms 
in our biology creates innumerable avenues through which it can be pathologically dis-
rupted (e.g. dopaminergic depletion in PD), or through which it can create pathology (e.g. 
SJL and risk factors). Clinical study of circadian disruption therefore requires a holistic, 
integrative approach that strives to measure both the circadian rhythm itself and the sus-
pected factors implicated in its disruption. As the circadian rhythm is inseparable from our 
behavior and environment, its disruption can only be crudely replicated in controlled la-
boratory settings, and this loss of ecological validity hinders the translation of scientific 
findings into clinical interventions (Andrade, 2018). Over the last several decades, techno-
logical progress has enabled the practical use of wearable devices capable of continuously 
monitoring circadian signals, such as RARs. While this nascent approach has significant 
obstacles still to overcome, it has nonetheless encouraged more ecologically valid studies 
focused on objectively measuring circadian rhythms in the authentic context of day-to-day 
life and human behavior. 
Furthering the scientific community’s understanding of sociogenic circadian dis-
ruption will be accomplished through the integration of complementary designs, synergis-
tic methods, and multimodal datasets to triangulate findings; motivated by its ubiquity in 
modern industrialized societies, it’s contribution to negative health outcomes, and its dis-
proportionate impact on critical infrastructure; facilitated by methodological consolidation, 
theoretical harmonization, and integration of sociological and other novel perspectives; and 
guided by an appreciation of the fundamentally important role the circadian rhythm plays 




growing acknowledgement that a diverse and broad battery of clinical biomarkers will be 
needed to accurately diagnose, characterize, and monitor disease progression shows that 






Chapter 3 Supplementary Information 
 
Figure A.1: Video Coding Scheme 
 
“Clinician” refers to the person directly administering and guiding the Subject through the as-
sessments. The Clinician is not face masked. 
 
“Subject” refers to the person undergoing the assessments and wearing the wearable sensors. The 
Subject’s face is masked. 
 
Scripted Motor Tasks 
 
Rigidity, Neck – The Clinician manually articulates Subject’s neck. 
- Initiation Frame: First visible movement of the neck or head clearly caused by the Clini-
cian through physical contact, including when the point of contact is out of view. 
- Termination Frame: Last visible movement of the neck or head clearly caused by the Cli-
nician, or when the Clinician is no longer touching Subject’s head and neck, whichever 
comes first. 
- MDS-UPDRS Instruction Criteria: Subject in relaxed position, Clinician slowly manipu-
lates major Neck joints, Subject allows passive movement of neck. 
- MDS-UPDRS Rating Criteria: Rigidity (w/o Activation Maneuver), Rigidity (w/ Activa-
tion Maneuver), Range of Motion, Difficulty of Achieving Range of Motion 
 
Rigidity, Right Upper Limb – The Clinician manually articulates Subject's joints on their right 
upper limb. 
- Initiation Frame: First visible movement of the right upper limb clearly caused by the Cli-
nician through physical contact, including when the point of contact is out of view. 
- Termination Frame: Last visible movement of the right upper limb clearly caused by the 
Clinician, or when the Clinician is no longer touching Subject’s right upper limb, which-
ever comes first. 
- MDS-UPDRS Instruction Criteria: Subject in relaxed position, Clinician slowly manipu-
lates Right Wrist and Elbow joints, Clinician does not manipulate other limbs or neck, 
Subject allows passive movement of RUE, [Subject performs Activation Maneuver] 
- MDS-UPDRS Rating Criteria: Rigidity (w/o Activation Maneuver), Rigidity (w/ Activa-
tion Maneuver), Range of Motion, Difficulty of Achieving Range of Motion 
 
Rigidity, Left Upper Limb – The Clinician manually articulates Subject's joints on their left up-
per limb. 
- Initiation Frame: First visible movement of the left upper limb clearly caused by the Cli-
nician through physical contact, including when the point of contact is out of view. 
- Termination Frame: Last visible movement of the left upper limb clearly caused by the 
Clinician, or when the Clinician is no longer touching Subject’s left upper limb, which-




- MDS-UPDRS Instruction Criteria: Subject in relaxed position, Clinician slowly manipu-
lates Left Wrist and Elbow joints, Clinician does not manipulate other limbs or neck Sub-
ject allows passive movement of LUE, [Subject performs Activation Maneuver] 
- MDS-UPDRS Rating Criteria: Rigidity (w/o Activation Maneuver), Rigidity (w/ Activa-
tion Maneuver), Range of Motion, Difficulty of Achieving Range of Motion 
 
Rigidity, Right Lower Limb – The Clinician manually articulates Subject’s joints on their right 
lower limb. 
- Initiation Frame: First visible movement of the right lower limb clearly caused by the Cli-
nician through physical contact, including when the point of contact is out of view. 
- Termination Frame: Last visible movement of the right lower limb clearly caused by the 
Clinician, or when the Clinician is no longer touching Subject’s right lower limb, which-
ever comes first. 
- MDS-UPDRS Instruction Criteria: Subject in relaxed position, Clinician slowly manipu-
lates Right Hip and Knee joints, Clinician does not manipulate other limbs or neck, Sub-
ject allows passive movement of RLE, [Subject performs Activation Maneuver] 
- MDS-UPDRS Rating Criteria: Rigidity (w/o Activation Maneuver), Rigidity (w/ Activa-
tion Maneuver), Range of Motion, Difficulty of Achieving Range of Motion 
 
Rigidity, Left Lower Limb – The Clinician manually articulates Subject’s joints on their left 
lower limb. 
- Initiation Frame: First visible movement of the left lower limb clearly caused by the Cli-
nician through physical contact, including when the point of contact is out of view. 
- Termination Frame: Last visible movement of the left lower limb clearly caused by the 
Clinician, or when the Clinician is no longer touching Subject’s left lower limb, which-
ever comes first. 
- MDS-UPDRS Instruction Criteria: Subject in relaxed position, Clinician slowly manipu-
lates Left Hip and Knee joints, Clinician does not manipulate other limbs or neck, Subject 
allows passive movement of LLE, [Subject performs Activation Maneuver] 
- MDS-UPDRS Rating Criteria: Rigidity (w/o Activation Maneuver), Rigidity (w/ Activa-
tion Maneuver), Range of Motion, Difficulty of Achieving Range of Motion 
 
Finger Tapping, Right Hand – Subject taps tips of their right index finger and right thumb to-
gether in rapid succession. 
- Initiation Frame: First visible movement of the right index finger or right thumb of the 
first tap of the series. 
- Termination Frame: Last visible movement of the right index finger or right thumb of the 
last tap in the series. 
- MDS-UPDRS Instruction Criteria: Subject taps right index finger against right thumb, 
Subject performs 10 taps, Subject taps as quickly as possible, Subject taps as big as possi-
ble, Subject does not tap fingers on left hand 
- MDS-UPDRS Rating Criteria: Speed, Slowing, Amplitude, Decrementing Amplitude, 
Number/timing of Hesitations, Number/timing of Halts, Freezes 
 
Finger Tapping, Left Hand – Subject taps tips of their left index finger and left thumb together 
in rapid succession. 
- Initiation Frame: First visible movement of the left index finger or left thumb of the first 




- Termination Frame: Last visible movement of the left index finger or left thumb of the 
last tap in the series. 
- MDS-UPDRS Instruction Criteria: Subject taps left index finger against left thumb, Sub-
ject performs 10 taps, Subject taps as quickly as possible, Subject taps as big as possible, 
Subject does not tap fingers on right hand 
- MDS-UPDRS Rating Criteria: Speed, Slowing, Amplitude, Decrementing Amplitude, 
Number/timing of Hesitations, Number/timing of Halts, Freezes 
 
Fist Open and Close, Right Hand – Subject flexes their right fingers as fully as possible to form 
a fist, then extends (“fist-open”) and flexes (“fist-close”) their right fingers as fully as possible in 
rapid succession.    
- Initiation Frame: First visible extension or flexion of any of the right fingers as part of the 
first fist-open or fist-close of the series. 
- Termination Frame: Last visible extension or flexion of any of the right fingers as part of 
the last fist-open or fist-close of the series. 
- MDS-UPDRS Instruction Criteria: Subject has right forearm flexed, Subject's right palm 
is facing the Clinician, Subject makes a fist with right hand, Subject opens and closes 
right hand, Subject opens right hand as quickly as possible, Subject opens right hand as 
fully as possible, Subject performs 10 open/closes, Subject does not open/close left hand 
[If Subject does not open fist quickly/fully, Clinician reminds Subject to do so] 
- MDS-UPDRS Rating Criteria: Speed, Slowing, Amplitude, Decrementing Amplitude, 
Number/timing of Hesitations, Number/timing of Halts, Freezes 
 
Fist Open and Close, Left Hand – Subject flexes their left fingers as fully as possible to form a 
fist, then extends (“fist-open”) and flexes (“fist-close”) their left fingers as fully as possible in 
rapid succession.    
- Initiation Frame: First visible extension or flexion of any of the left fingers as part of the 
first fist-open or fist-close of the series. 
- Termination Frame: Last visible extension or flexion of any of the left fingers as part of 
the last fist-open or fist-close of the series. 
- MDS-UPDRS Instruction Criteria: Subject has left forearm flexed, Subject's left palm is 
facing the Clinician, Subject makes a fist with left hand, Subject opens and closes left 
hand, Subject opens left hand as quickly as possible, Subject opens left hand as fully as 
possible, Subject performs 10 open/closes, Subject does not open/close right hand [If 
Subject does not open fist quickly/fully, Clinician reminds Subject to do so] 
- MDS-UPDRS Rating Criteria: Speed, Slowing, Amplitude, Decrementing Amplitude, 
Number/timing of Hesitations, Number/timing of Halts, Freezes 
 
Pronation and Supination, Right Hand – Subject flexes their right arm with fingers extended 
and with forearm extended and pronated; Subject then alternates between laterally rotating their 
right forearm until the palm is facing up (“supination”) and medially rotating their right forearm 
until the palm is facing down (“pronation”) in rapid succession.  
- Initiation Frame: First visible rotation of the right forearm as part of the first pronation or 
supination of the series. 
- Termination Frame: Last visible rotation of the right forearm as part of the last pronation 
or supination of the series. 
- MDS-UPDRS Instruction Criteria: Subject has right arm (and right forearm) extended in 




right palm up, Subject turns right palm down, Subject turns right palm up/down as fast as 
possible, Subject turns right palm up/down as fully as possible, Subject performs 10 
up/down palm turns, Subject does not turn left palm up/down 
- MDS-UPDRS Rating Criteria: Speed, Slowing, Amplitude, Decrementing Amplitude, 
Number/timing of Hesitations, Number/timing of Halts, Freezes 
 
Pronation and Supination, Left Hand – Subject flexes their left arm with fingers extended and 
with forearm extended and pronated; Subject then alternates between laterally rotating their left 
forearm until the palm is facing up (“supination”) and medially rotating their left forearm until 
the palm is facing down (“pronation”) in rapid succession.  
- Initiation Frame: First visible rotation of the left forearm as part of the first pronation or 
supination of the series. 
- Termination Frame: Last visible rotation of the left forearm as part of the last pronation 
or supination of the series. 
- MDS-UPDRS Instruction Criteria: Subject has left arm (and left forearm) extended in 
front of themselves, Subject begins with left palm facing downward, Subject turns their 
left palm up, Subject turns left palm down, Subject turns left palm up/down as fast as 
possible, Subject turns left palm up/down as fully as possible, Subject performs 10 
up/down palm turns, Subject does not turn right palm up/down 
- MDS-UPDRS Rating Criteria: Speed, Slowing, Amplitude, Decrementing Amplitude, 
Number/timing of Hesitations, Number/timing of Halts, Freezes 
 
Toe Tapping, Right Foot – Subject is Sitting with their right foot on the ground; Subject then 
lifts their right toes (dorsiflexion) and taps them back onto the ground (plantarflexion) in rapid 
succession. 
- Initiation Frame: First visible dorsiflexion of the right foot as part of the first toe tap of 
the series. 
- Termination Frame: Last visible plantar- or dorsiflexion of the right foot as part of the 
last toe tap of the series. 
- MDS-UPDRS Instruction Criteria: Subject is sitting, Subject is in a straight-backed chair 
with arms, Subject has both feet on the floor, Subject places right heel on the ground in a 
comfortable position, (Subject raises right toes off the ground), Subject taps right toes on 
the ground, Subject taps right toes as fast as possible, Subject taps right toes as big as 
possible, Subject taps right toes 10 times, Subject does not tap left toes 
- MDS-UPDRS Rating Criteria: Speed, Slowing, Amplitude, Decrementing Amplitude, 
Number/timing of Hesitations, Number/timing of Halts, Freezes 
 
Toe Tapping, Left Foot – Subject is Sitting with their left foot on the ground; Subject then lifts 
their left toes (dorsiflexion) and taps them back onto the ground (plantarflexion) in rapid succes-
sion. 
- Initiation Frame: First visible dorsiflexion of the left foot as part of the first toe tap of the 
series. 
- Termination Frame: Last visible plantar- or dorsiflexion of the left foot as part of the last 
toe tap of the series. 
- MDS-UPDRS Instruction Criteria: Subject is sitting, Subject is in a straight-backed chair 
with arms, Subject has both feet on the floor, Subject places left heel on the ground in a 




ground, Subject taps left toes as fast as possible, Subject taps left toes as big as possible, 
Subject taps left toes 10 times, Subject does not tap right toes 
- MDS-UPDRS Rating Criteria: Speed, Slowing, Amplitude, Decrementing Amplitude, 
Number/timing of Hesitations, Number/timing of Halts, Freezes 
 
Stomping, Right Foot – Subject is Sitting with their right foot on the ground; Subject then lifts 
their right foot off the ground and stomps it back onto the ground in rapid succession. 
- Initiation Frame: First visible movement directly related to lifting the right foot, including 
flexion of the right thigh, flexion of the right leg, movement of the right foot, or any other 
movement clearly connected to the preparation and/or execution of the first foot stomp of 
the series. 
- Termination Frame: Last visible movement of the right lower limb as part of the last foot 
stomp of the series. 
- MDS-UPDRS Instruction Criteria: Subject is sitting, Subject is in a straight-backed chair 
with arms, Subject has both feet comfortably on the floor, Subject places right foot on the 
ground in a comfortable position, Subject raises right foot off the ground, Subject stomps 
right foot on the ground, Subject stomps (raises) right foot as high as possible, Subject 
stomps right foot as fast as possible, Subject stomps right foot 10 times, Subject does not 
stomp left foot 
- MDS-UPDRS Rating Criteria: Speed, Slowing, Amplitude, Decrementing Amplitude, 
Number/timing of Hesitations, Number/timing of Halts, Freezes 
 
Stomping, Left Foot – Subject is Sitting with their left foot on the ground; Subject then lifts their 
left foot off the ground and stomps it back onto the ground in rapid succession. 
- Initiation Frame: First visible movement directly related to lifting the left foot, including 
flexion of the left thigh, flexion of the left leg, movement of the left foot, or any other 
movement clearly connected to the preparation and/or execution of the first foot stomp of 
the series. 
- Termination Frame: Last visible movement of the left lower limb as part of the last foot 
stomp of the series. 
- MDS-UPDRS Instruction Criteria: Subject is sitting, Subject is in a straight-backed chair 
with arms, Subject has both feet comfortably on the floor, Subject places left foot on the 
ground in a comfortable position, Subject raises left foot off the ground, Subject stomps 
left foot on the ground, Subject stomps (raises) left foot as high as possible, Subject 
stomps left foot as fast as possible, Subject stomps left foot 10 times, Subject does not 
stomp right foot 
- MDS-UPDRS Rating Criteria: Speed, Slowing, Amplitude, Decrementing Amplitude, 
Number/timing of Hesitations, Number/timing of Halts, Freezes 
 
Postural Tremor, Right and Left Hands – Subject flexes their arm with fingers extended and 
abducted and with forearm extended and pronated, then maintains this position. 
- Initiation Frame: First frame where Subject meets all criteria and is not intentionally 
moving their upper limb; this does not include unintentional motion (e.g. tremor, sway, 
shaking, etc.) or minor intentional movements performed to maintain this position (e.g. 
flexing the arm to compensate for drop, etc.). 
- Termination Frame: Last frame Subject meets all criteria, or the last frame before Subject 




- MDS-UPDRS Instruction Criteria: Subject has arm stretched in front of their body, Sub-
ject's arm is palm down, Subject's wrist is straight, Subject's fingers are comfortably sep-
arated without touching, Subject maintains behavior for 10 seconds 
- MDS-UPDRS Rating Criteria: Presence of Tremor (including Re-Emergent Rest 
Tremor), Amplitude of Tremor 
 
Kinetic Tremor, Right Hand – The Clinician stands in front of Subject with a single raised fin-
ger within Subject’s reaching distance; Subject then alternates between touching the Clinician’s 
finger and their own nose using a finger from their right hand. The Clinician may use an object 
instead of their finger. 
- Initiation Frame: First frame with visible movement of Subject’s right upper limb directly 
related to and continuous with the action of reaching to touch their nose or the Clinician’s 
finger. 
- Termination Frame: Last frame where Subject is touching their nose or the Clinician’s 
finger during the last nose-touch or finger-touch of the series. 
- MDS-UPDRS Instruction Criteria: Subject has right arm outstretched, Subject performs 
the finger-to-nose maneuver, [Subject touches Clinician's finger with their right finger], 
[Subject touches their nose with their right finger], Subject's right arm is as outstretched 
as possible when touching Clinician's finger, Subject performs finger-to-nose maneuver 
slowly enough to not hide tremor, Subject repeats finger-to-nose maneuver at least three 
times, Subject does not perform finger-to-nose maneuver with their left arm 
- MDS-UPDRS Rating Criteria: Presence of Tremor, Amplitude of Tremor 
 
Kinetic Tremor, Left Hand – The Clinician stands in front of Subject with a single raised finger 
within Subject’s reaching distance; Subject then alternates between touching the Clinician’s fin-
ger and their own nose using a finger from their left hand. The Clinician may use an object in-
stead of their finger. 
- Initiation Frame: First frame with visible movement of Subject’s left upper limb directly 
related to and continuous with the action of reaching to touch their nose or the Clinician’s 
finger. 
- Termination Frame: Last frame where Subject is touching their nose or the Clinician’s 
finger during the last nose-touch or finger-touch of the series. 
- MDS-UPDRS Instruction Criteria: Subject has left arm outstretched, Subject performs 
the finger-to-nose maneuver, [Subject touches Clinician's finger with their left finger], 
[Subject touches their nose with their left finger], Subject's left arm is as outstretched as 
possible when touching Clinician's finger, Subject performs finger-to-nose maneuver 
slowly enough to not hide tremor, Subject repeats finger-to-nose maneuver at least three 
times, Subject does not perform finger-to-nose maneuver with their right arm 





Sit-to-Stand – Subject starts Sitting and attempts to Stand in one continuous action. 
- Initiation Frame: Subject makes an intentional movement related to the Transition, in-
cluding extension of the legs, repositioning of the hands and/or feet, flexion or extension 
of the torso, extension of the hip, or any other movement clearly connected to the prepa-




- Termination Frame: Last frame before Subject meets criteria for a PGT behavior, or last 
visible movement continuous with the Transition, whichever occurs first. 
 
Stand-to-Sit – Subject starts Standing and attempts to Sit in one continuous action. 
- Initiation Frame: Subject makes an intentional movement related to the Transition, in-
cluding flexion of the legs, repositioning of the hands and/or feet, flexion of the torso, 
flexion of the hip, or any other movement clearly connected to the preparation and/or ex-
ecution of the Transition. 
- Termination Frame: Last frame before Subject meets criteria for a PGT behavior, or last 




Figure A.2: Frequency of errors of commission and errors of omission made by pairs of 





Chapter 4 Supplementary Information 
Table A.1: Number (%) of valid participant-days with less than 15% missing data* by H&Y Stage and by day of the week.**  
  Sunday Monday Tuesday Wednesday Thursday Friday Saturday All 
H&Y Stage 1/2 2 (100%) 0 (0%) 2 (100%) 2 (100%) 2 (100%) 2 (100%) 2 (100%) 12 (85.71%) 
H&Y Stage 2 6 (50%) 2 (16.67%) 10 (83.33%) 10 (83.33%) 11 (91.67%) 9 (75%) 7 (58.33%) 55 (65.48%) 
H&Y Stage 2/3 5 (83.33%) 0 (0%) 6 (100%) 6 (100%) 6 (100%) 5 (83.33%) 4 (66.67%) 32 (76.19%) 
H&Y Stage 3 4 (66.67%) 0 (0%) 4 (66.67%) 5 (83.33%) 5 (83.33%) 4 (66.67%) 3 (50%) 25 (59.52%) 
All 17 (65.38%) 2 (7.69%) 22 (84.62%) 23 (88.46%) 24 (92.31%) 20 (76.92%) 16 (61.54%) 124 (68.13%) 
*Participant-days with greater than 15% of the activity data missing were not modelled with cosinors. 








Table A.2: Cosinor parameters** of the final analytical cohort and their associations*** with baseline characteristics.  
    Age † BMI † MMSE † ESS † Levodopa † Sex ◊ Handedness ◊ 
MESOR 
95% CI [-2.43, -1.24] [-2.71, -1.05] [-5.52, -1.30] [-1.70, 0.26] [0.01, 0.03] [0.93, 098] [0.91, 0.97] 
Coefficient/Odds Ratio -1.83 -1.88 -3.41 -0.72 0.02 0.95 0.94 
p-value < 0.01* < 0.01* < 0.01* 0.15 < 0.01* < 0.01* < 0.01* 
Amplitude 
95% CI [-2.28, -1.14] [-2.48, -0.86] [-6.08, -2.15] [-1.89, -0.03] [0.01, 0.03] [0.92, 0.98] [0.91, 0.97] 
Coefficient/Odds Ratio -1.71 -1.67 -4.11 -0.96 0.02 0.95 0.94 
p-value < 0.01* < 0.01* < 0.01* 0.04* < 0.01* < 0.01* < 0.01* 
Acrophase 
95% CI [-1:48, 6:22] [-2:48, 8:03] [-29:04, -3:09] [-8:43, 2:59] [0:02, 0:09] -- -- 
Coefficient/Odds Ratio 2:17 2:37 -16:07 2:52 00:05   
p-value 0.27 0.34 0.02* 0.33 < 0.01*   
**Note that MESOR and Amplitude are reported in AC, and Acrophase in time (minute:second). 
***For all regressions, the sample analyzed contained both weeks had a total n = 124, and degrees of freedom of F(1, 122). Coefficients 
are reported as change in Cosinor Parameter per 1 MDS-UPDRS score.  
Abbreviations: AC (Activity Count), CI (Confidence Interval), MESOR (Midline Estimating Statistic Of Rhythm), MDS-UPDRS (Move-
ment Disorder Society’s Unified Parkinson’s Disease Rating Scale). * = p < 0.05 
† Simple Linear Regression, reporting coefficient 




Figure A.3: Flow chart of participant inclusion and assignment to sub-groups based on 
Hoehn and Yahr (H&Y) Stage. Participants were rated by clinicians during an in-lab visit 
following each week of in-home recording. The two in-lab visits were an average of 36.31 







Chapter 5 Supplementary Information 
Figure A.4: Predicted marginal means for rest-activity rhythm parameters (MESOR, Amplitude, and Acrophase) and sleep tim-
ings (Sleep Onset, Sleep Mid, and Sleep Offset) derived from the by-Chronotype across-Day one-way linear mixed model. 
[A.4A] Rest-activity rhythms visualized by-Chronotype across-Days using cosinor models. Shaded areas represents the range of the 








































































































































[A.4B] Sleep timings by-Chronotype, across-Days. Error bars represent +/- standard error. ** indicates between-Chronotype Wald 









Figure A.5: Predicted marginal means for rest-activity rhythm parameters (MESOR, Amplitude, and Acrophase) and sleep tim-
ings (Sleep Onset, Sleep Mid, and Sleep Offset) derived from the by-Day across-Chronotype one-way linear mixed model. 
[A.5A] Rest-activity rhythms visualized by-Day across-Chronotypes using cosinor models, both for individual days and for week-
ends/weekdays. Black squares denote the hour of peak activity (i.e. Acrophase). Monday, Tuesday, Wednesday, Thursday, and 
Friday were considered weekdays; Saturday and Sunday were considered weekends. Note that Tuesday/Thursday were included 






























Rest-Activity Rhythm Cosinors: Predicted Means By-Day (for individual Days), Across All Chronotypes








































[A.5B] Sleep timings by-Day, across-Chronotype. Error bars represent +/- standard error. Wald tests were conducted between 
individual Days and Sunday (reference day) for all sleep timings; ** indicates p-value < 0.05, * indicates p-value ≥ 0.05 and < 0.10. 
  
** ** ** **
** ** ** ** **






Table A.3: Number (%) of valid participant-days analyzed in this paper by day of the week, across weeks of the study, divided by 
Chronotype. Only participant-days with both a cosinor model and an overnight sleep period were considered valid. 
Evening Chrono-
type 
Saturday Sunday Monday Tuesday Wednesday Thursday Friday All Days 
Week 1 8 (53.33%) 8 (53.33%) 8 (53.33%) 8 (53.33%) 8 (53.33%) 7 (46.67%) 9 (60.00%) 56 (53.33%) 
Week 2 11 (73.33%) 8 (53.33%) 11 
(73.33%) 
10 (66.67%) 12 (80.00%) 13 (86.67%) 10 
(66.67%) 
75 (71.43%) 








(86.67%) 58 (96.67%) 




(86.67%) 14 (93.33%) 
15 
(100.00%) 13 (86.67%) 
12 
(80.00%) 97 (92.38%) 
Week 5 12 (80.00%) 8 (53.33%) 2 (13.33%) -- -- -- -- 22 (48.89%) 
All Weeks 46 (76.67%) 39 (65.00%) 34 
(56.67%) 






type Saturday Sunday Monday Tuesday Wednesday Thursday Friday All Days 
Week 1 6 (66.67%) 6 (66.67%) 6 (66.67%) 6 (66.67%) 6 (66.67%) 6 (66.67%) 6 (66.67%) 42 (66.67%) 
Week 2 6 (66.67%) 6 (66.67%) 5 (55.56%) 6 (66.67%) 8 (88.89%) 8 (88.89%) 8 (88.89%) 47 (74.60%) 















Week 4 7 (77.78%) 7 (77.78%) 
9 
(100.00%) 8 (88.89%) 
9 
(100.00%) 8 (88.89%) 8 (88.89%) 56 (88.89%) 


















Sleep Clinic: Participant-day includes time spent in the scheduled mid-study sleep clinic visit; these participant-days were excluded from 
all analyses due to the controlled nature of the sleep clinic’s environment. 




Table A.4: : Estimated variance components for each variable at each nested level in a two-
way (Chronotype x Day of the Week) Linear Mixed Model (LMM); components are pre-
sented as % of Total Variance for their respective variables. 
Variable Participant Study Week 
Day of the 
Week Residual Total 
MESOR 55% 4% 35% 6% 100% 
Amplitude 32% 3% 58% 6% 100% 
Acrophase 7% 0% 86% 7% 100% 
Sleep Onset 44% 6% 41% 8% 100% 
Sleep Mid 20% 15% 57% 8% 100% 
Sleep Offset 18% 23% 51% 9% 100% 
Time in Bed 26% 11% 54% 9% 100% 
Average Activity during 
Sleep 10% 24% 58% 9% 100% 
Peak Activity during Rest 36% 8% 47% 10% 100% 
Sleep Onset Latency 16% 10% 64% 10% 100% 
Sleep Offset Latency 8% 10% 70% 11% 100% 
Sleep Efficiency 16% 3% 69% 13% 100% 
Wake After Sleep Onset 29% 0% 54% 17% 100% 
Total Sleep Time 7% 8% 62% 23% 100% 
Percent Sleep Time 22% 5% 48% 24% 100% 
Fragmentation Index 19% 5% 37% 39% 100% 






Table A.5: Descriptive statistics of raw cosinor and sleep data for each Chronotype across Days of the Week, and the p-value of 
between-Chronotype t-tests. 
Variable 

























MESOR (AC) 46.50 (17.22) 0.0001 ** 
41.90 
(13.96) < 0.0001 ** 
44.72 
(16.18) < 0.0001 ** 0.0015 ** 0.0090 ** 
Amplitude (AC) 38.51 (18.20) < 0.0001 ** 
33.20 
(14.47) < 0.0001 ** 
36.46 
(17.04) < 0.0001 ** 0.0005 ** 0.0040 ** 
Acrophase (Time) 16:46 (2:03) 0.8230 15:41 (2:02) 0.0082 ** 16:21 (2:06) 0.0915 * 0.8774 < 0.0001 ** 
Sleep Onset (Time) 01:22 (1:39) 0.0001 ** 00:03 (1:31) 0.4431 00:48 (1:43) 0.1682 0.1821 < 0.0001 ** 
Sleep Mid (Time) 04:59 (1:38) 0.8102 03:46 (1:17) 0.1354 04:27 (1:36) 0.0150 ** 0.0001 ** < 0.0001 ** 
Sleep Offset (Time) 08:37 (1:58) 0.1251 07:28 (1:26) 0.0306 ** 08:07 (1:51) 0.0001 ** < 0.0001 ** < 0.0001 ** 
Time in Bed (Hours) 7.25 (1.61) < 0.0001 ** 7.42 (1.50) 0.0128 ** 7.32 (1.56) < 0.0001 ** 0.2420 0.0867 * 
Average Activity 
during Sleep (AC 
per Minute) 
12.51 
(11.05) < 0.0001 ** 12.07 (7.39) < 0.0001 ** 12.31 (9.62) < 0.0001 ** < 0.0001 ** 0.1230 
Peak Activity during 
Rest (AC per 15 sec-
onds) 
277.31 
(150.84) < 0.0001 ** 
269.43 
(116.33) < 0.0001 ** 
273.87 
(136.81) < 0.0001 ** < 0.0001 ** 0.9420 
Sleep Onset Latency 
(Minutes) 
41.83 
(59.86) < 0.0001 ** 
36.25 
(57.25) < 0.0001 ** 
39.40 
(58.75) < 0.0001 ** 0.4710 0.2545 
Sleep Offset Latency 
(Minutes) 
30.59 
(36.91) < 0.0001 ** 
32.68 
(44.41) < 0.0001 ** 
31.50 
(40.33) < 0.0001 ** 0.0023 ** 0.7160 
Sleep Efficiency (%) 76.77 (10.79) 0.0001 ** 
77.16 
(10.80) < 0.0001 ** 
76.94 
(10.78) < 0.0001 ** 0.9802 0.3747 
Wake After Sleep 
Onset (Hours) 0.84 (0.52) < 0.0001 ** 0.89 (0.48) < 0.0001 ** 0.86 (0.50) < 0.0001 ** 0.3024 0.1196 
Total Sleep Time 





Percent Sleep Time 
(%) 88.55 (6.15) < 0.0001 ** 88.13 (5.53) < 0.0001 ** 88.37 (5.89) < 0.0001 ** 0.0869 * 0.2440 
Fragmentation Index 
(%) 10.35 (5.51) 0.0001 ** 11.14 (4.62) < 0.0001 ** 10.70 (5.15) < 0.0001 ** 0.0044 ** 0.0070 ** 
* p-value 0.05 < 0.10 





Table A.6: Predicted marginal means and Wald test p-values derived from one-way LMMs. 
[A.6A] Predicted marginal means (standard error) for each Chronotype across all Days of the Week derived from the by-Chrono-





Marginal Mean (Standard Error) 
MESOR (AC) 46.47 (3.38) 43.05 (4.45) 0.5609 
Amplitude (AC) 37.30 (2.76) 35.69 (3.63) 0.7368 
Acrophase (Time) 16:35 (0:12) 15:50 (0:16) 0.0329 ** 
Sleep Onset (Time) 01:09 (0:12) 00:10 (0:16) 0.0062 ** 
Sleep Mid (Time) 04:46 (0:11) 03:57 (0:14) 0.0084 ** 
Sleep Offset (Time) 08:24 (0:11) 07:44 (0:14) 0.0370 ** 
Time in Bed (Hours) 7.26 (0.15) 7.57 (0.20) 0.2455 
Average Activity during Sleep (AC per Minute) 13.59 (1.42) 11.16 (1.86) 0.3250 
Peak Activity during Rest (AC per 15 seconds) 291.21 (25.07) 270.30 (33.00) 0.6323 
Sleep Onset Latency (Minutes) 39.40 (7.26) 38.82 (9.53) 0.9635 
Sleep Offset Latency (Minutes) 30.31 (3.67) 34.61 (4.79) 0.5032 
Sleep Efficiency (%) 76.74 (1.32) 77.57 (1.74) 0.7186 
Wake After Sleep Onset (Hours) 0.88 (0.07) 0.87 (0.09) 0.8916 
Total Sleep Time (Hours) 6.38 (0.17) 6.71 (0.22) 0.2502 
Percent Sleep Time (%) 88.01 (1.00) 88.51 (1.31) 0.7750 






[A.6B] Predicted marginal means (standard error) for each Day of the Week across all Chronotypes derived from the by-Day 
across-Chronotype one-way linear mixed model, the p-values of between-Day across-Chronotype Wald tests (each individual Day 
was compared to Sunday, the designated reference Day), and the p-values of the joint Wald tests. 
	
Variable Monday Tuesday 
Wednes-
day 






















































0.0001 ** 0.0013 ** 0.0008 ** 0.0029 ** 0.0110 ** 0.4405 Base 

















** 0.0001 ** 0.0003 ** 
< 0.0001 
** 
0.0006 ** 0.0848 * 0.8117 Base 


























0.0001 ** 0.6775 Base 





















































Variable Monday Tuesday 
Wednes-
day 
Thursday Friday Saturday Sunday Joint 
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